Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Has anyone got any faith in this stock eventually turning around and realising all the potential that is promised....

You would thought that ETQ with its UVGI unit, it should be already selling a large number of filters worlwide.



The Nightingale UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications. The UVGI filter had, prior to ETQ's anouncement in Nov02,a prototype tested at the Defence Science Technology Laboratory ('Dstl') at Porton Down, the centre for excellence for the Ministry of Defence, which 99.9% certified that the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis spores, a simulant for Anthrax bacteria.

Why, when considering the facts regarding 1)the MRSA super bug (amongst others like Legionaires) in NH Trust Hospitals (Southampton & Bournemouth amoungst many other UK cities)over the past year or so, 2) the problems with SARS Virus mainly in the far east but spreading quickly worldwide with aircraft travelers, 3) biological terrorist threats in the USA and UK and latest 4) the recent news regarding P&O's cruise liner Orianna (now in Southampton Docks)that this companies share price has not rocketed.

There should be at least one in every UK hospital by now as the UK governments Dstl at Porton Down certified it 99.9% OK.

As I understand it, ETQ will have a Nightingale UGVI filter in an NH Hospital next month. Haven't heard if it is yet being tested for gaining UL approval for entry of the product into USA market. Surely ETQ ought to have at least one tested on a passenger aircraft.

I think I'll give them a call tommorrow and try to find out what they are up to.

Price & volume up today so far by 5.7%

Legins looks like the recovery may be here at last ! I can remember when this beauty was 30p+

We have had constant selling so would expect a fairly strong rise if this buying spree continues.

Legins just been catching up.Take a look at this extract from the last figures released.I think I will add further tomorrow;

RNS Number:0121N
Energy Technique PLC
01 July 2003




Energy Technique Plc

Preliminary Announcement 2003

Chairman's Statement

Overview

In my first Chairman's Statement since my appointment in January 2003, I am
pleased to report the year ended 31 March 2003 has been a successful period for
the group:

- Profit before tax of #0.263 million compared with last year's loss of
#0.635 million.

- Balance sheet gearing has been further reduced to 78% from 118% at the
previous year-end.

- Diffusion Refrigeration and Distribution was formed as a distributor of
branded Panasonic and LG Electronics packaged air conditioning systems,
expanding the Group's market opportunity from #50 million to #500 million.

- The innovative new Nightingale UVGI air filtration product is nearing
commercial launch and has just won the coveted "Air Movement Product of the
year" at the HVAC industry's H & V News Awards 2003.

Group financial performance

Sales of #11.7 million remained at the same level as last year, but operating
profit improved by 37% to #0.369 million.

The Board is very pleased with this result, because the reported operating
profit is stated after charging to profits #0.417 million on research and
development, including in particular the new Nightingale air filtration product,
and #0.258 million start-up operating losses on Diffusion Refrigeration and
Distribution.

Profit before tax is #0.263 million, compared with last year's loss of #0.635
million, which included a loss on the disposal of Benson Heating. Profit before
tax on continuing activities improved by 18%.

Group cash flow

The Group generated a strong cash inflow from operating activities of #0.487
million, resulting in a further reduction in debt to #0.947 million at 31 March
2003, representing a gearing level of 78%. Interest paid was covered 3.5 times
by operating profit.

Working capital continued to be tightly controlled and has remained
substantially unchanged, notwithstanding a planned stock build of #0.285 million
to service the new Panasonic and LG Electronics distribution business.

Capital expenditure on plant, infrastructure, and computer systems amounted to
#0.2 million. This was the first year of a continuing capital expenditure
programme, which has started to redress the many years of under-investment
caused when the Group funded loss-making activities now disposed of.

Dividends

The Board does not recommend payment of a dividend.


Operations

ET Environmental experienced historically high levels of demand for its fan coil
and commercial heating products in the first nine months of the year, but the
air conditioning market took a sudden downturn in January, following the
deferral of certain property developments. This resulted in much lower sales in
the final quarter of the year, and regrettably in May 2003, 25 redundancies were
announced to adjust the cost base down to ongoing expected sales levels.

The formation of Diffusion Refrigeration and Distribution represents the first
steps in broadening the Group's product range with complementary packaged air
conditioning systems. The newly introduced Lifebreath air filtration and
Airtrade acoustics products build on this strategy. This new subsidiary
incurred start-up operating losses of #0.258 million in its first eight months
of trading.


New UVGI air filtration product

In November 2002, the Company was pleased to announce its exciting new
Nightingale UVGI air filtration product, to be produced by a new joint-venture
company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited.
This rapid response mobile air filtration unit is capable of killing the MRSA
super bug and other airborne pathogens.

The Nightingale UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ("UVGI")
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ("Dstl") at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Directors

The Board is saddened to report the ill health of Steve McNeice, the Group
Finance Director and Company Secretary. The Board wishes Steve a speedy
recovery.

Geoffrey Dart stepped down as Chairman and from the Board on 28 January 2003.
Paul Barham resigned from the Board on 18 March 2003. I would like to thank
them both for their contribution to the restructuring of Energy Technique plc
over the past two years.

Gerard Thompson was appointed to the Board on 26 March 2003 as a non-executive
director. He brings significant experience to the Board in finance and
technology development.

Robert Unsworth was re-appointed to the Board on 1 July 2003 as an executive
director, responsible for finance and company secretarial matters during Steve
McNeice's absence.


Management and employees

On behalf of the Board, I would like to thank all employees for their continued
hard work, dedication and commitment during the year, and particularly during
the current testing market conditions.


Current trading and prospects

The Group incurred a loss in April and May due to redundancy costs incurred in
May and to very low sales levels, particularly in April. The low sales were
attributed to significantly reduced market demand facing the air conditioning
sector. However, sales in May recovered and this has continued into June. The
current order book, enquiry levels and outlook are now much more encouraging
than in the early part of 2003 and the Board remains optimistic about the
Group's prospects.

Since November the Board has explored many potential opportunities for marketing
and further developing the exciting new Nightingale UVGI air filtration unit,
and a number of these are turning into potential business opportunities. The
UVGI product has the potential for improving the Group's financial performance,
and the Board is exploring opportunities for raising the capital necessary to
fully exploit the potential of the UVGI product. The Board expects to make
further announcements updating shareholders on this and other UVGI developments
in due course.



Graham R Mackenzie
Chairman

Last few avaialble at 9.5p ;-)

Good buying today. Maybe a buy order being filled at this level which is holding the price back !!

We should have figures this week or very soon. Any news on the Nightingale unit will certainly have a marked impact on the share price !

On news I have seen ETQ rise by over a 100% !!

DYOR but don't be left out of this oversold beauty ;-)

LOL !

3 on the bid 1 on the offer. Next move very soon ;-)

LOL !

anyone knows the result date? thanks.

Was the 19/11 last year.

Good day.One of the only BLUE stocks on my monitor.Some good buying at the end and with 3 vs 1 on L2 I would expect to see a quick move up tomorrow.

Another good day. Don;t expect to hold that 10.5p offer for much longer !

I have recently done some legwork and managed to speak at length to the senior management who work for the company on the UVGI division. Here is the latest info I’ve gleaned from ETQ.

Energy Technique already have their new stand alone Nightingale UGVI air conditioning & filtering units in production and available to ship customer orders with delivery in just two weeks.

Most existing air conditioning units in office blocks and public buildings have the air inlet and outlet exhaust grills at ceiling level so do not efficiently exchange the air at floor to desk zone (the lower half of a room). It is at this zone that a very large percentage of the population congregates to work, study, wait or socialise and breath in contagious viruses and germs in the atmosphere. One of the biggest causes of the loss in productivity and profits for industry & commerce is sick leave for the common cold, flu, or other strains of virulent chest infections.

The circle of cross infection with bronchial viruses doesn’t care where it starts but infections most often start with your children who are more prone to respiratory & chest infections and pick them up in the classroom, they take the infection home and give it to their parents who in turn, take it into the office and infect their colleagues who in turn, take it home and infect their children. And so it goes on, ad-infinitum.

ETQ says their Free-Standing Nightingale UGVI Unit, is the ultimate weapon for industry and commerce to significantly reduce the absenteeism in companies’ workforces from these illnesses. The unit has been specifically designed to remove any air that can become contagious with air-born cold & flu viruses from the workplace & frequented public indoor spaces where people congregate. The UGVI units extract air from the floor zone and returns clean decontaminated air to desk & standing height zones where cross infection amongst a workforce would otherwise most likely take place.

With two different sized free-standing “Plug and Play” models now in production and available for delivery, it is now at no better time of the annual season for industry & commerce to buy these units for their workplaces, its late autumn, winter and early spring when they are in most need to prevent cross infection off their staff. National and Local Government Departments and Authorities ought to be the first buyers of the UGVI filtered units for schools, hospitals and other public buildings. ETQ are putting their sales and marketing efforts into winning the orders that eventually will come through as it’s the waiting game for committees and budgets to be approved.

However, ETQ’s Nightingale UVGI division are placing their priorities in their marketing efforts to sell the USP’s of ‘Plug & Play’ UVGI units to Industry and Commerce which they see will have immediate benefits to health & safety in workplaces. In the short term this is the market where they see their first orders will shortly be announced. The units should help UK Industry and Commerce to reduce employee sick leave and save ?Millions p.a. from losses in productivity.

In the medium term, ETQ believe that once the success of the use of the Nightingale UVGI units by Industry and Commerce in the workplace is proven that it significantly reduces the number of productivity hours lost through staff illness and absenteeism from these illnesses then, National & Local Governments would soon follow and buy the units for schools & colleges to protect school children & working families and break the circle of being cross infected.

In the long term, ETQ expect that the UVGI filters will be used in all public bus, coach and rail carriages, passenger ships & aircraft and perhaps eventually could almost eradicate cross infection of air-born viruses and germs. This cross-infection is something that is currently common place in society.

In my view the Nightingale will be a huge sucess for ETQ

http://www.uvgi.co.uk

What a Bullish chart



Good work Leggins.Can you please copy that onto ADVFN ?

Wow!

If that doesnt sound positive I don't know what does.....maybe a little optomistic on the world domination of air filtering..or not? If you don't mind i'll copy and paste it over on ample with credit where it is definately due..well done, thanks, we all knew we were holding on for something and once we see those order announcements then the rise will really start.

GN

See investors are still like Lemmings.Why did the price hold so well today ? A bargain at 11p.

late night Post by Legins on BB of ECK ( in error)


As perhaps you may know, ETQ's management want to get the Nightingale out in the market and being used as quickly as possible. Hence the reason they focused on the two stand-alone portable models first.

The cost of upgrading an existing air conditioning system in large buildings e.g. hospitals etc., would mean an extremely long lead-in time for the budgets for these types of contracts to be approved. This is because it is not just a simple matter of adding the filters to the air conditioning ductwork system but also to lower the position of the air extraction inlet and sanitised air outlet grills from ceilings to extracting air from floor level and deliver sanitised air at desk / standing zone of a room. Therefore, it would be sometime before sales for UVGI filters in existing air-conditioned systems for public, commercial & industrial buildings would show to build-up. New buildings in the future may well be designed to incorporate the Nightingale UVGI filters in new air conditioning systems but this will not happen overnight.

In the mean time, the stand-alone portable Nightingale UVGI filters are an immediately effective air sanitation unit that can work alongside air conditioning systems or on their own. These units give ETQ & UVGI a much faster route into the market and show its products effectiveness. The unit which will be on trial with NHS sometime next month will mean that relative quickly they will not just be accredited by Porton Down 'Dstl' but also by the U.K. public health authorities.

UVGI believe that the first companies to buy & make use of the filters is the Food Processing and Co's in industry, Insurance Co's in commerce & Passenger Cruise Lines Co's in Travel/Leisure industry.

I would have thought that it is near to the time UL labs in USA will have completed tests and accredited with approvals for entering that market. Certainly I think the City has some knowledge and confidence in this coming to fruition and news of this could be any time but are waiting for this to come out before the share price will begin to head north.

OK,

The next thing to find out is

What is the price of their product & what rival products are available or available soon & at what price?

Product Info

http://www.energytechniqueplc.co.uk/admin/upload/files/pdf/brochure3.pdf

ETQ has been mentioned in the Lancet...if it gets into the national press ETQ will fly.

Whats the Lancet?

Lancet is a Top Medical Mag

It is a scientific magazine.

The article recommends that all offices fit UVGI systems to help cut down absenteism due to illness.

apple

You are correct.

Don't get over excited about ETQ.

They have got a good method of killing bugs BUT it looks like they are already on Plan B for making money out of it.

Difficult to get customers to change their existing air conditioning for something new & that is where the big profits are likely to come from.

So quite a good Plan B is to sell a floor standing unit for which there may be a market IF the price is right

& then this will build a reputation for the technology & help them to sell big air conditioning systems with this technology.

What we need to know now is what is the price of the floor standing unit?

BUT this is not really available yet as far as I can tell & is only at the customer evaluation stage NOT in full production.

How far away is full production.

Small company, hardly traded, WIDE SPREAD on share price. How risky is it?

I wondered if Doctors would buy it for their waiting rooms.

Personally, I'm fed up with catching other people's bugs in the waiting room.

So I wondered if the price would be attractive for them to buy it.

1st, it is leased, not sold.
5 Year Lease.

Unfortunately, the Lease is 2000/Year

PLUS

4000/Year Maintainence

Sooooo, I doubt that many of them are going to rush to sign up.

IMHO, this business could build up steadily BUT the SPREAD is rather offputting.

So what do the rest of you think?

Down 2.5%

If it drops a lot more then maybe I might buy.

From todays Independent refering to published report in the Lancet. I think this may be the beginning of the real newsflow that gets the interest back in ETQ

Ultraviolet light in ventilation system cures sick-building syndrome, study claims
By Maxine Frith, Social Affairs Correspondent

28 November 2003

Millions of people who suffer from sick building syndrome could be cured if ultraviolet lights were installed in office ventilation systems, according to a new study.

The lights kill the germs in the environment that cause people to develop ailments at work.

So-called sick building syndrome (SBS) is caused by the increasing use of air conditioning in modern offices. Bacteria can build up in the ventilation systems and leave office workers suffering from a range of problems, such as breathing difficulties, headaches, sore throats, stuffy noses and itchy eyes.

SBS was first recognised in 1982 and is estimated to affect 80 per cent of people who work in air-conditioned offices.

The study into ultraviolet lights was published in the medical journal The Lancet today.

Researchers from the Montreal Chest Institute in Canada tested three offices in the city where people suffered from SBS. They installed UVGI (ultraviolet germicidal irradiation) in the ventilation systems of the buildings and compared reports of illness when the lights were turned on with sickness rates when they were off.

The lights resulted in a 20 per cent reduction in all symptoms. There were 40 per cent fewer complaints about respiratory problems and a 30 per cent reduction in people complaining of stuffy noses. Muscular complaints also halved, according to the study.

Scientists said the UVGI killed the bacteria and molds in ventilation systems. Installing the systems would be relatively cheap and could save companies millions by reducing rates of sickness.

Dick Menzies, the lead researcher, said: "Installation of UVGI in most North American offices could resolve work-related symptoms in about four million employees caused by microbial contamination of heating, ventilation and air-conditioning systems.

"The cost of UVGI installation could, in the long run, prove cost effective compared with the yearly losses from absence because of building related illness." Around 70 per cent of people in the West now work in air-conditioned offices, and SBS is estimated to cost companies millions of pounds a year in reduced productivity and sick days.

Some good posts. Regarding the spread isn't it funny that they will actually pay 10p to buy your shares still !!

Looks like they want some cheap stock !!

The facts which the Lancet & Independent have reported on, is just the sort of publicity that UVGI technology needs. The more pubblicity there is, the better public awareness is of UVGI and ETQ's Nightingale filters.

Also the greater the force HSE Authorities will be required to test air-conditioning plant in Office blocks, Hospitals, Doctor Surgeries, Schools, Hotels, Restaurants, Theatres etc. for bacteria and viruses and enforce the upgrade of adding UVGI filters.

ETQ's portable floor standing Nightingale UVGI filters may be the best cost effective solution, as the regular maintenance for UVGI filters is the accessibility to change the UV Bulbs and filtration meshes. Most existing air-conditioning plant & ductwork is above ceilings so regular maintenance could prove to be inaccessible and/or disruptive whenever they need to change a UV light bulb.

There are a very large number office and public buildings that do not have air-conditioning plant but never-the-less people who work, study or are a visitor to any of these buildings are at risk of contracting air-borne virus and bacterial infections from cross-infection with close contact whenever in a group of people. E.G. Doctors Surgery or School class room. ETQ is soon to be launching the smaller model they have developed for their floor standing Nightingale UVGI unit range and ideal to sanitise the air in smaller public areas where there is a high risk of cross-contamination in people with common viruses and baterial infections. The cost of these units should be far more acceptable to smaller businesses particularly when the volume in orders and ecconomies in scale of production come in.

ETQ have had the foresight to design products for a huge market demand that will come as public, industry and commerce awareness of their UVGI filters pick up.

Agree fully with the above comment.We are looking at a company with the product to fullfill the above requirements and as soon as the market see's this potential we will see a marked improvement in ETQ's share price.

Posted by Fair Dinkum on Ample

The Government is set to take action on the antibiotic-resistant "superbugs" which kill 5,000 hospital patients every year.

Health Secretary John Reid is backing proposals from the Chief Medical Officer to revolutionise the way potential infections are handled in hospitals and other health providers.


Chief Medical Officer for England Sir Liam Donaldson is also set to announce the latest rates of MRSA infections across individual NHS trusts.

He plans a radical shake-up of almost every aspect of the ways hospitals work, with every member of staff having to make preventing infection a priority.

Rise in deaths

The moves will include establishing dedicated Infection Control Teams, new rules on handwashing and disinfection and curbs on procedures which can cause infection.

Earlier this year Sir Liam announced a 12m drive to tackle hospital-acquired infections, which can lead to patients having to have limbs amputated and in some cases death.

Figures for the first half of last year showed that 3,500 people in England were struck down with MRSA - methicillin-resistant staphylococcus aureus.

There has also been a steep rise in "superbug" deaths in the past decade.

It is believed that the over-prescription of antibiotics in recent years has played a part in the development of infections such as MRSA.

Priority

The bug normally enters the wounds of patients in hospitals weakened by disease or injury and is especially dangerous after surgery.

It is estimated that 100,000 people a year pick up some form of infection while in hospital and the cost of the problem is estimated at around 1bn a year.

John Reid said: "Preventing as many hospital-acquired infections as possible is a top priority. That's why action is being taken now, across the NHS, to fight them.

"The greatest concern is, of course, the illness and death that result from these infections, but the economic costs are also high, and provide a compelling reason to reduce the number and severity of these infections."

Morning Dinkum,

I have just seen this mentioned on the morning news, yesterdys New Scientist also reported on the American (Canadian?) research into office infecctions and use of UV systems - does anyone know if this was using ETQ equipment or some other version which I think was discussed some time ago on this board.

Also many months ago there was a discussion here on the effectiveness of UVGI on MRSA. The initial reports seem to suggest teams telling staff how to wash their hands, no mention of equipment installation but surely this will arise as a solution.

Lets hope this mornings initial rise continues as more news continues to flow. We have seen this all over the news this last few weeks, what we need is some news from the company with regard to their involvment in all of this.


GN

Ultraviolet light can cure 'sick buildings'
14:27 28 November 03 NewScientist.com news service

Zapping bugs which flourish in office ventilation systems with ultraviolet radiation could cut the sickness suffered by millions of office workers, suggests a new study.

"Sick building syndrome", recognised as a medical condition in the 1980s, results in symptoms such as a stuffy nose, itchy eyes and throat and respiratory problems like asthma. The symptoms are especially common in people who work in air-conditioned offices, where heavy growth of bacteria and fungi is common within the ventilation systems.

Dick Menzies at McGill University in Montreal, Canada, and colleagues found that by installing UV germicidal irradiation (UVGI) lamps in the air-conditioning systems of three office blocks they could cut all such symptoms by 20 per cent.

"Installation of UVGI in most North American offices could resolve work-related symptoms in about four million employees," he says.

"A lot of people think sick-building syndrome is all in people's heads," Menzies told the Toronto Star newspaper. "The fact that you can install UV lights and a susceptible subgroup get biologically plausible improvements tells me that at least some of the problem is clearly not in their head."


Survival time

The team had UVGI lamps installed in the cooling coils and drip pans of the ventilation systems of three office blocks in Montreal. Resistant bugs sitting on the surfaces were predicted to have a survival time of less than four minutes.

The lamps were switched off for the first 12 weeks of the study, while 771 office workers were quizzed on the specific symptoms they suffered. The lamps were then switched on for four weeks, and off again for 12. In total, three on/off cycles were tested over 48 weeks.

In workers reporting symptoms, switching on the UVGI lamps resulted in a 20 per cent overall reduction. It also slashed respiratory symptoms by 40 per cent, and mucosal symptoms by 30 per cent.

These effects were greatest in people with known allergies and in workers who had never smoked. Muscular complaints were halved in people who never smoked.


Microbes and endotoxins

The team says the UVGI lamps resulted in a 99 per cent cut in the concentrations of microbes and of endotoxins - poisons in the cell walls of certain bacteria. Endotoxins have been associated with flu-like symptoms.

As 70 per cent of employees in North America and Western Europe now work in offices, the researchers suggest that installing UVGI may be a cost-effective way of reducing employee absence due to sick building syndrome.

More on this story

Subscribe to New Scientist for more news and features


Related Stories

Ionising air conditioners 'zap flu'
11 September 2002

Biocidal gas could kill anthrax in infected buildings
30 October 2001

Call centre early warning system for stressed staff
6 September 2001


For more related stories
search the print edition Archive



Weblinks

Dick Menzies, McGill University

Sick building syndrome, US Environmental Protection Agency

The Lancet



Other methods of cleaning office ventilators are being developed, including ones that use filters or ionisation to stop the microbes reaching workers.

However, Roy Anderson, an infectious diseases expert at Imperial College in London, UK, cautions that disinfecting ventilation systems alone is unlikely to stop outbreaks of all contagious respiratory diseases.

"You've got multiple methods of transmission and for control, you need to address all of them," he told Associated Press.

Journal reference: The Lancet: (vol 362, p 1785)

Hmmmmmmm,

I still can't see any reason why sales could take off rapidly.

As I said before, it is leased, not sold.
5 Year Lease.

Unfortunately, the Lease is 2000/Year

PLUS

4000/Year Maintainence

So who wants to pay 30,000 over 5 years just to protect 1 room?

Not many people, I would think.

So sales will only build up slowly until they manage to cut the costs of the product by developing a MUCH cheaper version.

That could take some years I suppose.

Anyway, I'm not sure that they would have the ability to rapidly increase production even if the demand was there.

This product is helpful to them to persuade people to buy their big air conditioning systems & have this technology included.

Apparently this technology can't be fitted to existing systems.

That would make a difference.

The rest of their business seems rather unexciting & the UVGI is still being evaluated by potential customers.

At the moment, the rest of their business is the business.

This is such an important application for a product BUT the price just seems too high at 6000/year.

I wanted to invest in ETQ but I was disappointed when I found out some of these facts.

Where did you get this information from ? What product are you reffering too ?

Just found a site advertising the "Nightingale"

www.uvgi.com.hk/

click "products" and scroll down.

Interesting !

Apple,

Those lease costs are going to severely hinder this, if they are correct!

30,000 to protect 1 room for 5 years seems somewhat OTT!

I can't see any great future if those costs are correct.
Are you sure?

I phoned them & asked about the costs.

DYOR, I did.

It seems that you were surprised by the costs even though I mentioned them in message 29.

If the share suddenly goes up a bit then it will just be hype, it will come down again when people realise this.

18% Spread on this share so it has got to go up a lot just for you to break even.

Product Info
http://www.energytechniqueplc.co.uk/admin/upload/files/pdf/brochure3.pdf

Apple I think you are wrong and have also contacted them ! If this is the new Nightingale unit how could you get a price for a unit that has not undergone field trials and is not commercially available ?

I am not sure what line of work peope are in, I myself am an Architect, and although I can see that 30,000 sounds alot of money, if you have any knowledge of the cost of 'ordinary' air handling equipment you will see that 6000 a year may not sound too bad. The issue is not about 1 room but rather the rate and volume of air filtration. The fact that the unit is portable is also significant. As with all new technology initial prices are high until supply is ramped up once demand can be accuratley assessed.

Clearly the price is sensitive dependant on who is the purchaser, governments, health services will tend to be cornered into paying for items due to public demands for the benefits and particularly in the US where the fear of litigation is primary - sue the hospital for $500 million because they didnt have sufficient protection with an available system and i got sick....'

The site above seems to have a number of uvgi systems, no clear mention of manufacturers in my brief look, how unique is the etq/suvair product?

We are all awaiting clear information from the company to give a clear perspective of prospects for the company..and the share price....lets see....

GN

thanks for the link apple, just read through the brochure.....interesting

moneyman,

I phoned them & they gave me the mobile number of the salesman, his name is Joe Tufo.

He gave me those figures for the Nightingale.

If you phone the sales number, they don't give you prices on this yet but will pass you on to Joe Tufo who deals with it.

BTW, he didn't use words such as "approximately" or "about"
he said that the costs were 6000/year.

Soooooooo, how can I be wrong about the cost?

Phone him yourself!

Don't bother with email, use the phone!

apple how can he quote you when the unit has not passed field trials and is not available !! Does not make sense i think you would agree ?

moneyman,

Big Customers like the NHS are evaluating it so it is available.

They have also got some others that are not being evaluated & can be delivered in 2 weeks. Joe Tufo of ETQ said 2 weeks.

Are they available in quantity?

I doubt if they would answer that question.
I doubt if they are, this is the beginning of production.

Anyway, at 6000/Year, I suggest that the demand for large quantities won't be there.

IMHO, the real purpose of this product is to get the technology known & evaluated in the NHS & other large customers as a way in to selling large air conditioning systems with the UVGI technology.

The large systems are where the real money is BUT this is going to take TIME.

So this is going to be a Long Term Investment & of course, like any other, it may not succeed.


The rest of their business is not UVGI & seems rather unexciting.
Don't forget, at the moment, the rest of their business is the business.


It seems that you still don't believe me about the price.
Why bother arguing with me, just pick up the phone & ask ETQ.

jonathen - 21 Jan'04 - 20:46 - 679 of 679


Received an e-mail today from Joe Tufo, timed at 17.04, it reads...

Dear A

As prevoiusly explained, the situation with the Nightingale is potentially price sensitive. I can confirm that the first units have now been supplied to the Hospital and have been well recieved. Further releases will be issued and authorised by the chairman at a point in the next couple of months.

I trust this will provide sufficient information, thank you for your interest.



Regards


Joseph Tufo
Managing Director UVGI Systems LTD


That is the message word for word....it states that units have been well recieved....and IMO he has confirmed that an RNS or news on their web site will be issued if and when appropriate within the next two months, this is earlier than I expected.

This has boosted my confidence somewhat.


Cheers

Has anyone found out which NHS hospital the Nightingale units are in? This could be fantastic if the RNS is released in the next two months with initial results from trials showing that the UVGI air sanitation units are eliminating MRSA and other viruses or bacteria from killing and disabling patients and visitors.

Once this news is out to this effect it will hit the National Press & TV. Whats more, if any other hospital in the world reports an MRSA or SARS outbreak in one of their patients or visitors, knowing that this technology is available and would have prevented any infection had it been used, then their legal cost would far outwiegh the cost of a lease and maintenance contract.

There was a report on Central News tonight about the New Birmingham hospital due in 2008. It claimed the hospital would boast a brand new air circulation system the would help to combat airbourne viruses. There can't be too many options for a contract of that size, and the NHS are testing the units at Basingstoke at the moment.

Regards, Rocky

New Birmingham hospital - has to be ETQ's UVGI technology - must be the RNS we are expecting within the next two months.

Legins, the interesting thing about the Birmingham Hospital Central News item yesterday, was the fact that they showed a picture of a new ward with the air treatment system apparently in place (this was when they mentioned that the system was designed to reduce hospital infections.) The question is, was that a mock up of what the ward will look like, or the system already in place in an existing new ward in another hospital? Anyway nice to see the pick up in price today?

Regards, Rocky

http://www.e4engineering.com/item.asp?id=50941&type=News&pub=eng

Confident rumour on rival board that a 4,000,000 placing with institutions has taken place.

If that is correct the institutions must very confident in the future of ETQ.


cheers

Global Nomad Thursday 10:36
Subject: Info from the web Opinion Weak BUY Recommendations This message has been recommended once Message

Some further information on the trials / commercialisation that I found today whilst trying to dig out some info......


News

From The Engineer, 12 January 2004, in Home

On the Web

Medical
Health & Safety
Warding off airborne germs
A UK hospital is to test ultraviolet air-cleansing technology following a deal between the NHS and the Surrey company that developed the system and is now attempting to commercialise it.
Energy Technique said the unnamed hospital would fit two filtration units equipped with the technology, called UVGI, in its A& E department.
UVGI uses a combination of advanced filtration and UV light to eradicate hard-to-kill airborne microbes such as the MRSA 'superbug' - currently the cause of much concern in the NHS.
The same hospital is expected to begin trials of two further units - branded Nightingale for sale into the healthcare system - in its isolation ward next autumn.
The pilot installation is an important step toward establishing the technology in the NHS, a task that Energy Technique admitted was 'proving far more difficult and protracted than anticipated'.
The company spent 2003 developing Nightingale, adding more powerful UV lamps and functions such as remote monitoring via GSM wireless link. It hopes the system will soon be able to create a sanitised micro-climate around individual hospital beds, providing a bug-free environment for particular patients without the need to equip the whole ward with the system.
Commercialisation of UVGI began in 2002 following successful tests of the system at the Defence Science Technology Laboratory (DSTL) at Porton Down. Energy Technique is the majority partner in a joint venture called UVGI Systems, set up to develop and market the technology.
Other potential applications for UVGI include installation on trains, aircraft and boats.
The system is highly efficient at killing anthrax, according to its developers, and could be used to limit the effects of bio-terrorism attacks.
A positive outcome from the NHS pilot would be a major boost to Energy Technique, which has had its cash reserves sapped by the costs of developing the system.
The company's situation was not helped by a sharp downturn in its wider environmental control markets which suffered the knock-on effects of a slump in construction projects during the Iraq conflict.
However, the potential of UVGI has convinced Energy Technique to launch an air treatment division. This will develop systems and look for new opportunities to apply ultraviolet technology within the commercial air treatment market.
The company said it will look to raise extra capital to allow it to fully develop the products in the air treatment division.

more info from the web

A sample of the other UVGI results on the web.

NOTE this does not refer to ETQ and it appears UVGI has been around for decades....so ETQ are maybe doing it better but it is not neccesarily as unique and open market as thought. customers will need convincing that this system is more effective than previous and presumably worth the extra cost.

from the WEB

Edd Helms is Your
Indoor Air Quality Specialist!
Edd Helms Air Conditioning Protects your Home or Office from Airborne Bacteria



Most air conditioning systems recirculate the air in your home or office about 80 times a day. Edd Helms Air Conditioning can install a UVGI air purification system into your central air conditioner to help protect your family and employees from airborne diseases. UVGI has been used for years in the food industry to kill bacteria, and it was recently mentioned in many national anthrax news stories.

UVGI Frequently Asked Questions

Q: HOW LONG WILL IT TAKE FOR THE EDD HELMS TECHNICIAN TO INSTALL MY UVGI SYSTEM?
A: Most installations for central air conditioners up to 5 tons are normally completed within 4 hours. For larger central systems, installation times will vary, but most can be completed within several days.

Q: HOW MUCH DOES THE COMPLETE UVGI SYSTEM COST TO INSTALL?
A: Over the phone prices start at $697 for central air conditioners up to 5 tons. Prices for larger systems vary depending on the size of the central air conditioner.

Q: HOW DO I PLACE MY ORDER AND MAKE AN INSTALLATION APPOINTMENT?
A: Complete our on-line order form or call us at 1-800-329-2530 and tell us when you would like your system installed. We accept all major credit cards.

Q: WHO IS EDD HELMS AIR CONDITIONING?
A: We are a division of the Edd Helms Group who, for the past 27 years has served South Florida with air conditioning, electrical, and data communications services. Our thousands of satisfied of residential and commercial customers are evidence of our commitment to customer satisfaction.-

Q: WHAT IS A UVGI AND HOW DOES IT WORK?
A: UVGI is the abbreviation for Ultraviolet Germicidal Irradiation. The use of UVGI for the sterilization of microorganisms has been studied since the 1930's. Microbes are uniquely vulnerable to the effects of light at wavelengths at or near 253.7 nanometers (UV-C germicidal) due to the resonance of this wavelength with the molecular structure. Looking at is another way, the quantity of energy UVGI possesses is just the right amount of energy to break organic molecular bonds. This bond breakage translates into cellular damage to the bacteria, fungus, or viruses. With 11 watts of output per lamp, the UVGI intensity is 125 microwatts per cubic centimeter within 12 inches of each lamp. Most central AC systems up to 5 tons require two lamps, which give an effective UVGI intensity inside the air handler of approximately 250 microwatts. Larger systems require additional lamps to maintain the required UVGI intensity levels.

Q: HOW MUCH CONTINUOUS UVGI EXPOSURE IS REQUIRED TO KILL VIRUSES OR BACTERIA?
A: Some microorganisms are killed in fractions of a second while others require longer exposure. Manufacturers of UVGI equipment provide several charts which outline a list of microorganisms and the approximate kill time required. Those charts are based on findings of researchers, with some studies showing different kill time values than others. Accordingly, the varying kill times are included in the manufacturer's charts. Research performed by Mitscherlich and martin in 1984 found that 99% of all Bacillus Anthraci bacteria were killed within 3.6 seconds with 25 microwatts per cubic centimeter, and 99% of Bacillus Anthraci spores were killed within 230 seconds with 25 microwatts per cubic centimeter. A chart provided by one manufacturer indicates that with one hour of continuous air conditioning system operation, the airborne concentrations of Viral Colony Forming Units (CFU) per cubic meter is reduced from 500 CFU's to less than 10 CFU's; Bacterial CFU's reduced from 500 to less than 100; and Spore CFU's reduced from 500 to less than 300. That same chart shows that after 3 hours of continuous air conditioning system operation, both Viral and Bacterial CFU's are virtually eliminated while Spore CFU's level off at about 100 per cubic meter.

Company info Subject: units available Recommendations This message has not been recommended Message
I found out today in my role as an architect that the nightingale units are available currently on only a two week delivery.
As mentioned previously these are suitable for different size rooms, a smaller model is in development as is a unit for integration into a ducted system. The unit is remotely monitored through a GSM data connection for a series of performance related issues as well as a security( anti theft) GPS locater. Lease for 5 years at 6000/pa inclusive of monitoring,maintenance and parts and setting up for optimum use. Net cost of unit circa 10k but not being marketed in this way to ensure units are only used in optimal manner.

I didn't ask how well or how many were being sold, but the information was detailed and informative.

The trials of the units in the hospitals is about the in situ trial for specific uses rather than proving the unit per se which has been completed at Porton Down previously.
These new units also form only part of the full range of air treatment that can be provided and they are also in the process of integrating with another provider to offer a full sevice treatment to include surfaces as well as air, a sort of one stop shop for providing a 'clean' environment.

Any forthcoming news would therefore likely involve how many units are selling rather than when sales start or further evidence of its effectiveness in a particular (real)situations.

This company must already be on the way...unfortunately very little news means no reflection in the share price... I will continue to be patient

GN

Looks like it may have turned the corner today !

Taking the piss, raising 3m when you have a market cap of 4m.Glad i held back on these. Will review in 6 months.

Shame you missed the bottom then momentum !

Anybody got any news on Energy technique? Is it cheap enough to buy? It was 28p about 9 months ago

Express

ENERGY TECHNIQUE (Gossips believed that hospital trials for its air filtration equipment had gone well and more contracts were in the pipeline) - Broker's

As I said before UVGI air filtration is a small part of their business & the portable unit is not cheap enough & full scale building aircon version not on the horizon.

One to avoid!

Massive share dilution.

Move to AIM so that ISA holders are FORCED to SELL.

Bad track record.

Take another look this time next year.

apple maybe you should be called sour grapes ;-)

You missed the rise from 9p to 15p and now from 4.5p to 6p.

Daily Express

"Share Whisper:

*Gossips believe that hospital trials for Energy Technique (LSE: ETQ.L - news) 's air-filtration equipment have gone well and more contracts are in the pipeline

Happy1

What really happened is that I missed a very short lived SPIKE caused by pump & dump rampers. (See Chart.)

This was VERY risky & I was proved right as those who LOST from that pump & dump know only too well.

I then missed a CRASH down to about 4p.

My only regret is that I wasted a lot of time researching this company when I could have been looking into something better.

This share may well be ramped up a bit again BUT what a RISK!

Note the spread is 12.5% BUT it is usually 20%


See below & my previous messages on this thread starting at message 21.

-----------------------------------------------------------------

apple - 05 Dec'03 - 17:43 - 38 of 68 edit

Hmmmmmmm,

I still can't see any reason why sales could take off rapidly.

As I said before, it is leased, not sold.
5 Year Lease.

Unfortunately, the Lease is 2000/Year

PLUS

4000/Year Maintainence

So who wants to pay 30,000 over 5 years just to protect 1 room?

Not many people, I would think.

So sales will only build up slowly until they manage to cut the costs of the product by developing a MUCH cheaper version.

That could take some years I suppose.

Anyway, I'm not sure that they would have the ability to rapidly increase production even if the demand was there.

This product is helpful to them to persuade people to buy their big air conditioning systems & have this technology included.

Apparently this technology can't be fitted to existing systems.

That would make a difference.

The rest of their business seems rather unexciting & the UVGI is still being evaluated by potential customers.

At the moment, the rest of their business is the business.

This is such an important application for a product BUT the price just seems too high at 6000/year.

I wanted to invest in ETQ but I was disappointed when I found out some of these facts.

Happy1

If I were you I would out as soon as you can.

Only the rampers will make a profit out of this one, those who lose from the ramp will have to wait until next year or longer to get their money back.

In the LONG term this company may do well but it is a big risk & there are better opportunities elsewhere.

The share dilution will help to hold it back & may be followed by another one.

So wait & see & forget about the ramp, it may be almost as bad as the last spike.

I would have a read of the post on ADVFN tonight as if it is true then there will be a sharp mark up in price.

Me,I am sitting on 30K free,so what the heck !

DOWN 13%

Happy1

I hope you got out in time.

Good tradeing stock in at 4.5 out at 5.25

Big mark up !

Recovered from yesterdays big drop.

Good chance to sell before it goes down again unless the rampers make it go a bit further.

But do you want to risk it, the spread is 23%

apple what is your problem ?

You go on about rampers but your are the No1 deramper !

No problem Happy1, but I do have a grudge against rampers.

I'm just pointing out the facts & warning you that you are taking a big risk.

You said, "No1 deramper," now that is just ludicrous.

Please don't engage in personal attacks, stick to the facts.
There were no facts in your last message.

apple you have not posted anything to stop people buying except to say that the stock is being ramped !

Sorry but if you don't hold a pos then why post ?

Happy1

Yes I have said more than it is being ramped.

I have posted facts & my opinion on then.

See below & my previous messages on this thread starting at message 21.

-----------------------------------------------------------------

apple - 05 Dec'03 - 17:43 - 38 of 68 edit

Hmmmmmmm,

I still can't see any reason why sales could take off rapidly.

As I said before, it is leased, not sold.
5 Year Lease.

Unfortunately, the Lease is 2000/Year

PLUS

4000/Year Maintainence

So who wants to pay 30,000 over 5 years just to protect 1 room?

Not many people, I would think.

So sales will only build up slowly until they manage to cut the costs of the product by developing a MUCH cheaper version.

That could take some years I suppose.

Anyway, I'm not sure that they would have the ability to rapidly increase production even if the demand was there.

This product is helpful to them to persuade people to buy their big air conditioning systems & have this technology included.

Apparently this technology can't be fitted to existing systems.

That would make a difference.

The rest of their business seems rather unexciting & the UVGI is still being evaluated by potential customers.

At the moment, the rest of their business is the business.

This is such an important application for a product BUT the price just seems too high at 6000/year.

I wanted to invest in ETQ but I was disappointed when I found out some of these facts.

Well if thats the only research which you have done then shame ! There is alot more informed research available elsewhere.

Have any of you guys checked out the UVGI site recently...some interesting facts on infection control.

Yes saw the new products the other day.

Yes BMW I have seen it.

It is very positive & should help them with their share issue BUT wait until the shares have dropped & maybe look next year especially with a 23% spread.

See below.

-------------------------------------------

apple - 27 Apr'04 - 09:31 - 66 of 82


As I said before UVGI air filtration is a small part of their business & the portable unit is not cheap enough & full scale building aircon version not on the horizon.

One to avoid!

Massive share dilution.

Move to AIM so that ISA holders are FORCED to SELL.

Bad track record.

Take another look this time next year.

AIM - Tax advantage

Bad track record ?

Dilution - Maybe there is a reason !

Bid rumour in the papers today.

Hi Happy1

Thanks for the update which paper is it in?

EVO intiate coverage with a BUY recommendation

http://www.evbgresearch.com/docview.asp?document=3339

UK smallcap opening - Energy Technique up on product sale in US
AFX


LONDON (AFX) - Energy Technique was a prime mover after news that the company has sold its first Nightingale air filtration system -- developed to kill the MRSA hospital superbug, TB, and other dangerous germs -- into the US healthcare system.

The first unit will be sold to the Northwest Hospital Center in Randallstown, Maryland, the company said.

Nightingale uses ultraviolet radiation combined with air flow systems to attack the DNA of killer germs such as the MRSA hospital superbug, anthrax and TB.

Energy shares were 1.50 firmer at 5.50 pence by 8.33 am.


Surely this now leads to sustainable growth in the longer term as the title of this thread suggested almost one year ago!

Suprising that it coincides with the MRSA news. Expect a positive update from the Basingstoke trials soon !

Yoyo

Look at the chart, there have been sudden spikes like this before.

It will fall back again & the downward trend will continue.

The Nightingale is too expensive, see my previous posts starting at post 21 & especially post 38.

Click on the All messages button & read this thread.

I know that Happy1 will disagree because he bought in much higher & wants it to recover.

I think Happy1 is wrong about this one but he was right about Superscape so he is probably much happier about that.

apple you were saying it is only for rent not for sale. You are a bloody deramper by the looks of things. You would have told people not to buy at 4p and then denied them of a 43% rise in their money !!

Issued by First City Financial Ltd

PRESS RELEASE

First sale of Nightingale bug killer into US health system NHS targetted
July 7, 2004: Energy Technique plc has sold its Nightingale air filtration system - developed to kill the MRSA hospital superbug, TB, and other dangerous germs - into the US healthcare system.

The breakthrough sale comes as Energy Technique continues discussions to use
Nightingale within the National Health Service.

The first unit sold in the US will be used by the Northwest Hospital Center in
Randallstown, Maryland. Other sales to US hospitals are expected to follow through Energy Techniques partnership with the US manufacturer, NQ Environmental.

Energy Technique Managing Director Leigh Stimpson said: Following the careful
development and pre-marketing work we have put into Nightingale, this landmark
early sale is great news for Energy Technique.

We are confident it will strengthen our case for this product to be used within the NHS, where its powerful infection control capabilities could have enormous impact.

Energy Technique is currently discussing numerous prospects with several NHS
trusts following successful trials of Nightingale at the Health Protection Agency laboratories at Porton Down. Two units are currently undergoing clinical trials with the Basingstoke NHS Trust in Hampshire.

Nightingale uses ultraviolet radiation combined with sophisticated air flow systems to attack the DNA of killer germs such as the MRSA hospital superbug, anthrax and TB.

First announced at the end of 2002 following prototype testing, the system has
subsequently undergone further development ahead of extensive commercial
marketing.

For further information contact:
Leigh Stimpson, Managing Director, Energy Technique plc: 07919 214 882
07879 845 288
Allan Piper, First City Financial Public Relations: 020 7436 7486
07736 064 982
www.energytechniqueplc.com Ticker symbol: ETQ

Apple I hear what you are saying, but the previous spikes are to be somewhat expected when a stock has been purely speculative. The product is now in the market place as fact and is no longer fiction. To get a new product into the high street shops is not easy, ask James Dyson. ETQ have jumped THE major hurdle and have an exciting future.

no UP 68.7%

That is more than just a spike, it's a VERY NICE SPIKE!


Last year, I phoned the company & Joe Tufo said the Lease is 2000/Year

PLUS

4000/Year Maintainence

Has this changed?

I suggest that you phone the company & ask especially before diving in after a 68.7% rise!

Head office
Tel: +44 (0) 208 783 0033
Fax: +44 (0) 208 941 7780
Basingstoke office
Tel: +44 (0) 1256 814162
Fax: +44 (0) 1256 817815

Joe Tufo
Direct: +44 (0) 1256 383438
Tel: +44 (0) 1256 817815
Mobile: +44 (0) 7050 276 720
Fax: +44 (0) 1256 358561
Email: joe@uvgi.co.uk

I think that if you are in then it is time to get out!

Good luck!

apple read the RNS - Here I will help you

S O L D

SOLD/BOUGHT/CUSTOMER HAS PAID MONEY

Kapiche ?

Regardless of your old bit of news your stuburness has made yourself lose an awaful amount of potential money !

Happy1

Don't start personal attacks just be happy that you can get some of your money back.

I guess from your posts since January that you need more than 10p to get all your money back.

Good luck!

Yep, I missed a nice big spike but we can all say that with hindsight.
A hindsight of a temporary speculative spike.

It has already fallen back & I will be very surprised if it gets to 10p within a year.

Be happy with your recent gains on SPS, you picked a very good one there!

Not personal just annoyed with your ramblings. No I am sitting on free shares having sold out at 15p keeping the profit in stock ;-)

Hold on wave 2

Wednesday July 7, 04:31 PM

Related Quotes
Energy Technique PLC
ETQ.L
6.25
+2.25

More on Yahoo! Finance
The Latest Share Tips
Breaking Financial News
Mortgage Advice
Insurance Quotes

Energy Technique makes strong gains on upbeat product news
Energy Technique (LSE: ETQ.L - news) shares were up by 56.3 per cent at 6.3p in late trade in London on Wednesday after it announced the sale of its first Nightingale air filtration system - designed to kill the hospital superbug MRSA, TB and other dangerous germs - to the US healthcare system.

The company said the sale strengthened its case for the product to be used in the NHS.

Click here for more from FT.com

London & Boston has a is a big share holder in Energy Techniquesee see details below. Have a look at L&B web site it seems to be moving in the right direction at last.

Energy Technique Plc


In accordance with the Companys enhancement policy, London & Boston organised a consortium (including Harrell, the Chairman of Rotch, a company connected with the family of Geoffrey Dart and London & Boston) to invest 1.1m for 50.2% of Energy Technique, which has a full listing on the London Stock Exchange. The investment was completed on 15 June 2001. At that time London & Boston invested 230,354 in cash and 182,000 by the issue to Energy Technique of 1,820,000 Existing Ordinary Shares of 2p each in London & Boston at 10p each in exchange for the issue to London & Boston of ordinary shares in Energy Technique representing approximately 18.81% of Energy Techniques share capital plus options over a further 4% of this company exercisable within 5 years. Geoffrey Dart resigned as chairman of the company and Graham Mackenzie was appointed. Stephen Komly remains the senior non-executive director.

First established in 1879, Energy Technique specialises in the design, manufacture and distribution of high quality air conditioning and heating products. With an impressive customer list, including the Houses of Parliament, Nat West, HSBC and Barclays Banks, Marks & Spencer, Land Securities and Hilton hotels, The Savoy and Claridges hotels. The company has developed a high tech, energy saving, air conditioning system called the Ambassador System for commercial and hotel use. The consortium has brought and will continue to bring new introductions and business opportunities to expand Energy Techniques core Diffusion business.

The company has caused considerable excitement due to its innovative development of a system which removes all known airborne pathogens. The Company won the Fastest Moving Share Award for 2002 rising to 30p per share at one point from the 3p at which London & Boston arranged the re-financing of the company in June 2001

Well a retractment was expected.

Now time to add further.

TODAYS FINANCIAL TIMES mentions ENERGY TECHNIQUE as one of the SHINERS of last week stating that with the USA deal the UK deals with the NHS should follow due to this breakthrough! Give this a few more months and this should be at a reasonable level. The pattern so far has been like TADPOLE and YOOMEDIA a doubling of shareprice with a slight dip back and then onwards with more deals no doubt. We should see 20p within months I reckon -good luck all that are in!!

Author Chis Lines View Profile | Add to favourites | Ignore
Date posted today 12:24
Classification Press info
Subject: WAR DECLARED ON MRSA
Recommendations This message has not been recommended
Message

There is no mention of ETQ in these reports but lets hope the government decides to employ new technology rather than just 'spin'


http://www.sky.com/skynews/article/0,,30000-1142573,00.html

http://politics.guardian.co.uk/publicservices/story/0,11032,1258831,00.html

Mention in the Evening Standard and again in the FT

Energy Technique and Bioquell, both working on products to combat the hospital superbug MRSA, were up 16.5 per cent at 8p and 1.6 per cent at 160p respectively after the UK government unveiled its own plans to combat the spread of the infection

Just tipped by City Equities in their July newsletter !

RNS Number:9188A
Energy Technique PLC
16 July 2004


Energy Technique plc ("the Company")


Holding in Company


The Company was notified on 15 July 2004 by Insinger de Beaufort that it has an
interest in 14,314,444 ordinary shares of 1p each in the Company, representing
9.57 per cent of the current issued share capital of the Company.


16 July 2004






This information is provided by RNS
The company news service from the London Stock Exchange

END
HOLZGGMNGVGGDZM

ETQ is starting to look interesting. Keeping an eye on these.

Todays's News of the World Newspaper:

EXCLUSIVE: Ridding hopsitals of MRSA isn't rocket science Mr Blair..just try cleaning them


MRSA hospital disgrace



By Melanie Swan and David McGee

THIS is the disgusting, grime-infested sight that appalled a frantic dad when he took his three-day-old baby to an MRSA-infected hospital for surgery.

The 35-year-old father rushed his son Alexander to St George's Hospital in Tooting, south-west London hoping doctors would reassure him about the baby's bowel problem.

But he ended up fearing for the tot's life when he realised medics would OPERATE on his child in the filthy room, with its blood-stained floor strewn with used dressing packets and dirty swabs.

Doctors surgically removed a small piece of tissue from Alexander's lower intestine for testing, using invasive surgery which could have exposed him to deadly MRSA.

Syringes

"It was a disgrace," said the engineer from south London, who does not wish to be named.

His pictures reinforce our campaign for Tony Blair to wipe out MRSAwhich kills up to 20,000 people each yearby making sure hospitals are kept clean. They show:

Used NEEDLES on chairs yards from baby Alexander's incubator

A BLOOD-STAINED bedside cabinet

Thick DIRT on the child's life-saving intravenous drip machinery.

The tot's furious dad added: "This dirt was so thick I could scrape it off. I couldn't believe these were the conditions supposed to be curing my son.

"Used bits of equipment were all over the place, including syringes on seats. And to top it all, the blood on the floor had footprints going through it. Staff just shrugged when I asked about it. I asked for a cleaner to come and it took six hours. But the dirt on the intensive care machine was never cleaned up.

"The z-bed we were given to stay on overnight had holes in it with stuffing falling out. And there was something that could only be described as old blood dripping down a cabinet."

St George's Healthcare Trust is ranked the 11th most infected by MSRA among specialist hospitals in Britain. It had 93 cases last year.

We showed the shocking photographs to News of the World columnist Dr Hilary Jonesand he spelled out just how lucky baby Alexander was to have survived the ordeal unscathed.

Grimy

"These pictures appear to show grimy intravenous equipment, stains on the floor potentially harbouring micro-organisms and even blood on incubators," he said.

"Bacteria hazards build up and include infections such as pneumonia, meningitis and septicaemia, which has a 20 per cent mortality rate. One of the major causes of death in tiny babies is infection.

"We're seeing more cases of MRSA in paediatric wards than ever before. Conditions need to be absolutely sterile to reduce the risk of infection."

St George's spokesman Paul Spindler said: "Specialist hospitals have many cases involving invasive treatment, which make them more susceptible to infections such as MRSA.

"We try to maintain the highest standards of cleanliness and will be looking into your story very closely as a way of learning any lessons."

Bug plan is not enough

PLANS to tackle the deadly MRSA superbug don't go far enough, say the News of the World's Patients' Panel.

Health Secretary John Reid has vowed to give patients bedside hotlines to cleaners, increase ward inspections and give nursing chiefs more powers.

But pensioner panellist Alf, who picked up MRSA during a heart op several years ago, says: "There need to be more isolation wards to contain the bug. And hospital staff need more training."

Mum Diana, who has a diabetic seven-year-old son,said: "Every time I walk into the hospital I worry he might pick up something.

"I hope this isn't all just more hot air from the government."

Tanker driver Steven, 42, suffers from heart disease and says nurses must fully embrace the measures if we are to stamp out the threat.

Mum-of-three Anna, 32, who has breast cancer, says: "If the hotline is to work there has to be immediate action."

Final Patients' Panellist, pregnant trainee teacher Susan, 33, said: "My baby is due in six months but I'll be terrified if we don't get results by then."

Our undercover panel of five patients is monitoring the NHS to see whether Tony Blair is delivering his health promises.

Nearly ready to buy into these, siginificant retreat from highs of 8 pence three weeks ago, current price : 5.00-5.75 pence. Waiting now to see if the price holds at this level, if it does, I am in.

Looks like I was right again about spikes in this stock.

This was just another spike.

The fundementals don't support the share price & the price of the current product is too high.

This company can be a winner if it uses the technology in big air con system but that may not happen til next year.

Hi apple, I think the price dropping back was due to their results which were announced last week for the period ending 31 March 2004.

Release after Market close today :

RNS Number:2342B
Energy Technique PLC
26 July 2004


Energy Technique plc ("the Company")

Holding in Company

Further to the RNS released on 16 July 2004 under RNS No 9188A, the Company
wishes to clarify that the announcement made on 16 July 2004 was incorrect and
should have identified Triandra Limited and not Insinger de Beaufort, as
interested in 14,314,444 Ordinary Shares in the Company.

The notification followed sales from Triandra Limited between 8 July 2004 and 12
July 2004, which reduced its holding from 17,064,444 to 14,314,444 Ordinary
Shares. Accordingly, Triandra Limited's interest in the current issued share
capital of the Company fell from 11.4 per cent. to 9.57 per cent. on 12 July
2004.

26 July 2004



This information is provided by RNS
The company news service from the London Stock Exchange

END
HOLFGGZNVVKGDZM

RNS Number:0578B
Energy Technique PLC
21 July 2004


Energy Technique plc
Preliminary Announcement 2004


* #3 million share placing to finance growth of the new high-value divisions

* First sale of UVGI Nightingale system in the USA in July 2004,following
successful completion of testing by the Health Protection Agency

* Diffusion Heating and Cooling sales recovery in third quarter in competitive
market

* Diffusion DX Air Conditioning sales up from #0.8 million to #2.6 million

* Exclusive EU distribution rights obtained for NQ Environmental ultra violet
products to complement the Group's Nightingale UVGI unit

* Exclusive EU distribution rights obtained from Nutech of Canada

Overview
Following a year of extremely difficult operating conditions caused by a sharp
and unexpected downturn in the Group's traditional markets, I am pleased to be
able to report that we have now put in place both the funding and new
distribution agreements needed to develop and grow the new Diffusion Air
Treatment division and Diffusion DX Air Conditioning.

I am pleased to report that a #3 million share placing was completed on 30 April
2004, which has re-financed the Group and will provide the necessary capital
base to fund the planned growth of the Group. In the first quarter of the
current financial year, Diffusion Heating and Cooling continued its recovery.


Current trading and prospects

The group incurred a small loss in the first quarter of the year ending 31 March
2005, due primarily to operating losses incurred by Diffusion Air Treatment:

* Diffusion Heating and Cooling slightly exceeded its expected sales
levels, but only managed to break even, due to a combination of weaker than
expected sales mix and margin. Importantly, Diffusion Heating and Cooling
generated operating profits in both May and June and has good trading
prospects for the second quarter.

* Diffusion DX Air Conditioning operated close to its expected sales and profit
levels and the forward order prospects are excellent.

* The operating losses for Diffusion Air Treatment were lower than expected,
due to a combination of sales below expectations offset by lower operating
costs. The investment in additional resources could not be started until the
proceeds of the #3 million share placing were received in early May, but
investment in development and marketing of the new product ranges is now
proceeding as fast as is feasible.

The Group is now soundly financed, following completion of the #3 million share
placing and the Board is now confident of realising its full potential over the
next 24 months.


Group financial performance in the year ended 31 March 2004

Group sales fell from #11.7 million to #10.8 million and an operating loss after
exceptional items was incurred of #1.472 million.

Diffusion Heating and Cooling sales fell to #8.0 million (2003: #10.9 million),
due to a sharp deterioration in the fan coil market in the first half of 2003.
The division incurred an operating loss for the first time in many years of
#196,000 before exceptional items (2003: profit of #883,000).

Diffusion DX Air Conditioning sales grew strongly in its second year of
operation to #2.6 million (2003: #0.8 million for eight months trading). The
division incurred a reduced operating loss of #124,000 (2003: #258,000) as sales
moved further towards the projected sales targets.

Diffusion Air Treatment generated initial sales of Lifebreath products of
#182,000. The division incurred an operating loss of #338,000 due to start up
losses on Lifebreath, combined with engineering and development costs associated
with the Nightingale UVGI unit.

Central costs rose to #311,000 (2003: #256,000), due to the additional costs
incurred during the long-term illness of Stephen McNeice.

Exceptional redundancy costs were incurred by Diffusion Heating and Cooling of
#75,000 in the first quarter of the financial year.

An exceptional loss was incurred on the disposal of the Company's investment in
the shares of London and Boston Investments of #311,000.

Group cash flow

The group incurred a cash outflow of #869,000 (2003: inflow of #209,000) due
primarily to the operating losses incurred. Investment in stocks and debtors
increased due to the higher sales volumes achieved in the fourth quarter,
compared with the previous year. As a result of the cash outflow from operating
activities, capital expenditure was contained at #33,000 (2003: #142,000).

In February 2004, the Company sold its entire investment in the shares of London
and Boston Investments plc for #203,000, at a price of 4 pence per share. This
followed a prolonged period when the share price had been around or below the
price achieved.

The accounts include a pro-forma balance sheet at 31 March 2004, showing the
impact on the audited balance sheet as if the #3 million share placing proceeds
had been received on that date. This pro-forma balance sheet shows a net
positive bank position of #896,000.


Dividends

The Board does not recommend the payment of a dividend (2003: nil).


Operations
Diffusion Heating and Cooling ("Diffusion HC")

Diffusion HC experienced its worst year of trading for many years. The market
for fan coils and commercial heating products took a sudden and sharp downturn
in the first half of 2003 due to the uncertainty created by the global political
and economic situation at the time of the Iraq war. From a low point in the
first quarter of #1.524 million, sales subsequently recovered for the remainder
of the year to reach #8.0 million for the full year. This was significantly
down on the previous year's sales of #10.9 million.

As a result, for the first time in many years, Diffusion HC incurred an
operating loss of #196,000, before an exceptional charge for redundancies of
#75,000. A redundancy programme was completed in May 2003 involving 25 staff,
adjusting the cost base down to expected reduced sales volumes. The operating
loss was incurred in the first half year. Diffusion HC made a small profit in
the second half year on the increased sales volumes experienced. A dominant
feature of the current market place is the much shorter order lead times
demanded by contractors, which have adversely affected manufacturing
efficiencies due to the lateness in receiving final manufacturing instructions.

Diffusion HC's fan coils and heating products have continued to feature in many
prestigious office and hotel developments during the year, including The London
Stock Exchange, Scottish Parliament, Aspreys New Bond Street, Esso Glen Building
2, Standard Life, Lloyds TSB, HM Treasury, B & Q, and MBR Whitehall. The award
winning and patented Ambassador hotel fan coil unit gained further accolade from
the City Inn Westminster Hotel, where the external design team were successful
in winning the Best New Hotel Award at the recent European Hotel and Design
Conference 2003.

Diffusion HC continues to re- position itself by growing its commercial heating
product range, reducing reliance on fan coil sales. The commercial heating
product range is mid-way through an update programme and sales management
changes have been effected. The benefits of this strategy are expected to show
through in the latter part of the current financial year.


Diffusion DX Air Conditioning ("Diffusion DX")

Diffusion DX is now in its second year of operation and is becoming much more
established in the market place as a distributor of Panasonic and LG Electronics
packaged air conditioning equipment. This division continued to rapidly grow
during the year, with sales of #2.6 million, achieving excellent progress
towards reaching the annual sales targets set when the operation was first set
up in August 2002.

Diffusion DX moved into operating profit in the quarter ended 30 September 2003,
but incurred losses during the winter months, due to the traditionally seasonal
nature of the packaged air conditioning sector. Much marketing effort is being
directed towards larger value project led work, so as to reduce the seasonal
nature of this business.

The division's product offering was significantly enhanced in January 2004, when
Diffusion DX was granted distributor status for the Fujitsu range of packaged
air conditioning equipment. Diffusion DX is now in a strong position in the
market place as a distributor for three leading manufacturer's air conditioning
products. The Board is confident the addition of Fujitsu will enable
achievement of our objective for Diffusion DX to become one of the leading
distributors for the estimated #300 million UK market for packaged air
conditioning equipment.

Diffusion Air Treatment ("Diffusion AT")

The Diffusion AT division was formed in November 2003 to coordinate the Group's
activities in developing the air treatment and energy efficiency markets. This
division offers two product ranges:

* The Nightingale UVGI unit and NQ Environmental Inc's range of ultrab violet
products treat and sanitise air containing harmful airborne pathogens
such as TB, SARS and MRSA.

* The Lifebreath product range supplies fresh air ventilation to domestic homes
to manage the airtight construction methods required by new UK building
regulations.

Nightingale and NQ Environmental

In November 2002, the Company announced the prototype of its new Nightingale
unit and in April 2003 it won the Air Movement Product of The Year Award at the
2003 HVAC industry's H & V awards. During 2003, a second-generation production
model of the Nightingale unit was developed, and the accreditation test of this
production model, carried out at the Health Protection Agency, has now been
successfully completed.

The Group is in advanced discussions with a leading European manufacturer of air
handling plant to jointly develop a duct-mounted version of the Nightingale unit
and also to act as exclusive distributor of the Nightingale unit in Scandinavia.

The Board has identified the need to offer a wider range of products using ultra
violet technology in addition to the premium priced, high specification
Nightingale unit. The Group has therefore entered into an exclusive
distribution agreement with the American company, NQ Environmental Inc., to
distribute a complete range of low to medium specification ultra violet air
treatment products in the UK and elsewhere in the European Union. NQ
Environmental has supplied its products to approximately 700 hospitals,
predominantly in the USA and Canada and has a distribution agreement with Owens
and Minor Inc, the largest US medical equipment distribution company, to
distribute products throughout the USA.

NQ has been granted a period of exclusivity to 30 September 2004, to enable it
to explore opportunities for marketing the Nightingale unit in the US and
Canadian markets. The Nightingale was exhibited by NQ at a commercial trade
show in the USA in June where interest was very encouraging. The initial sale
in the USA of product using Nightingale technology was achieved in July 2004 to
the Northwest Hospital Center in Randallstown, Maryland.

Lifebreath

The Group has established an exclusive agreement with the Canadian company,
Nutech, to distribute its Lifebreath range of products in the UK, and elsewhere
in the European Union and Switzerland. Lifebreath products are filtration and
heat recovery systems targeted primarily at the domestic home market. The
products are capable of complying with building regulations by providing fresh
air ventilation (helpful for asthma, hay fever and other allergies caused by
poor air quality) to offset airtight construction methods and at the same time
recovering up to approximately 70% of normal heating energy loss.

The first Lifebreath sales in the UK were made in the year ended 31 March 2003.
A sales team has now been recruited and prospects for rapid growth are
excellent.

Directors

Robert Unsworth was re-appointed to the Board on 1 July 2003 as an executive
director, responsible for finance and company secretarial matters whilst Stephen
McNeice remains on long term sick leave. The Board wishes him a speedy
recovery.

Management and employees

On behalf of the Board, I should like to thank all employees for their continued
hard work, loyalty and commitment during the difficult trading conditions last
year.

Graham R Mackenzie
Chairman


Group profit and loss account
for the year ended 31 March 2004
2004 2003
Note #000 #000

Turnover 3 10,819 11,704
Cost of sales (8,508) (7,884)

Gross profit 2,311 3,820
Distribution costs (2,466) (2,388)
Administrative expenses (889) (1,063)


Operating (loss)/profit
Before exceptional items 3 (969) 369
Exceptional items 4 (75) -

(Loss)/profit before interest (1,044) 369
Loss on disposal of fixed asset investment 4 (311) -
Interest payable (117) (106)

(Loss)/profit on ordinary activities before taxation (1,472) 263

Tax on (loss)/profit on ordinary activities - -

(Loss)/profit for the financial year (1,472) 263
Dividends on equity shares - -

Transfer (from)/to reserves (1,472) 263

Earnings/(loss) per share:
Basic 5 (2.01)p 0.36p
Diluted 5 (2.01)p 0.31p
Before exceptional items 5 (1.48)p 0.36p

Both the turnover and operating results shown above are entirely in respect of
continuing operations.

There are no other recognised gains or losses other than as recorded in the
profit and loss account for the year.


Group balance sheet
At 31 March 2004 31 March 31 March
2004 2003
#000 #000
Fixed assets
Intangible assets 17 -
Tangible assets 317 401
Investments - 514
334 915
Current assets
Stocks 1,323 1,040
Debtors 2,654 2,153
Cash at bank - 186
3,977 3,379
Creditors - amounts falling due within one year (4,515) (2,949)

Net current (liabilities)/assets (538) 430

Total assets less current liabilities (204) 1,345

Creditors - amounts falling due after more than one year (7) (129)

(211) 1,216

Capital and reserves
Called up share capital 746 731
Share premium account 1,587 1,557
Other reserves 7,449 7,449
Profit and loss account (9,993) (8,521)

Equity shareholders' funds (211) 1,216

Note:

The group was re-financed with a #3 million share placing completed on 30 April
2004. A pro-forma balance sheet showing the impact of this share placing at 31
March 2004 is set out on page 12.


Reconciliation of movements in shareholders' funds
For the year ended 31 March 2004

Group
2004 2003
#000 #000

(Loss)/profit for the year (1,472) 263
Issue of ordinary shares 15 -
Increase in share premium account 30 -

Movements in shareholders' funds (1,427) 263

Shareholders' funds at beginning of year 1,216 953

Shareholders' funds at end of year (211) 1,216



Group cash flow statement 2004 2003
For the year ended 31 March 2004
#000 #000

Cash (outflow)/inflow from operating (905) 487
activities
Returns on investment and servicing of (117) (106)
finance
Capital expenditure and financial investment (33) (142)
Expenditure on intangible assets (17) (30)
Disposal of shares in London & Boston
Investments plc 203 -

Cash (outflow)/inflow before financing (869) 209
Financing:
Issue of share capital 45 -
Increase in debt 638 14
(Reduction)/increase in cash during year (186) 223


Reconciliation of net cash flow to movement in net debt
2004 2003
#000 #000

(Reduction)/increase in cash in year (186) 223
Increase in debt (638) (14)

Change in net debt resulting from cash flows (824) 209
New finance leases - (26)

(Increase)/reduction in net debt (824) 183
Net debt at start of year (947) (1,130)

Net debt at end of year (1,771) (947)


Reconciliation of operating profit to operating cash flows

2004 2003
#000 #000
Operating (loss)/profit before exceptional (969) 369
items
Exceptional items (75) -

Operating (loss)/profit after exceptional (1,044) 369
items
Depreciation and amortisation 117 149
Stocks (283) (316)
Debtors (501) 487
Creditors 806 (202)
(905) 487

Notes to the accounts

1. Accounting policies

The financial information set out above has been prepared using accounting
policies consistent with 2003.

2. Basis of preparation

The financial information for the year ended 31 March 2004 and 2003 set out
above does not constitute statutory accounts within the meaning of section 240
of the Companies Act 1985. The information has been extracted from the
statutory accounts of Energy Technique plc for the year ended 31 March 2004,
which have not yet been filed with the Registrar of Companies. Statutory
accounts for the year ended 31 March 2003 have been delivered to the Registrar
of Companies. Statutory accounts for the year ended 31 March 2004 were approved
by the Board of Directors on 20 July 2004, are audited and will be delivered to
the Registrar of Companies following the Annual General Meeting on 6 October
2004.

The Company's auditors, Milsted Langdon, have reported on the 2004 and 2003
accounts under section 235(1) of the Companies Act 1985. Those reports were not
qualified within the meaning of section 235(2) of the Companies Act 1985 and did
not contain statements made under section 237(2) and 237(3) of the Companies Act
1985.

3. Segmental analysis

Turnover Operating profit/ Operating net
(loss) assets
2004 2003 2004 2003 2004 2003
#000 #000 #000 #000 #000 #000
Diffusion Heating and Cooling

Before exceptional items 7,994 10,930 (196) 883 - -
Redundancy costs - - (75) - - -

After exceptional items 7,994 10,930 (271) 883 1,130 1,409
Diffusion DX Air Conditioning 2,643 774 (124) (258) 476 326
Diffusion Air Treatment 182 - (338) - 37 -
Central and Plc costs

Before exceptional items - - (311) (256) - -
Sale of unlisted investment - - (311) - - -

After exceptional items - - (622) (256) (83) 428
10,819 11,704 (1,355) 369 1,560 2,163

Borrowings (1,771) (947)
Taxation - -
(211) 1,216

4. Exceptional items
2004 2003
#000 #000
Operating items
Redundancies and employee termination costs 75 -
Loss on disposal of shares in London and Boston Investments plc 311 -
386 -

The exceptional items have been classified as follows:
Cost of sales 75 -
Loss on disposal of fixed asset investment 311 -
386 -
The tax effect of exceptional items is to increase trading and capital losses
carried forward.

5. (Loss)/earnings per share

The (loss)/earnings per share calculations have been arrived at by reference to
the following earnings and weighted average number of shares in issue during the
year.
2004 2003
#000 #000
Basic
(Loss)/profit after tax (1,472) 263

Before exceptional items
Operating (loss)/profit (969) 369
Interest payable (117) (106)
Tax payable - -

(Loss)/profit after tax (1,086) 263

No. No.
Weighted average number of shares in issue 73,337,751 73,075,456
Weighted average number of shares on a diluted basis 83,612,779 84,828,723

Supplementary basic (loss)/earnings per share have been calculated to exclude
the effect of redundancy costs and the loss on the disposal of the Company's
investment in the shares of London and Boston Investments plc.

6. Posting of Report and Accounts

The 2004 Report and Accounts will be posted to shareholders on 28 July 2004.

Contacts:

Allan Piper, First City Financial Public Relations: 020 7436 7486
07050 203304

Graham Mackenzie, Chairman, Energy Technique plc: 07901 550577

Leigh Stimpson, Managing Director, Energy Technique plc: 07919 214882

Rob Unsworth, Finance Director, Energy Technique plc: 020 8783 0033


Pro-forma balance sheet
At 31 March 2004
31 March Adjustment for 31 March
2004 Share 2004
Audited Placing Pro-forma
#000 #000 #000
Fixed assets
Intangible assets 17 - 17
Tangible assets 317 - 317
334 - 334
Current assets
Stocks 1,323 - 1,323
Debtors 2,654 - 2,654
Cash at bank - 928 928
3,977 928 4,905
Creditors - amounts falling due within one year
Borrowings (1,764) 1,739 (25)
Other creditors (2,751) - (2,751)
(4,515) 1,739 (2,776)
Net current (liabilities)/assets (538) 2,667 2,129
Total assets less current liabilities (204) 2,667 2,463
Creditors - amounts falling due after more than one year
Borrowings (7) - (7)

(211) 2,667 2,456

Capital and reserves
Called up share capital 746 750 1,496
Share premium account 1,587 1,917 3,504
Other reserves 7,449 - 7,449
Profit and loss account (9,993) - (9,993)

Equity shareholders' funds (211) 2,667 2,456


The pro-forma balance sheet shown above has been extracted from the audited
balance sheet at 31 March 2004, adjusted only for the impact of the #3 million
share placing completed on 30 April 2004, net of estimated costs of #333,000.
No adjustments have been made for trading since 31 March 2004 or for any other
adjustments.


This information is provided by RNS
The company news service from the London Stock Exchange
END

TA (Technical Analyis is looking good after today's close at these prices) :

Investtech Analysis after today's close :

Positive Candidate (Short term) - Jul 26, 2004
Is within an approximate horizontal trend, which indicates further development in the same direction. The stock has support at p 4.30 and resistance at p 8.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock and increases the chance of a break up. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically positive for the short term.

Positive Candidate (Medium term) - Jul 26, 2004
ENERGY TECH. ORD 1P has broken the falling trend and reacted strongly up. For the time being, it is difficult to say anything about the future trend direction. The stock has resistance at p 8.70. The RSI curve shows a rising trend, which could be an early signal for the start of a rising trend. The stock is overall assessed as technically positive for the medium long term.

Neutral (Long term) - Jul 26, 2004
Has broken the falling trend down, which indicates an even stronger falling rate. Has reacted back after the break of the inverse head and shoulders formation. There is support around 3.79, which now indicates good buying opportunities. An established break through this support will neutralize the positive signal. The stock has support at p 2.70 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically neutral for the long term.

Promising :

---------The RSI curve shows a rising trend, which could be an early signal for the start of a rising trend.

---------Volume balance is also positive (i.e. more buying than selling), which weakens the falling trend and could be an early signal for a coming trend break.

Mrs Ewing your doing your best to pump this stock,you must be in at double figures id imagine.

Downtrend lately....sob sob!

I used to have these but sold at good profit (fortunately)

now its `ring a ring a roses, atishoo atishoo etc`

I had been monitoring these this week as I mentioned and I think the price has bottomed out today. I bought in this morning at 4.95 pence. The selling has virtually dried up now. Why I say the price has bottomed out now is because buyers came in heavily today when the offer price hit 5.00 pence today and the same thing happened yesterday when the offer price hit 5.25 pence. There has been no sizeable sells in terms of more than 100K, whereas the buying has been good over the last week in terms of size ie. a 200,000 buy was reported as delayed at 5.00 pence and a 500,000 T buy came through at 5.00 pence in the afternoon session. The latter was worked through the day and came through in the afternoon. Level 2 closed very strong, the best it can get at 3 v 1. The potential downside is to 4 pence whereas the upside potential is huge from these levels.

Price closed at 4.75-5.50 pence.

Sue very little buying today when the offer was raised above 5p. Still a little profit taking to be worked through.Expect the price to resume uptrend sometime tomorrow. Was hoping the Nas would not rally, as i expect an early mark up which the price may rally from.Missed the boat today at 4.89p b****** phone, may have cost me a few bucks if i have to pay 5.25p or above tomorrow.,as i expect the sp to be 6p or above by early next week.

Hi momentum, thanks for your input.

Contrary to what is published in the buy/sell columns : the actual buy and sell figures were :

Buys - 1,336,349
Sells - 1,540,645
Rollover trades - 200,000.

Buys and Sells nearly equated to the same amounts for the first time in the last seven trading days.

Night!

SH take a look at FAR but be quick.

Hi suehelen had to pay 5.5p today. Thankx some good post today on III today.
Looks like when resistance at 5.5p is overcome we could have some good upside to test the previous high. Not tempted into CMS at the moment ?, im very bearish (chart looking dead )possible further downgrading of contracts that were expected to be signed.

Hi momentum, that was still a good price.

We finished with a shooting star (see below candlesticks chart) on the candlesticks for today which is a bullish signal. Buyers came back today and the selling appears to finish as re: my post yesterday but today the buys outnumbered the sells (see trades page). Price finishing up 4.90% today to 5.00-5.75 though the real spread seemed to be about 5.10-5.50 pence. Level 2 closing at 3 v 1 which is the strongest it can get for the second day running. I expect another blue day tomorrow.



Stars make up part of four separate reversal patterns:

Morning Star

Evening Star

Doji Star

Shooting Star (Inverted Hammer)

Shooting Star -- a small real body near the lower end of the trading range, with a long upper shadow. The color of the body is not critical. Not usually considered a major reversal sign, only a warning.

http://www.tradersedgeindia.com/candlestick.htm

Memo from Graham Mackenzie below : reply to an email sent.

Thank you for your e mail comments.

I would respond to your comments as follows.

The ETQ share price has fallen back slightly in the past few days because there has been heavy selling of shares because of profit taking by certain investors who took up stock in the recent placing, and because one major shareholder from the original consortium that bought in to ETQ three years ago, Harrel Hospitality has sold its complete holding in the company in order we believe to finance a hotel purchase.That sales have resulted in great liquidity in the stock.

As regards the marketing of Nightingale you should not forget that this is a sophisticated product selling for 6000 to 8500 pounds depending on the spec.. This is not a consumer sale so our marketing is directed at NHS Trusts and the private hospital groups such as BUPA. Any consumer or media coverage is peripheral to the main marketing effort where, for example, ETQ has made presentations to two major NHS Infection Control conferences in the last few weeks.

You can be assured that every hospital Chief exec and infection control director in the NHS has been made aware of Nightingale.

The problem is the bureaucratic morass of NHS purchasing procedures which delay the procurement process endlessly.

Why don't you tackle your local MP about the general comments you make about infection control in the NHS? We stand willing to supply Nightingale and have ensured that we have several in stock for immediate delivery should a hospital break out of its red tape and order one.

Regards
Graham Mackenzie

This is a link to one of the presentations he mentioned.

http://www.otjonline.com/download/june04.pdf (page 14)

and also this:

http://www.otjonline.com/download/may04.pdf (page 12)

On 28 April 2004, Joseph Tufo, Managing Director of UVGI Systems
Ltd. gave a presentation to 160 delegates at the Tackling Infection
Control conference held at the Copthorne Tara Hotel in London.
Participating in the conference was leading infection control
specialists, consultant microbiologists and clinical governance
managers from across the UK.
Mr. Tufo presented on the importance of air quality in the built
environment and explained how technology has advanced from simple
HEPA fi lters to products such as UVGIs Nightingale unit which draws
in air and includes four primary levels of protection including HEPA
fi lters plus a decontaminating section containing two banks of four
low-pressure UV lamps, located outside the airstream behind quartz
screens. Mr. Tufo described the problems associated with airborne
microbials and how UV treatment can sanitise bacteria.
Kathy Lee, an Acute Medical Ward Sister with over 30 years experience
in the NHS, then discussed treatment of immuno-compromised and
infectious patients, including a case study at North Hampshire hospital,
Basingstoke on using Nightingale to create a positive pressure room
and similar experience in handling SARS at a Toronto Hospital with
negative pressurisation. In these studies, another advantage of the
Nightingale system was the added benefi t of being highly mobile.
Other presentations at the conference included Nigel Tomlinson,
Principal Scientifi c Advisor, Centre for Healthcare Engineering, NHS
Estates who stated that early tests by NHS Estates had indicated the
positive results shown by UV treatment of airborne antimicrobials and
the likely recommendation from NHS Estates as to the use of such UV
fi ltering systems in hospitals.
Different forms of tackling control were also described at the
conference including a presentation from Julie Storr, Assistant Director
of Safety Solutions, NPSA who talked about the NHS clean your
hands campaign to encourage patients to ask nursing and medical
staff if they has cleansed their hands prior to treatment.
Other topics discussed included understanding the impact of the NHS
Winning Ways directive. Dr Louise Teare, Director of Infection Control
and Consultant Microbiologist at Mid-Essex Hospital Services NHS
Trust described interpreting the infection control timetable and what is
required including integrating infection control with clinical governance
and care planning.
The fi rst multi-parameter test - Cardiac Risk
- tests for total cholesterol, HDL, LDL and
triglycerides. The Cardiac Risk test identifi es
and monitors patients at risk of developing
Coronary Heart Disease (CHD), the leading
cause of death in North America and Europe.
Additional strips under development include
tests for renal, liver and metabolic functions.
For further information please contact:
Will Col, Oxford Biosensors Ltd,
Oxford Industrial Park, Mead Road,
Yarnton, Oxfordshire OX5 1QU.
Tel: 01865 849100. Fax: 01865 849200.
email: will.collon@Oxford-Biosensors.com
Website: www.Oxford-Biosensors.com
When responding to adverts please quote OTJ
The presenters informed the audience about the methods for tackling
infection and how to comply with current NHS legislation and guidelines.
The Chief Medical Offi cers publication of Winning Ways in December
2003 put the onus for effective infection control fi rmly onto the senior
management of acute trusts. Without improved infection control,
hospitals star ratings will be affected, the patient experience will be
compromised, billions of pounds may be squandered and thousands of
lives could be lost.
The strong line-up of speakers helped to address issues of infection
control, clinical governance and the Winning Ways directive as well as
tackling crucial questions of accountability, risk management and how to
carry out increased surveillance and reporting requirements, as well as
those of staffi ng and resourcing change.
For further information please contact:
Joseph Tufo, UVGI Ltd
Telephone: 01256 814162 joe@uvgi.co.uk
Joseph Tufo and Kathy Lee present at the Tackling Infection Control
meeting in London.
Tackling infection control is the priority for UVGI

UVGI Ltd. have jointly sponsored a meeting entitled Redesigning
Chronic Disease Management which was held on 25th May at the
Sheraton Park Lane Hotel, London. The one-day conference included a
keynote lecture from Sir Liam Donaldson, Chief Medical Offi cer.
The subject of chronic disease management is of major signifi cance to
UVGI who manufacture Nightingale, a new environmental disinfection
method that uses ultraviolet light to tackle the problem of hospitalbased
pathogens. The Nightingale is the fi rst ever British mobile air
sanitisation system with the ability to provide positive or negative
room pressurisation in line with CDC and NHS guidelines.
The UVGI sponsored meeting was specifi cally designed for Primary
Care Trusts. The conference addressed the overall issue of the
management of Chronic Medical conditions, specifi cally concentrating
on the practicalities of implementing a coordinated approach.
With the introduction of new initiatives, including the Expert Patient
Programme, hospitals now recognise the opportunity to make a
signifi cant change to the care and management of chronic disease.
Some of the crucial issues that were covered included how to learn
lessons from the US on case management of chronic disease, training
and development of staff to avoid unnecessary hospital admissions
and taking a whole systems approach to redesigning chronic disease
management.
Chronic diseases can affect as many as 17.5 million adults in the
UK and represent a huge and increasing burden on NHS resources.
International experience has shown that better integration between
primary, secondary and social care can reduce hospitalisation and yet
provide better care for patients. PCTs are in the ideal position to bridge
the gap and plan for integrated care. In order to meet this challenge
services will need to be replanned and redesigned to give a more
coordinated, responsive and integrated approach.
Speakers, including Sir Liam Donaldson, Chief Medical Offi cer and
Gary Belfi eld, Head of Primary Care and Policy for Chronic Disease,
Department of Health, discussed experiences including patient selfmanagement
programmes, the development of staff skills, multi-agency
integrated working and preventative measures to avoid unnecessary
and inappropriate hospital admissions. The authoritative panel of
speakers described the different models of care available, giving the
audience the opportunity to update on the latest trends taking place
nationwide and receive advice on how to take forward current systems
and procedures.
A panel discussion and Q&A sessions gave an excellent opportunity
to question experts and share views. The audience numbered 260
with delegates working in Nursing, Operations, Intermediate Care,
Commissioning, Clinical Leads as well as those involved in the
planning, commissioning and delivery of chronic disease management
services.
For further information please contact: Joseph Tufo UVGI Ltd
Telephone: 01256 814162 E-mail: joe@uvgi.co.uk
UVGI sponsor

Further : They mention UVGI rather than ETQ in the above but it is ETQ's presentation promoting UVGI.

In the second one there was a reference to an NHS Estates chap who really liked it and was going to recommend to the Trusts that they take up UV.

Some good news out today :

Evolution Beeson Gregory (Evo) have upgraded Energy Technique (ETQ) from Overweight to BUY!! It was on Bloomberg.

That explains why EVO moved from the offer to the bid on Level 2 and were actively bidding for stock.

Evolution Beeson Gregory Website :

Don't think we can get in though as if one selects private individual then the registration doesn't seem to complete.

http://www.evbgresearch.com/

The last candle in post 122 in in fact a doji and a bearish doji at that


macd is definitely not positive. Anyone thinking of buying should wait to see if there is a bounce off 4p with strong positive volume

EVO just bought out a new buy note.

The 500,000 trade reported at 5.25 pence this morning which has appeared in the sell column is a buy. The buy was filled when the offer price dropped to 5.50 pence for a few seconds before going back up to 5.75 pence. That action happened roughly before the buy went through at 09.27 and reported 1 hour later.
WINS also changed to the bid at 9:27.
The 500K was a definite buy and the buys outweigh the sells, I saw we've the movement on L2 just before the buy was put through at 09.27, the movement of the MM's. The price was 5.00-5.50 pence when the 500K order was put through. Then the offer ticked back up to 5.75 pence.
The other 500K trade at 5.00 pence on Tuesday was also a buy.
Someone has been hovering up all the sells this week, sells have been very small in size since last week and the buys that have come fewer but have been large.

Technical Analysis from Yahoo Finance updated today :

Technical Analysis: Energy Technique (ETQ.L) Last Time Updated Thursday July 29

Short Term Commentary

Watch out for price pullbacks, since levels under 7.43 can be opportunities to enter long in the market, when the trend slope at its highest levels.

Medium Term Commentary

Medium term price trend for Energy Technique is still bullish this week. This stock underperforms the FTSE 100 INDEX by -29.97 %. Volatility has been increasing during last month.

http://uk.biz.yahoo.com/tech/e/etq.l.html

We have another bullish candlestick on the charts for today : same as the one that appeared before the news came and the big rise happened (see below candlesticks chart). In addition, interestingly, the candlestick on the charts we have for today is the same one CFP had yesterday and CFP is up 23.00% today.

Bearish last candle on this chart says much more than an indecision doji on the above chart. Note the fact that higher prices were attempted but did not hold plus the downward pointing MA

** it is dangerous to trade against the trend. This is a falling knife scenario **



PS I no longer hold shares in this stock so am unpredjudiced

if you must buy then wait for good positive buying volume on your own chart. My chart shows that OBV (on balance volume) is falling

Best - Charts :

On Balance Volume is Bullish.

definitely not. Updata TA realtime chart. Daily

Potential punters: look at charts on different time scales. If you want to buy and hold then look at a longer-term chart wrt the primary trend

IMO this stock will (and should) test 4p. If it bounces off 4p with good volume then even I would buy it

I've just checked with Best-Charts. Volume Balance is also positive, confirmed by Investtech.
With regards to the trades, the small sells less than 50K appearing don't interest me, the 500K buys is what I am interested in. We will know the reason for the 500K block buys soon.

Investtech Analysis after today's close :

Weak Positive Candidate (Short term) - Jul 29, 2004
Has broken the ceiling of the falling trend, which indicates a slower initial falling rate. The stock has support at p 5.00 and resistance at p 6.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Weak Positive Candidate (Long term) - Jul 29, 2004
Shows a weak development within a falling trend channel. A further negative development is indicated, and there is resistance against the ceiling of the trend channel. Has reacted back after the break of the inverse head and shoulders formation. There is support around 3.79, which now indicates good buying opportunities. An established break through this support will neutralize the positive signal. The stock has support at p 2.70 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

Below is the copy of the BUY note from Evolution Beeson Gregory (EVO) which came out yesterday who upgraded ETQ from add to outright BUY which also happened yesterday.


Energy Technique (ETQ) Buy (from Add)
Mkt cap: 8m Net cash: 1m Recommendation change Price: 5p
Set to hot up
Over the last week the share price has fallen by nearly 40%. Our
fundamental view of the business remains in tact and we are raising our
recommendation to a BUY.
On 7th July Energy Technique announced it had sold its first Nightingale air
filtration system in the US. Investors responded positively and the share
price doubled. Whilst we remain confident the shares remained good value
in the long term, the shares looked unlikely to perform in the short term.
Therefore, on 21st July we reduced our recommendation to Add. Since then
the shares have fallen c 40% and we once again see some short term upside
in the share price. As a consequence we are raising our recommendation
back to a BUY.
We anticipate share price movements over the coming months are likely to
be stimulated by news flow from either the branded distribution operation
or the air treatment division. Preliminary results showed the branded
distribution operation is now established and poised to move into
profitability during the current financial year. We would expect the
company to update the market on its progress at the AGM stage. However,
the largest potential upside resides within the air treatment side of the
business. As experienced earlier this month, the market is likely to respond
favourably to any positive news flow from the division.
Following share price fall we are
raising recommendation to BUY
News flow will be key
ENERGY TECHNIQUE
JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL
2
4
6
8
10
12
14
16
Source: DATASTREAM

"Since then the shares have fallen c 40% and we once again see some short term upside in the share price. As a consequence we are raising our recommendation
back to a BUY".


---So EVO must reckon that 7.00-8.00 pence which was the price when they changed their recommendation the last time is fair value for ETQ in the short term until further news comes.

Sue you should give credit to who posted the EVO note !

Happy1 are you are refering the post on iii from smiler23 alias sue helen. You have to comend her, when she gets her teeth stuck into a stock she certainly does her homework and digs out some very useful information.Must admit i was a little suspicious of SH when intially reading her post( ramping).Although she does have an uncanny nack of picking undervalued ( oversold ) penny shares.

uk-wire website. All current info on etq

http://www.uk-wire.com/cgi-bin/index?search_type=3&words=etq&go.x=12&go.y=9

Interestingly the price is unchange for today but a blue candlestick has appeared on the candlesticks chart (see below) for today :

SP held up well today, considering a small Share Mag article advises a sell.

Hi momentum, the broker buy note published yesterday was good enough for me.
Well just 4 small sells reported today, against 14 buys have come through even though they have been small buys. Next step for next week is for large buys to start coming in now...

Online buying price had ticked up slightly to 5.45 pence from 5.40 pence towards the close.

Support has been built at 5.00 pence this week.

Buys = 245,688
Sells = 88,329

Investtech Analysis after Friday's close :

Weak Positive Candidate (Short term) - Jul 30, 2004
Has broken the ceiling of the falling trend, which indicates a slower initial falling rate. The stock has support at p 5.00 and resistance at p 6.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock. RSI is oversold. The stock can still fall further, and we should see an increasing RSI before this is used as a positive signal. The stock is overall assessed as technically slightly positive for the short term.

Press Mention : in Today's Daily Mail Newspaper, should get the buyers in next week.

Daily Mail today under Broker Buys:
Energy Technique: Evolution says buy at 5p (now 5.75p). Upward movements over the coming months should be stimulated by news from the branded distribution operation or the air treatment division.

Not a cheerful recommendation from shares magazine this week - sell

5.38p now

hyleo98 SM fails to mention the Nightingale recent deal and possible news from the NHS. Instead concentrates on its general air con business which is not why people are buying into ETQ.

The following buy note from Evolution Beeson Gregory towards end of the week hlyeo98 has more substance:

Energy Technique (ETQ) Buy (from Add)
Mkt cap: 8m Net cash: 1m Recommendation change Price: 5p
Set to hot up
Over the last week the share price has fallen by nearly 40%. Our
fundamental view of the business remains in tact and we are raising our
recommendation to a BUY.
On 7th July Energy Technique announced it had sold its first Nightingale air
filtration system in the US. Investors responded positively and the share
price doubled. Whilst we remain confident the shares remained good value
in the long term, the shares looked unlikely to perform in the short term.
Therefore, on 21st July we reduced our recommendation to Add. Since then
the shares have fallen c 40% and we once again see some short term upside
in the share price. As a consequence we are raising our recommendation
back to a BUY.
We anticipate share price movements over the coming months are likely to
be stimulated by news flow from either the branded distribution operation
or the air treatment division. Preliminary results showed the branded
distribution operation is now established and poised to move into
profitability during the current financial year. We would expect the
company to update the market on its progress at the AGM stage. However,
the largest potential upside resides within the air treatment side of the
business. As experienced earlier this month, the market is likely to respond
favourably to any positive news flow from the division.
Following share price fall we are
raising recommendation to BUY
News flow will be key

Up 11.6% today, excellent buying volume after the release of the buy note along with the press coverage at the weekend. More gains should be forthcoming during rest of the week...

Re : my post at the weekend that the buyers should return this week. Some large buys have been reported, 150K at 6.12 pence, 300K at 6.12 pence, 2*400K at 6.25 pence as well as many other good buys. Very strong buying volume and volume has topped 3.5 million for the day already.

suehelen,

2 x 400k was a rollover!

Hi Andy, I don't think so as they were both a full minute apart and at the same price as well. Rollovers would have been one trade at 6.20 pence and another at 6.25 pence within a few seconds of each other.

Strong buying has continued throughout the day.

From Leaders and Laggards on the MONEYAM Home Page :

Energy Technique were ahead 13.9% at 12.30pm on consistent buying based on hopes that there may soon be new deals to add to the recent maiden sale of their MRSA-busting air conditioning unit to a US hospital.

Further : 2*100,000 Buys have just come through at 6.50 pence, again they are not rollovers. One of the 100,000 buys is a broker buy where a broker has purchased 100,000 shares on behalf of a client at a premium offer price of 6.50 pence.

One of the 100,000 buys at 6.50 pence has been deleted and put through at 6.24 pence, the broker buy remained at 6.50 pence. Nonetheless, the offer price has now ticked up to 6.50 pence.

suehelen,

Bit of a coincedence 2 x 400,000 trades seconds apart don't you think?

A decent broker could achieve better prices than you suggest, although I do take your point about the price being the same.

I still think it was a rollover, but accept I may be wrong.

Hi Andy,

The 950,000 trades at 6.00 and 6.03 pence is a rollover, doesn't affect the price, though someone out there is holding 950,000 shares at 6.03 pence.

Price is up 23.2% now for the day at 6.25-7.00 pence, strong buying has continued throughout the afternoon session as well.

Further gains are likely tomorrow now with press coverage and the price broke the 6 pence resistance today which in turn will be the new support (ie. 6 pence is the new support). Investtech Analysis should confirm this tonight.

250,000 trades at 6.49 and 6.51 pence is a rollover. Though again someone out there is holding 250,000 shares in ETQ at a price of 6.51 pence respectively.

What was that 1.500.000 mio single protected transcion??? a sell or a buy?

Hi Xmortal, I believe it was a buy. It was actually a 1.25 million trade that came through at 6.15 pence, it looks like a buy and was worked through during the day possibly. Order was probably put in when the price was 5.75-6.25 pence this morning or when the price was 6.00-6.25 pence, at both of those points the price was static for long periods. If it was a sell, I don't think it will matter with the huge amount of buying of which nearly all of it occured over 6.00 pence. The 500K T trade at 6.00 pence looks like a sell to me. Again, these trades were worked through the day so I don't think they matter for the next trading day.

The snippet which appeared on the HOME page under Leader & Laggards on MONEY AM at lunchtime today may mean they is some press coverage about today's rise in the newspapers tomorrow.

After the dull phase of last week when the price was building support at 5.00 pence (sitting on the 50 day moving average) with just few trades going through, TA was improving & is looking really good now after today.
Just the crossover on the MACD is left....

A positive signal was formed when the price broken the resistance at 6.00 pence today and there is support at 6.00 pence now. All this should be confirmed by Investtech Analysis tonight.

Contrast to last week more than 10 million shares traded today in 198 trades, huge compared to last week.

Suprised there was wasnt further upside today given the buying volume. Imho will push up to the previous high before a slight pull back. and a test of 10p. If this volume is repeated over the next few days, expect a big break. May be a rumour filtering through. Topped up again today at 6p.

The price has crossed the ten day moving average this morning which usually provides a boost. The MACD should do the crossover (see below chart + indicators) and go bullish tomorrow if the price starts to rise again which looks likely :

Hi momentum, this was more than what I expected today though I'm very happy having got into these at a very good price. Look at the snippet I have posted from the Home Page and gives some indication as to why the huge buying occured today.

Signs were there last week that the price was going to start rising :

1. EVO upgrade (Buy note) came out on Wednesday
2. The above was mentioned in the Daily Mail Newspaper on Saturday
3. The sellers had been cleared by end of last week
4. TA indicators were improving (especially the above candlestick chart where I specifically mentioned how a blue candlestick was formed for friday when there shouldn't have been one, and the bullish sticks for the previous 2 days)

Hi sue, cant see a lot of resistance up to 8p, where it will be flirting with the 200 day. I would expect a slight pull back from here ( 10-15%)

Next resistance point is exactly at 8.10 pence.

Hi Momentum, I bought more today at 6.55 pence (about 64,000 odd shares) adds to my holding of 100,000 shares at 4.95 pence which was purchased last week. I think these could do very well in the next month or so.

Check out their website and look at the customer list and the geography....massive potential for ETQ if this comes off..and not just in the USA.....

http://www.nqinc.com/a.html

Buys still slowly trickling in which shows how ETQ is on many radars albeit not at yesterday's ferocity.

Buys come to about 1.0 million shares for today and sells are about 470,000.

Level 2 stable at 1 v 1.

Buyers took the upper hand again following on from yesterday, very encouraging that the price held onto its gains (besides the offer price moving from 7.00 pence to 6.75 pence, ie. the spread became better) as well from yesterday.
250,000 delayed buy at 6.50 pence came through at 5.22pm from an hour ago.

Figures :

Buys = 1,554,825
Sells = 597,047.

Best - Charts at close :

2 Buy Signals
0 Sell Signals

13 Bullish Indicators
3 Bearish Indicators.



MACD (Moving Average Convergence/Divergence) is poised to the crossover soon and go bullish (see above MACD indicator).

Interesting project being conducted in the US :

CU-Boulder Professor To Study Controls For Hospital-Acquired Infections
Feb. 2, 2004

A new study that aims to significantly reduce the incidence of hospital-acquired infection by providing clear data on the effectiveness of ultraviolet germicidal irradiation (UVGI) is getting under way at the University of Colorado at Boulder.

The overall goal of the study, which is being funded by the N.G. Gilbert Foundation, is to quantify the effectiveness of ultraviolet germicidal irradiation, or UVGI, in controlling hospital-acquired infections from opportunistic airborne bacteria and fungi.

The research is being led by CU-Boulder engineering Professor Shelly L. Miller. Miller is an expert on indoor air quality, assessing exposures to infectious diseases and developing and evaluating control measures.

The rate of hospital-acquired infection has remained stable over the last 25 years at six per 100 hospital admissions, although the rate per 1,000 patient days has increased 36 percent because of shorter inpatient stays. In 1995, it was estimated that hospital-acquired infections resulted in medical costs of $4.5 billion and contributed to more than 88,000 deaths.

Miller has conducted previous studies on UVGI controls for reducing exposure to infectious diseases for the National Centers for Disease Control and Prevention and the National Science Foundation. The studies have looked at a variety of factors that can influence the effectiveness of UVGI but have shown that under the proper conditions, UVGI has significant potential to inactivate airborne bacteria and prevent infection in hospitals.

Two UVGI systems will be investigated in the new study: one is an in-room system that achieves irradiation of upper-room air through wall- and ceiling-mounted UV lamps; the second is an in-duct system installed in HVAC equipment.

The research will be conducted in two phases, the first of which will take place over a six-month period in a controlled laboratory setting at CU-Boulder's College of Engineering and Applied Science. Phase II will then involve controlled studies at the University of California-Los Angeles Medical Center.

The current design of Phase II includes testing first in unoccupied patient rooms retrofitted with proven UVGI systems, followed by detailed clinical studies of the effectiveness of UVGI against hospital-acquired infections.

The Gilbert Foundation hopes the study findings will be the catalyst for medical facilities to begin using UVGI on a comprehensive basis to significantly reduce hospital-acquired infections.


Contact: Shelly L. Miller, (303) 492-0587
Carol Rowe, (303) 492-7426

http://www.colorado.edu/news/releases/2004/30.html

Investtech Analysis updates after today's close : TA has improved greatly this week from the improved TA of last week.

Weak Positive Candidate (Short term) - Aug 3, 2004
Has broken the ceiling of the falling trend, which indicates a slower initial falling rate. The stock has support at p 5.10 and resistance at p 8.10. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Neutral (Medium term) - Aug 3, 2004
Shows a weak development within a falling trend channel. A further negative development is indicated, and there is resistance against the ceiling of the trend channel. The moving average indicator has, however, given a positive signal. In isolation this signals a continued rise, but the slowness of the indicator often means that one has lost much of the upside. The stock has support at p 3.50 and resistance at p 11.20. The RSI curve shows a rising trend, which is an early signal for a possible trend break up. The stock is overall assessed as technically neutral for the medium long term.

Positive Candidate (Long term) - Aug 3, 2004
ENERGY TECH. ORD 1P does not show any clear trend. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which strengthens the stock. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically positive for the long term.

SueHelen

How long is long term. 1 week, 1 month, 1 year or several years.
I know this is Mystic Meg stuff but any pointers would be great.

You certainly do your home work. You've got to be in the pro league.

Regards
Mickeyskint

SH get your people into FAR and SPD NOW

Hi Mickey, long term for me is about 6 months, medium term for myself is about 3 months & short term again for myself is about 1 month.

Press mention : was in today's Daily Mail Newspaper, page 58.

Heavy buying in response to an Evolution recommendation lifted Energy Technique 1 1/4 p to 6 5/8 p.

SueHelen,

I read your posts and find them very informative. Can you tell me what TA stands for in your post of 175.

Hi Safety, TA is an abbreviation I use for Technical Analysis.

Level 2 at 1 v 3, MMs are shaking the price today to get stock back, barely any sells.
The market makers need to balance their books, they have sold 6-7 million shares this week and have got back about 1.75 million shares this week. That's all there is to the small drop today. Buys still trickling in.
Evident with the way buys still outweigh sells today :

Buys = 211,489
Sells = 182,741.

Treeshake is so evident, there are just no sellers about. Need to balance their books ???

The same actions occured last week and it was so evident. These kind of actions normally happens before good news is about to come...same occurence last week before the EVO buy note came.

Important when these kind of actions occur it is a good ideas to see what they do with the offer price, as any would be buyer need to look at that, with the bid price they'll keep moving it around to get stock back. Keep an eye on the offer price, see how low that goes if it does do so.

I think the price will consolidate at 6.00 pence now this week just like the price consolidated and built support at 5.00 pence last week. Then the price may follow onto 7.00-7.50 pence next week.

High volume days in rising prices and low volume days in falling prices strengthens the stock. This occurence has been happening to ETQ since the product sale announcement in the first week of July.

I have bought now. All short term indicators are screaming buy on this short term chart and the necessary retracement has happened. Buyer beware and look at my later posting re long term trend, which is down. This buy refers only to the short term trend

Hi Snip, re : my posts last week, I had a feeling that it was going to happen as my TA was giving me the indication of a nice uptrend about to happen. Anyway I'm in at 4.95 pence from last week and bought another four thousand pounds worth yesterday at 6.55 pence.

The Market Makers got it so wrong with their attempted treeshake today, they could not get much stock back.

At close :

BUYS = 348,285
SELLS = 344,279
????? = 12,741.

25 Buy Trades
11 Sell Trades
1 ???? Trade.

Buyers continued to accumalate stock for the third consecutive trading day.

SueHelen

You seem keen on this stock and I was tempted to get on board. But before doing so decided to do some research.

This company has a risk grade of 713 bearing in mind the FT100 is 100. This is higher than DES which is frontier stuff it's self. Also its revenue for end of march 04 was 10.819 with a pretax loss of -1.472, net income -1.472 and total share capital/reserves of -0.211. The last div paid was 1998.

This one to me seems a real risk. Why are you so positive about it with a balance sheet like this.

Off to light the bbq and have a couple of g&t's so I won't be able to pick up your reply untill tomorrow.

Regards
mickeyskint

mickey I agree with you. I got over 4000 shares for 300. That is a small fraction of my spend on a `reliable` stock. Chartwise risk/reward is pretty good though with a SL at 4.60 and a potential rise to 15. However I shall be watching carefully.

Have a look at the HSD thread to see how I handle a risky stock

Hi Mickey,

There wasn't anything surprising or untoward in the results, the market was expecting a loss of around 1 million pounds.

From the Product Sale announcement in the first week of July :

Product sale

The Company is pleased to announce the sale of its first Nightingale air filtration system - developed to kill the MRSA hospital superbug, TB, and other dangerous germs - into the US healthcare system. The first unit will be sold to the Northwest Hospital Center in Randallstown, Maryland.

Energy Technique Managing Director Leigh Stimpson said: Following the careful development and pre-marketing work we have put into Nightingale, this sale is ahead of our expectation on timing and is great news for the Company.

We are confident further sales will follow in due course both within the UK and US in line with our business plan and validates the Companys extensive development of the product. Further to this we believe the sale can only strengthen our case for this product to be used within the NHS.

Nightingale uses ultraviolet radiation combined with sophisticated air flow systems to attack the DNA of killer germs such as the MRSA hospital superbug, anthrax and TB.

Financial Times on 10 July 2004 :

Mentioned ENERGY TECHNIQUE as one of the SHINERS of the previous week stating that with the USA deal the UK deals with the NHS should follow due to this breakthrough!

Reply from the Department of Health :

Thank you for your e-mail of 12 July 2004.

The majority of bacteria transmitted between patients are transferred on
the hands of attendants, hence the continued emphasis placed on hand
decontamination before patient contact. The problem of airborne
transmission is associated with specific problems such as the potential for
fungal infection in cancer patients and the spread of respiratory viruses.

The Government is always interested to hear of new products, however you
will understand that we cannot endorse any particular one. Introduction of
a new product would need careful consideration by Trusts to establish the
evidence that it prevents infection and has no adverse effects on patients.
It is to help the NHS make such assessments that we are developing a rapid
review process to assess new procedures and products for which claims of
effectiveness are made for their ability to prevent or control healthcare
associated infections (HCAIs). We will contact Energy Technique when the
review process has been etstablished.

This is part of our new approach to tackling healthcare associated
infections, "Winning Ways - Working together to reduce Healthcare
Associated Infection in England", published on 5th December. This is
available at http://www.dh.gov.uk/assetRoot/04/06/46/89/04064689.pdf. This
is part of our drive to put quality of care and patient safety at the heart
of NHS practice and we are confident that implementation of "Winning Ways"
will reduce infection rates.

Yours sincerely

Shares Magazine on 15 July 2004 :

With almost a 10% risk of infection for hospital in-patients from the MRSA superbug, TB, anthrax and other dangerous germs, the government has launched a campaign to cut the death toll.

One beneficiary should be Energy Technique (AIM:ETQ) whose shares have doubled to 8p since it announced the first US sale of its Nightingale air filtration system to the Northwest Hospital Center in Randallstown, Maryland. More US sales are expected to be announced shortly. The system, a free standing air conditioner the size of an American fridge and costing 5,000 uses ultrviolet radiation combined with sophisticated qir flow systems to attack the DNA of killer germs.

The lenghty trial of two units at Basingstoke Hospital comes to an end in Autumn. Energy Technique is hopeful this will finally kick start long-awaited sales to the NHS.

Meanwhile licensing and manufacturing deals have beed struck with major companies to gear up production assuming demand takes off. The company's own factory at Basingstoke can make only about 1,000 units a year.
Full results will be released shortly and will show a 1 Million-plus loss. The company is trading profitably and is well funded after a 3 Million placing at 4p a share in March

Shares Says: Air Filtration market offers huge potential

17 July 2004 :

Tipped by City Equities in their July newsletter !

Below is the copy of the BUY note from Evolution Beeson Gregory (EVO) which came out last week who upgraded ETQ from add to outright BUY :

Energy Technique (ETQ) Buy (from Add)
Mkt cap: 8m Net cash: 1m Recommendation change Price: 5p
Set to hot up
Over the last week the share price has fallen by nearly 40%. Our
fundamental view of the business remains in tact and we are raising our
recommendation to a BUY.
On 7th July Energy Technique announced it had sold its first Nightingale air
filtration system in the US. Investors responded positively and the share
price doubled. Whilst we remain confident the shares remained good value
in the long term, the shares looked unlikely to perform in the short term.
Therefore, on 21st July we reduced our recommendation to Add. Since then
the shares have fallen c 40% and we once again see some short term upside
in the share price. As a consequence we are raising our recommendation
back to a BUY.
We anticipate share price movements over the coming months are likely to
be stimulated by news flow from either the branded distribution operation
or the air treatment division. Preliminary results showed the branded
distribution operation is now established and poised to move into
profitability during the current financial year. We would expect the
company to update the market on its progress at the AGM stage. However,
the largest potential upside resides within the air treatment side of the
business. As experienced earlier this month, the market is likely to respond
favourably to any positive news flow from the division.
Following share price fall we are
raising recommendation to BUY
News flow will be key
ENERGY TECHNIQUE

Check out the improved website at :

http://www.energytechniqueplc.co.uk

Good case for the use of UVGI :

http://www.infectioncontroltoday.com/articles/481feat1.html

Investtech Analysis update :

Weak Positive Candidate (Short term) - Aug 4, 2004
Has broken through the ceiling of a falling trend channel. This indicates a slower falling rate initially, or the start of a more horizontal development. The stock has support at p 5.10 and resistance at p 8.10. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

SH with respect. You say that you put quite a lot of money into the stock (relative to the stock price). You would hold approx 164 thousand shares. So every 1p rise above your break even point would show a profit of 1640

(Tongue in cheek here) Do you think you might have a vested interest in ramping the stock?

Anyway you are brave

Hi Snip, I didn't see that coming as I got in as you well know at 4.95 pence intially last week with 100,000 shares. Now you were well aware of how I decided to buy in with my first purchase whilst you were very negative. So I should be posting the question to you as from one of your post yesterday afternoon you wrote down this is a screaming buy now...so what is different from mine apart from that I back my views with facts which have proved right.

My long post last night, I was answering Mickey's question. This is the average amount of sums that I put in each of my stock.

How about admitting that you were wrong last week with your analysis and I was right.

SH I am purely a chartist and not a gambler on `hearsay` from whatever source. I invest and withdraw when my charts looks right

I wish I could post the signals from my (very powerful) updata TA system. You will find that I always post a comment without the words `I think` or `might` as they are gambling words

The reward/risk ratio must also be worthwhile. Hence my low investment in this stock but nevertheless involving over 4000 shares.

When someone wins on a stock then someone else has to lose. Simple!!!

I couldn`t morally ramp such a dangerous stock to jo public

And.....

I've done the same if not better with explaining everything since my first post here.
"
I couldn`t morally ramp such a dangerous stock to jo public" - What are you implying Snip.

Dangerous stock - this is the lowest risk stock that I hold. All my stock picks are in oversold firms.

I'm not get into a slanging match with you and waste my time. How about you start unearthing some information as well. You didn't see the broker buy note coming and when it came you were still negative...and suddenly yesterday afternoon you were all positive.

To all the etq watchers
Draw the downtrend line from the top of the chart. It is hit three times so is reliable. Extend the line and then watch the stock carefully to see if it bounces down off the downtrend, or up through the trend, when it will be in a breakout situation provided that volume is higher than normal. The test area will be at approx 6.5p mid price



ps SH I don`t do slanging matches either but neither do I ramp to suck in unaware punters

agree with snip cant see how anyone can say this is in a uptrend 1 day rally? uptrend not at the moment.cheers woodie

snip
just popped into an internet cafe to have a rest from the beach and blazing sun ( and the kids ).

it is a common misconception that when someone wins on a stock, another loses. that case could be argued for a stock such as this, but is generally not true. a share that forever varies between , say , 3p and 5p and never breaks from these prices ( up or down ) would be a candidate. if you look at share prices for a stock over a year for example, there are often long up or down trend periods.

snip
I see you have updata TA. Would you recommend it as it is quite expensive and also there courses. Many thanks

merseyside it is the BEST charting software I have ever used. I actually went on a course two days ago with David Linton, Jeremy du Plessis and Marc Rivalland. Expensive? well that is relative because the software makes it easy to pick out stocks and trades via the optimiser or highlighter tools. I can make the years cost (of realtime) on one good trade. It is incredibly reliable and easy to use with support second to none. I would not be without it. If you want to know more then please start a thread because I appreciate that we are off topic. ps it did (via obv) forecast a drop in BSY and that was picked up during the course. www.updata.co.uk they are very obliging phone up and ask for a free trial (no harm in asking)

re ETQ. It is an eratic stock with not that much data so chart interpretation is down to the skill of the operator rather than automatic signals

Hi Woodie, Is it the below statement posted by Snip yesterday afternoon that you agree with?

"I have bought now. All indicators are screaming buy and the necessary retracement has happened"

SH it isn`t grown up to use wooden spoons. I will qualify my statement by adding `short term `in front of indicators. Post 182 is now duly modified and more instructive

As you probably know indicators can vary according to the timescale. MACD and other indicators such as STOCHS are lagging indicators whereas RSI and OBV can be effectively used as foreward indicators provided that the reader is aware of various techniques such as positive and negative divergences from the trend. The primary trend is down hence my caution to those who are tempted to jump in and hold. The secondary trend is up from only june this year. It is very much a case of BUYER BEWARE and be awake or at least use a stop loss

That's better then Snip, as your post yesterday was sounding more like a ramp with nothing to back it up. Please look at all my posts since last week and tell me which you think are a rampish nature and you do know I was spot on as well even though your TA was saying something altogether different compared to mine last week. After putting the hours in digging valuable information which not everyone can find, I don't know how it can be called a ramp.

snip
just to say thanks for the advice

sh it is my own view,with all the good news in the market at the moment it is a weak stock as stated before 1 up day ,looks like another red day today.cheers woodie ps downside looks limited.

Thanks for your input Woodie.

5.50-6.50 pence, MMs couldn't get any sells first at 6.25pence, then 6.00 pence, then 5.75 pence this week and are now trying to get some stock back at 5.50 pence as buys outweigh sells again today for the fourth consecutive trading day. They have to balance their books and buys (see trades page from Monday) have totalled about 10 million this week compared to about 3 million sells this week. Let's see how low the offer goes. Keep an eye on the offer price!
Another pointer with regards to lowering the bid, they desperately want stock back. Online bid price is stil 5.88 pence.
Unless there is some news to come, like a mention in IC tomorrow. A 1 pence spread must mean something.

Each to their own peril though. The above is just my view.

Another pointer : Level 2

4 vs 4

All square!

All MMs are on the same bid and offer. Some news or mention in IC could be coming. Not seen 4 v 4 on Level 2 for ETQ before.

SueHelen - have seen a couple of times you mention that the mm's have to balance their books. I don't think they do - they can, and often do, hold long or short positions for extensive periods (many months)

my broker is now offering etq at 6.20

sh thanks for your polite responses to my posts,with the amount of time you have put into the research of this stock regardless of other peoples view you deserve to come out quids in.cheers woodie

SueHelen

Thanks for the large post of last night. I can see why you feel the way you do and agree with Woodie the amount of work you put in you deserve to come out on top. Too risky for me though. I think that for hospitals to have complete protection they will have to buy a lot of units. As they are a stand alone unit and about the size of an american fridge there range of cover must be limited, hence more will be required and with a cash strapped NHS who knows.

Any product that can clean up our hospitals and get rid of that awful MRSA bug has got to be good news. I really do hope they succeed then everyone is a winner not least of all the patients.

My do dars are'nt big enough for this one but any one holding good luck.

mickeyskint

ps. sold aal short by 45p I all ways do this, any advice on when is it good to get out would be appreciated.

Snip

Will check out your way of handling risky stocks and tap into thread HSD.

Re : my previous post. Last 45 minutes of trading....3 out of the 4 MMs were supporting the 5.50 pence bid in that they were ready to gobble stock at the this cheap bid price, they were not getting sellers hence one the MMs lowered the offer to 6.25 panic holders into selling - (Level 2) which still didn't work.
Incidentally, Level 2 closed very strong the best it can be at 3 v 1.

Buys outpaced Sells again today for the fourth consecutive trading day. With regards to the MMs actions, one just has to look at all the heavy buying this week especially on Monday at prices of 6.10 pence and above and look at the size and amount of sells that were going through.

There were no sellers at 6.25 pence, 6.00 pence, 5.75 pence and now the bid if at 5.50 pence and no sellers have appeared. This strengthens the stock in that when the price is rising we have high volume days and when the price is falling we have low volume days.

Conclusion :

One has only to look at all the heavy buying this week especially on Monday and the peanuts selling which has been 100K or less on the other days. Something is definetely brewing here having witnessed level 2 this week. Each to their own and all that.

Hi Mickey, thanks for your input (& comments Woodie, Hotei). I have not been following aal so I can't make any comments just yet on that. I could try and have a look at it for you this weekend if you like.

The size of the Nightingale Units :

I emailed the CEO of ETQ asking if they have considered producing a smaller version of the Nightingale, and I've now had a reply. Well it appears there is a complete product range (and not just the one in the picture (website)) currently being marketed by N.Q. Environmental U.S.A. Here is the relevant part of the email:

"With regard to smaller versions of the product, we now have a complete product range on offer having signed an exclusive distribution agreement with N.Q. Environmental U.S.A.
They give us the opportunity to sell units as small as TV sets. Already N.Q. Environmental have sold and are selling the Nightingale unit in the U.S.A."

For SueHelen,

I am new to this game and it is a bit of fun for me (although anxious at times) but I would like to comemnt that I think as we are all supposed to be ADULT traders/investors the comments that you have endured today are somewhat unjustified. I say this because as ADULTS we have the ability to make our own decisions and to think for ourselves and I have yet to see any physical force in people deciding which stock to but and to sell. If people like your good self do research and deem to share your opinions with the rest of us tham I can only say that it is our choice as to whether to follow your comments or not and I for one value all comments whether I agree with them or not. Keep going some of us appreciate it.

Thanks patsym.

Investtech updates after yesterday's close :

Weak Positive Candidate (Short term) - Aug 5, 2004
Has broken the ceiling of the falling trend, which indicates a slower initial falling rate. The stock has support at p 5.10 and resistance at p 8.10. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Neutral (Medium term) - Aug 5, 2004
Shows a weak development within a falling trend channel. A further negative development is indicated, and there is resistance against the ceiling of the trend channel. The stock has resistance at p 8.70. Positive volume balance strengthens the stock in the short term. The stock is overall assessed as technically neutral for the medium long term.

Weak Positive Candidate (Long term) - Aug 5, 2004
Is within a falling trend and continued decline within the current trend is indicated. On reactions back, there is resistance against the ceiling of the trend channel. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.20. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

Strong buying this morning.

No wonder the buyers are back again!
LONDON (AFX) - Energy Technique PLC, the company behind the Nightingale air filtration unit that kills the MRSA hospital superbug, will address a health commission looking into the superbug crisis.

The company will report that Nightingale has been shown to be 99.8 pct effective by the Health Protection Agency at Porton Down, Wiltshire.

Energy Technique said it is still in talks to sell Nightingale units into the National Health Service.

In July, the company announced its first sale of a Nightingale Unit into a US hospital in Randallstown, Maryland.

newsdesk@afxnews.com

SueHelen hope you are smiling this morning you certainly deserve to be!!

What a call by myself, re : my post about the last 45 minutes of trading yesterday the market makers were looking a bit dodgy on Level 2 as I posted, excellent news out today. I'll be back later after I've had my breakfast.

Some excellent weekend press should be coming this weekend and more good gains should follow suit next week as well.

RNS Number:6878B
Energy Technique PLC
06 August 2004


Nightingale superbug killer in presentation to NHS chiefs

Energy Technique plc, the UK company behind the world-beating Nightingale air
filtration unit that kills the MRSA hospital superbug, is to address a health
Commission looking into the superbug crisis.

The company will tell NHS chiefs and members of the public how Nightingale has
been shown to be 99.8% effective by the Health Protection Agency at Porton Down,
Wiltshire.

The invitation to address the September 1st meeting at Newton Aycliffe, County
Durham, comes as Energy Technique continues discussions to sell Nightingale
units into the National Health Service.

Energy Technique Managing Director Leigh Stimpson said: "This marks a welcome
advance in our efforts to make contact with influential opinion formers and
decision makers within the NHS."

Mr Stimpson added: "We are especially pleased to be able to talk to members of
the public - the growing threat of MRSA in our hospitals is an issue that
affects everybody."

The Newton Aycliffe forum has been organised by the Commission for Patient and
Public Involvement in Health, an independent public body sponsored by the
Department of Health. Its forums - run independently of the DoH, are intended to
bring local needs into policy making agendas.

Energy Technique recently announced its first sale of a Nightingale Unit into a
US hospital in Randallstown, Maryland.

Nightingale uses ultraviolet radiation combined with sophisticated air flow
systems to attack the DNA of killer germs such as MRSA, anthrax and TB. First
unveiled at the end of 2002 following prototype testing, the system has
subsequently undergone further development ahead of extensive commercial
marketing.

For further information contact:

Leigh Stimpson, Managing Director, Energy Technique plc: 020 8783 0033
Duncan McCormick, First City Financial: 020 7436 7486
077 3918 5050


www.energytechniqueplc.co.uk




This information is provided by RNS
The company news service from the London Stock Exchange
END

LONDON (AFX) - Energy Technique PLC, the company behind the Nightingale air
filtration unit that kills the MRSA hospital superbug, will address a health
commission looking into the superbug crisis.
The company will report that Nightingale has been shown to be 99.8 pct
effective by the Health Protection Agency at Porton Down, Wiltshire.
Energy Technique said it is still in talks to sell Nightingale units into
the National Health Service.
In July, the company announced its first sale of a Nightingale Unit into a
US hospital in Randallstown, Maryland.
newsdesk@afxnews.com
jc

LONDON (AFX) - Hopes of a deal with the NHS provided the spur to Energy
Technique.
The company is behind the Nightingale air filtration unit that kills the
MRSA hospital superbug, and will address a health commission looking into the
superbug crisis.
Nightingale has been shown to be 99.8 pct effective by the Health Protection
Agency at Porton Down, Wiltshire.
Energy Technique, whose shares were 1.00 higher at 6.87 pence by 8.26 am,
said it is still in talks to sell Nightingale units into the National Health
Service.

Charts + Indicators, all looking good :



Level 2 currently very strong and the best it can get at 3 v 1.

SueHelen you certainly can pick them good on you, well done.

Dear Santa,
For christmas can I please have a bigger pair of do dahs so I can make lots of dosh like SueHelen.
Fully invested so can't join you on board not untill either gsk,vod,shel,dge come's across and that's not going to happen for a while. The last of it went on HNR.

Mickeyskint by name Mickeyskint by nature.

Good luck

sue helen everything you said is going to happen has happend, award yourself a mbbe for services to this bb

Thanks guys....

Couple of tick ups with the price at 6.75-7.50 pence now. Good buying continues with about 2.6 million in buys and 600,000 in sells reported. There should be lots of mentions in the weekend press leading to buying continuing into Monday.

Sue hows the level 2, Not sure how long they can keep the offer at 7.25p .Buys flooding in. Have 3 trades running at present. Rolled over at 7.2p- 7.25p on T25

Very heavy buying continuing. 2 * Market Maker buys have come through at 7.25 pence. WINS who are one of the market makers have another large buy order to fill. WINS were the ones who filled the 500,000 T (single protected purchase) buy at 7.12 pence earlier.

Level 2 at 1 v 1, 6.75-7.25 pence, further gains are likely on Monday.

Friday's Leaders & Laggards
MoneyAM

Energy Technique were ahead 1.25p (21.2%) on hopes that ongoing talks about an NHS deal for its superbug-beating Nightingale filtration system would be fruitful.

Sue cannot see what choice the NHS have. Here is a product that can help in the fight against MRSA .When Hospitals in the US are all ready starting to take up the product. If the NHS fail to support Nightingale and MRSA continues to kill, they ( NHS ) will find themselves with a PR nightmare, when the general public discover what is going on.

what is the price expectancy on this for 2004

just how many cases of superbug have been contracted from air , not many I would think , most cases from dirty hands , dirty everything else , HCEG has got more going for it.

Agree Mad doc also hold HCEG. Good threads on MW website.But a combination of both approaches will imho eradicate MRSA.At present though ETQ has the momentum behind it and is a 1/6th of the value of HCEG.

True MRSA is a contact bug, but the case for having an isolation ward for infected patients is a must and that environment should be kept as sanitised as is poss. Times are moving forward and I'm sure a few years from now people will think it their right to have clean air, especially inside a hospital and in the workplace. A machine such as this that kills 99% of all airbourne germs dead (just as domestos does the loo) has wider implications / benifits for any purchaser. An outbreak of SARS for example could be controlled more easily with proper facilities like isolation wards.

Yoyo , I agree with your argument but the other 1% can still get you !

Press mention : will appear in tomorrow's Daily Mail Newspaper.

Beyond the Footsie: Friday close
6 August 2004, This Is Money

Hopes of a deal with the NHS saw Energy Technique rally 1.13p to 7p. The company is behind the Nightingale air filtration unit that kills the MRSA hospital superbug, and will address a health commission looking into the superbug crisis.

http://www.thisismoney.com/20040806/nm81192.html

Investtech Analysis after today's close :

Weak Positive Candidate (Short term) - Aug 6, 2004
ENERGY TECH. ORD 1P has broken the falling trend and reacted strongly up. For the time being, it is difficult to say anything about the future trend direction. The stock has support at p 5.10 and resistance at p 8.10. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Neutral (Medium term) - Aug 6, 2004
Is within a falling trend, which indicates a continued decline. Has, however, received a positive signal from the moving average indicator, thus signaling a continued rise. The stock has support at p 3.50 and resistance at p 11.20. The volume balance is positive and strengthens the stock in the short term. The stock is overall assessed as technically neutral for the medium long term.

Weak Positive Candidate (Long term) - Aug 6, 2004
Is within a falling trend, which indicates a continued decline. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

Best - Charts update at close :

5 Buy Signals
0 Sell Signals

15 Bullish Indicators
1 Bearish Indicator

The bearish indicator is MACD which will do the crossover & go bullish on the next tick up though the MACD indicator on the MONEY AM MACD indicator has already gone bullish today. The line for today has appeared above the horizontal line (see below).

maddoc, yes an interesting statistic:- 1:1 people die!

http://www.moneyam.com/InvestorsRoom/ShowPostList?fID=1&tID=3592

Approximately 178,000 shares buy has gone through at a premium to the indicative offer price at a price of 7.375 pence. Interesting.

The 178,000 odd buy orginally went through at 8.13 this morning and reported 1 hour later. Trades over 150,000 shares are delayed in reporting by 1 hour.

With L2 at 1 v 2, a shake may be coming on the bid. One just has to remind themselves of all the heavy buying from roughly the open on Friday at 7.00-7.50 pence. And the 180K odd buy today at a premium price of 7.375 pence.

As always the market makers like playing with the bid price, keep an eye on the offer price.

sh do you know when the talks start with nhs,tried to speak with company this morning,poor communication was passed from one person to another without answer.cheers woodie

my broker is offering ETQ at 6.875

Woodie,

I think some discussions are underway already, these would certainly happen in parallel with trials.

The Health Commission that was mentioned in the RNS was September 1st meeting at Newton Aycliffe, County Durham. The Newton Aycliffe forum has been organised by the Commission for Patient and Public Involvement in Health, an independent public body sponsored by the Department of Health. Its forums - run independently of the DoH, are intended to bring local needs into policy making agendas.


Energy Technique Managing Director Leigh Stimpson said: "This marks a welcome advance in our efforts to make contact with influential opinion formers and decision makers within the NHS."

Mr Stimpson added: "We are especially pleased to be able to talk to members of
the public - the growing threat of MRSA in our hospitals is an issue that
affects everybody."

-------------------------

What will be important for energy tecnique is public knowledge and opinion..we all are aware how public pressure can often drive decisions ( positively or negatively) and this may force the hand, so to speak, of the NHS and other health bodies. I am sure that there maybe even more pressure from private patients towards BUPA and the like.

GN

gn thanks for reply.cheers woodie

Hi Woodie, I think the main meeting point in on the 1st of September (see below) :

The company will tell NHS chiefs and members of the public how Nightingale has
been shown to be 99.8% effective by the Health Protection Agency at Porton Down,
Wiltshire.

The invitation to address the September 1st meeting at Newton Aycliffe, County
Durham, comes as Energy Technique continues discussions to sell Nightingale
units into the National Health Service.

Energy Technique Managing Director Leigh Stimpson said: "This marks a welcome
advance in our efforts to make contact with influential opinion formers and
decision makers within the NHS."

WINS have moved up on the bid as reflected with the tick up on the bid to 6.50 pence on barely any buys. Well the bid price did tick down on barely any sells as well. As I say they do keep moving the bid price around, as always with this stock you get a better indication with what the offer price is at.

Level 2 : 1 v 3

whats the price expectancy on this short term

MMs really teasing us with the bid price today, bought another 62,902 shares at 6.94 pence just now (3rd batch, first at 4.95 pence, then at 6.55 pence and now at 6.94 pence). Buys outweigh Sells today with barely any sells of any significance.

250,000 T BUY reported at 7.00 pence (someone had order in to purchase 250,000 shares at 7.00 pence).

Another 250K T buy has come through at 7.00 pence four minutes after the first one.

That's the third large buy today : 180,000 odd buy first thing this morning and again any sells have been 100K or less today.

Hi thesaurus, I wouldn't like answer that question as it stirs trouble on the bulletin boards. I mostly buy oversold shares that have fallen from dizzy heights which show potential, and ETQ fits into that category.

etq have rigged out the houses of parliment with nightingale, i think this is a good endorsement for the product

TA is excellent at the moment -

Best - Charts at close :

3 Buy Signals
0 Sell Signals

14 Bullish Indicators
1 Bearish Indicator.

Hi Sue Helen & fellow investors, thanks for the excellent posts you are all contributing to this thread but especially to Sue who I'm learning from and understanding more about L2.

I have been a shareholder in ETQ since this thread was created and at present showing a loss but have viewed my initial investment to be long term. I am now adding as the TA indicators are very bullish particularly as MACD is staying above O and RSI(14) is above 50 and indicates that the share price will rise for a while to come. Once this share gets above 10.52 I'll be happy once again, and given all the hard work ETQ has and is doing to win orders for Nightingale since creating this thread I believe now this is all about to come to fruition.

The next six months should be giving out some very good sales news when the NHS realise that MRSA found in hospitals and infecting patients from surgical wounds were once or could have become airbourne. Sanitised air in these areas seems an immediate solution to an alarming problem the NHS and other private hospitals and their insurers have!

a lower high to contend with first

Large buy reported just now for 231,874 shares at 6.99 pence from an hour ago when the offer price was at 7.00 pence. 3 * 100K buys have also come through today after the attempted treeshake first thing this morning. Buyers having the upperhand again.

L2 ne1?

Level 2 is stable at 2 v 2, WINS and SCAP on the bid at 6.50 pence.

Drunker

You just dropped in a simple line about etq and houses of parliament, where did this come from? Havn't seen anything about that, surely thats the sort of info which would be v.important.

Dont forget ETQ installs 'normal' AC systems as well......

Please expand on this

cheers

GN

not sure were i read it but it was one of the reasons i bought this stock a couple of mths ago, i read that they had it installed to counter sars and other possible attacks

ETQ have installed air con, not UVGI, in the HP. This has nothing to do with SARS. Don't you think that if they had put a UVGI unit into the HP for SARS, the papers would be crawling all over it?

Tick up on the bid price to 6.75 pence....WINS moved up on the bid to 6.75 pence. Level 2 at 1 v 2.
Watch out for any more big buys that come through later on....had 3 yesterday. 2 in the afternoon towards close and 1 in the morning.
WINS are the ones who I believe filled the big buy orders yesterday and the large buy of around 230,000 shares at 7.00 pence this morning as well.

just a note from last Friday's Manchester Evening News: Tea Tree Oil may the answer to eradicate MRSA. In brief it read that there is some trials using the Tea Tree oils in a NW hospital. So if someone can get hold of the newspaper vi online would be good to get it posted here.

siver colloid
tea tree
manuka honey at a UMF activity of 10+ or more

also educate the great british public re washing properly esp before eating as bacteria enter through openings such as the mouth, cuts etc

once MRSA is in, it can be dormant for ages until the body is under stress

Having been in the red in early trading we finished with a 2% gain today with the price closing at 6.75-7.25 pence. Some good buying reported today including about 6 block buys of 100,000 shares and 230,000 shares buy at 6.99 pence. Two trades for 300,000 shares appeared around 7.25 pence in the afternoon. I'm inclined to assume that both of those could be buys and not a rollover. I say this because the first 300,000 trade has an L next to it meaning it has been reported as a late trade. The second one hasn't. So if we apply logic to this then the first 300,000 trade was put through at a much earlier time hence then they can't be a rollover and both of the 300,000 trades are buys.

almost at a very critical level

Level 2 at 1 v 2...WINS on the bid price at 6.75 pence.

Do we still need to look at the offer price, i'd like to top up here

Yes Xmortal I have re-iterated several times that with this stock one has to keep an eye on the offer price. On any small drops that have happened have immediately been erased with buyers accumalating more. The market makers have moved the bid price around this week but the offer price has stayed constant. What the offer price is at counts the most and is more important than the bid price.

Copied from investtech

"Shows a weak development within a falling trend channel. A further negative development is indicated, and there is resistance against the ceiling of the trend channel. The moving average indicator has, however, given a positive signal. In isolation this signals a continued rise, but the slowness of the indicator often means that one has lost much of the upside."

Don`t, for goodness sake, bet the house on this stock but it is nice for a flutter with money that you can afford to lose

Hi Snip, the first sentence of the Investtech Analysis was like that when I bought my first batch at 4.95 pence. That is not the only thing one needs to look at. Positive newsflow is coming from the company now which is more important.

like I said

It is very nice for a flutter

ok.

thanks sue

Over the next 4-6 weeks I would expect this to move steadily north. Resistance could be met at 12p in mid Sept.

Nice shake by the MMs, did this yesterday morning as well. 3 MMs sat on the 6.25 pence bid ready to gobble up stock on the cheap. As always keep an eye on the offer price...that gives a better indication.

Incidentally, Level 2 is at the strongest it can be now at 3 v 1, with just EVO on the offer at 7.00 pence.

As always with ETQ low volume days on falling prices and high volume days on rising prices strengthens the stock in the short term.

The MMs are shaking it hard today with EVO just lowering the offer to 6.75 pence.

100,000 buy comes through at 6.60 pence.

Level 2 at 2 v 1 now - MLSB on the offer - EVO in the middle 6p-7p

Another 100,000 buy comes through at 6.60 pence.

Level 2 tick down and now at 1 v 1.

They still not getting much in sells hence the MMs are continuing to work in tandem. We saw these actions last thursday before the good news came on Friday.

Another 100,000 buy comes through at 6.69 pence. Three 100K buys in the last 30 minutes. Bid price ticks up to 6.50 pence

Another 100,000 buy at 6.72 pence. Four 100K block buys in the last 30 minutes.

Buys having the upper hand again and buys are ahead of sells now :

Buys = 561,988
Sells = 439,000

50K buy comes through at 6.69 pence.

The offer price ticks back up to 7.00 pence. Price 6.50-7.00 pence. The treeshake by the market makers was too evident and atrracted just buyers.

Level 2 still positive at 2 v 1.

Tick up on the bid price to 6.75 pence. 6.75-7.00 pence.

Level 2 :

1 vs 1 (WINS vs MLSB)

ALL MM's blue..

mms will want stock ahead of shares mag due out thurs,should have a positive write up.

WINS moved back down to 6.50 pence on the bid on no sells. As always keep an eye on the offer price.
Leve1 2 is positive now - 2 v 1 - WINS dropped bid and joins EVO, MLSB still on the offer.
So 7.25 pence on the offer can still come.

How do you know that there will be a mention in Shares tomorrow Woodie if you don't mine me asking, not that I would compalain but would be a bonus.

sh i dont know for sure just a feeling rns statement last week was to late for last weeks issue as they have tipped the stock before should follow suit tommorrow with a write up.cheers woodie ps could be the reason mms want stock today for mark up in the morning.

Maybe Woodie, it will be a bonus I feel as even without it there is some excellent potential here.

At close : buys outweighed sells again for the eighth consecutive trading session.

Buys = 769,389
Sells = 574,927
????? = 25,000.

between heaven and hell



my directional movement indicator (unfortunately I don`t know how to post my charts) is saying that etq is going into a coiling mode for a while. ADXR is falling together with the positive line. This is not necessarily bad as it means that there is likely to be a period of consolidation and looking at past history, they seem to take approx a month or so

Please elaborate Snip as this is the second time you have posted a chart with no explanation after yesterday.

I would have thought that this is pretty obvious from the chart. Up through 200 MA is very likely to lead to higher prices. Down through 50 MA shows weakness

Thanks Snip. You do have take other things into account such as newsflow from the company as well and not just concentrate on charts. Remember when the EVO buy note came out at 5.50 pence and you were still analysing the charts instead of looking at the buy note. You'll improve your trading skills if you try to take a balance view using both charts and newsflow.
I'm not even looking at the charts at the moment with the amount of stock hungry buyers are snapping up in 100K blocks buys or more during the last two weeks. At this moment, it is more important to look at newsflow and speculation will start flowing soon in press reports from sources such as Shares and Investors Chronicle about the NHS presentations.

PS. When I first recommended these at 5.25 pence you mentioned that the MACD was bearish and hence further downside was likely to 4 pence and now the MACD is bullish so what are you views on that now please.

For your own benefit Snip, use the charts indeed but to catch the bottoms like I did at 4.95 pence when I bought my first batch but don't get too bogged down with them.

Improve my trading skills???

granny and eggs come to mind SH. I don`t have to post anything on this thread but I hate to see `vulnerable` people sucked in on `might` `if` `I think` etc etc

I am neutral re my holdings and therefore I am UNBIASED and I say it as it is

re catching the bottom. Good on you but luck and falling knives belong to the catching bottoms game.

Lets hope there is no spilt blood on anyone`s hands

but I hate to see `vulnerable` people sucked in on `might` `if` `I think` etc etc

_ when I have hinted that news will come has it not come on the previous two occassion, the EVO buy note and the RNS last Friday whilst on those occassion you've been still looking at the charts. Just remember the golden rule that TA goes out of the window when news comes.

PS. I didn't mean to cause offence, it was only a suggestion.

Level 2 did close positive at 2 v 1 today so I would expect 7.25 pence on the offer to come very quickly in the morning. After that one MM is on 7.25 pence on the offer and the other 2 are on 7.50 pence.

So in effect barring no MM games 7.50 pence on the offer could come quite quickly tomorrow.

got it wrong no mention in shares today cant understand why?

Hi Woodie, doesn't really matter. We did have one recommendation from them roundabout the 15th of July 2004...so may get another one in the coming weeks.

Shares Magazine on 15 July 2004 :

With almost a 10% risk of infection for hospital in-patients from the MRSA superbug, TB, anthrax and other dangerous germs, the government has launched a campaign to cut the death toll.

One beneficiary should be Energy Technique (AIM:ETQ) whose shares have doubled to 8p since it announced the first US sale of its Nightingale air filtration system to the Northwest Hospital Center in Randallstown, Maryland. More US sales are expected to be announced shortly. The system, a free standing air conditioner the size of an American fridge and costing 5,000 uses ultrviolet radiation combined with sophisticated qir flow systems to attack the DNA of killer germs.

The lenghty trial of two units at Basingstoke Hospital comes to an end in Autumn. Energy Technique is hopeful this will finally kick start long-awaited sales to the NHS.

Meanwhile licensing and manufacturing deals have beed struck with major companies to gear up production assuming demand takes off. The company's own factory at Basingstoke can make only about 1,000 units a year.
Full results will be released shortly and will show a 1 Million-plus loss. The company is trading profitably and is well funded after a 3 Million placing at 4p a share in March

Shares Says: Air Filtration market offers huge potential



The price is up today at 6.50-7.25 pence, MLSB were on the offer at 7.00 pence as I stated yesterday and have moved to a higher offer of 7.25p pence this morning.

Level 2 currently at 2 v 2, WINS and EVO on the bid and SCAP and MLSB on the offer.

MMs offering 6.70 on the bid online now, may see a tick up on the bid to 6.75 pence again.

In Level 2 terms WINS may move back onto the 6.75 pence bid.

Interesting, MMs offering 6.75 pence on the bid online now. A big premium of 0.25 pence on the bid...must mean something.

Its EVO the house broker who is after stock today and offering 6.75 pence on the bid online. It was EVO and not WINS who moved to 6.75 pence on the bid in the morning. Do EVO know something?


Still 2 v 2.

Good buy reported for 108,948 shares at 7.10 pence.

Sue did you take a look at cms yesterday. ( etq on iii )

Re : my posts in the morning, a 250,000 T buy has just come through at 7.00 pence. Someone had an order to purchase 250,000 shares at 7.00 pence.


Hi momentum, all funds tied up at the moment.

At close :

Buys = 632,199
Sells = 419,644

Buys outweigh Sells for the ninth trading session in a row.

Somebody is accumalating stock here at 7.00 pence, that has been the case this week. See the trades since Monday where the buys have been large ones at 100K, 200K+ and sells have been few generally at 50K and below.

Re:my posts earlier why the MMs were paying a premium of 0.25 pence on the bid at 6.75 pence online was that the 250K buy was going to come through just before close.

sh even though this is the 9th day in a row buys v sells why is the price not reflecting this seems static all week?

Hi Woodie, It is because there have been large buy orders that have been on the market makers books to fill at set prices between 7.00-7.50 pence. Looks like some clever accumulation going on - without causing too big a rise in price.

Have a look at this, a nice pattern :

Before last week the price was building a base at 5.00 pence
Last week the price was building a base at 6.00 pence
This week the price has been building a base at 7.00 pence.

PS. Ten trading days ago I bought my first batch at 4.95 pence so the price has risen 40% in the last ten trading days and has been as much as 50% up from that level.

Infection Alert at Hospital :

Now, if they'd been using Nightingales this might never have happened.

11:00 - 12 August 2004
Patients who booked in for joint replacement operations at Southmead Hospital have had their operations cancelled because of a possible infection risk in operating theatres. Around 20 serious operations involving invasive surgery at Avon Orthopaedic Centre have been cancelled as a result of problems with ventilation systems.

However, most smaller operations will continue to take place in the hospital theatres.

The North Bristol NHS Trust, which runs Southmead Hospital, said the theatres have been closed because an air flow problem may cause an increased risk of infection for joint replacement operations, which involve cutting and exposing more flesh than many other operations.

Alison Sullivan, aged 41, from Kingswood, was informed that an operation on her ankle had been cancelled.

Her husband Steve said: "I'm so angry, because this has put my wife under so much stress."

A North Bristol NHS Trust spokesperson said: "There may be a possible chance of a very small increased risk of infection for joint replacement operations, which are highly invasive procedures."

--------------------------------------------------------------------------------

Just shows how disgraceful the problems are and the top people still can't see them. Yes it will cost money to implement measures but is better than hospitals closing down and these people losing their jobs.

If anyone's looking for an opportunity to make some money aside from ETQ :-).

Cast any eye on DAG, it's set to explode. The five year graph shows where it may revisit, LESS shares in circulation this time around following the director buy-back.

DYOR etc

news of this product going into nhs hospitals could be part of mr blairs election campain- certainly make him more popular

New Investtech update (changed) which has been upgraded from weak positive candidate to positive candidate for the short term after yesterday's close.

Positive Candidate (Short term) - Aug 12, 2004
Is within a rising trend and continued advance within the current trend is indicated. On reactions back, there is support against the floor of the trend channel. The stock has support at p 5.10 and resistance at p 8.00. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which strengthens the trend. The stock is overall assessed as technically positive for the short term.

Neutral (Medium term) - Aug 12, 2004
Is within a falling trend and continued decline within the current trend is indicated. On reactions back, there is resistance against the ceiling of the trend channel. The moving average indicator has, however, given a positive signal. In isolation this signals a continued rise, but the slowness of the indicator often means that one has lost much of the upside. The stock has resistance at p 8.70. Positive volume balance strengthens the stock in the short term. The stock is overall assessed as technically neutral for the medium long term.

Weak Positive Candidate (Long term) - Aug 12, 2004
Is within a falling trend and continued decline within the current trend is indicated. On reactions back, there is resistance against the ceiling of the trend channel. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.40. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

although a holder of etq, i cannot understand why these fridge sized units are required at all. if hospitals cleaned properly and used tried and tested infection control techniques, the problems etq is trying to solve would disappear.

a rather crude analogy is eg the use of abs in car braking systems. the driver knows he can hit the pedal as hard as he likes and the machinery will do the work.

im not in etq because of the technology, im in because it appears they might start selling it.

Hi superrod, below is one of my earlier posts with regards to the size of the Nightingale units.

The size of the Nightingale Units :

I emailed the CEO of ETQ asking if they have considered producing a smaller version of the Nightingale, and I've now had a reply. Well it appears there is a complete product range (and not just the one in the picture (website)) currently being marketed by N.Q. Environmental U.S.A. Here is the relevant part of the email:

"With regard to smaller versions of the product, we now have a complete product range on offer having signed an exclusive distribution agreement with N.Q. Environmental U.S.A.
They give us the opportunity to sell units as small as TV sets. Already N.Q. Environmental have sold and are selling the Nightingale unit in the U.S.A."

SH

thanks, but that doesnt really answer my main concern. ie this technology shouldnt even be needed with good housekeeping. btw my wife is a nurse ( 25 years ) and agrees with me. these are not by any means new problems. im happy to make money on etq though, whether i should or not is another question.

The September presentations with the NHS chiefs is a great opportunity for ENERGY TECHNIQUE to get their message across which is that the NHS need to have as many methods/processes in place to prevent the MRSA problems.Hygiene involves many areas which need to be addressed and ENERGY TECHNIQUE will stress that airbourne infections can be prevented with their Nightingale product for which they have data from hospitals which have used their products showing the effectiveness of their product.The NHS will need to understand that they need to use ENERGY TECHNIQUE air products alongside other measures to ensure an hygienic environment.The ENERGY TECHNIQUE product is a preventative measure and that is what the NHS need to wake up too!
The extent of the MRSA problems means that they should take on board these issues because certain hospitals could be closed down unless they take on board every measure to overcome the problems!

Tuesday's Bloomberg article mentioned that hospitals in the USA were buying more products.Now the point is that whatever the products are they will also have a knock on effect on the hygiene problems which will also need to be addressed a great sign for ETQ.

More lawsuits (in the US) re MRSA - this may help sales of the Nightingale there if such lawsuits are successful!
http://www.courier-journal.com/localnews/2004/08/07ky/B5-jewish08070-4199.html

... and here is the latest cure for MRSA! ...straight off the Aussi press:
http://www.thesundaymail.news.com.au/common/story_page/0,5936,10371629%255E903,00.html

(even if it works it won't stop people becoming infected in the first place of course)

and finally, this article sums up why the MRSA problem has now become so tragically serious in our hospitals, as we all well know but the government does not want to admit.
http://www.newsandstar.co.uk/opinion/viewarticle.aspx?id=122601

Re : shareprice.

One change today is positive in that for the short term trading range it was stated as ETQ does not show any clear trend. Now it is stated that we are in a rising trend & continued rise within the trend channel is indicated.

Source : Investtech.

ukwire alert

"The Company announces that application has been made for a total of 3,052,560
ordinary shares of 1 pence each ('Ordinary Shares') to be admitted to the
Alternative Investment Market of the London Stock Exchange. The application is
pursuant to the exercise of the 2001 option agreement between the Company and
Harrell Hospitality Group Inc. granted in May 2001. Harrell Hospitality Group,
Inc. has no further options following this exercise of options.


Admission is expected to become effective on 18 August 2004."

received 9.30 13/8/04

Re : my postings yesterday about the premium on the bid, again today the market makers are offering 6.73 pence on the bid and 7.17 pence on the offer.

info about dilution of a stock (not etq just general stuff)

http://www.fool.com/news/commentary/2004/commentary040505pe.htm

Dilution : its only 3 million shares.

The additional listing refers to the below (May 2001):

The company is selling the loss-making Bensons Heating unit to a management
buyout team and has agreed to a cash injection from a consortium of companies
and individuals led by Harrell Hospitality Group Inc and Cybertec Holdings plc.
They will be subscribing for 36.7 mln new Energy Technique share at 3 pence
each and intend to pay 587,688 stg in cash for the stock and 514,312 in shares
in Cybertec.

ONLY 3million shares?

dont wish to appear negative as a holder, but 3million shares is the best part of 250k ( a significant percentage of the market cap )

as the ovehang is absorbed ( i hope ) punters wil be buying and selling. could be a long wait without news at todays trading rate.

Level 2 at 1 v 3, just WINS on the bid who are offering 6.73 pence on the bid and are chasing stock as they have done throughout this week. It has been WINS who have been filling the large buys that have come through every day this week.

WINS are still not getting any stock at 6.73 pence. Hence they might try to get some stock back from the usual suspects by moving onto the 6.25 pence bid. As always keep an eye on the offer price.

Level 2 has just improved after the 70,000 buy at 7.00 pence. EVO have joined WINS again on the bid at 6.50 pence. Level 2 from 1 v 3 is now at 2 v 2.

7.2 pence on the offer now

Hi patsym,

Level still at 2 v 2 after EVO the house broker joined WINS on the bid mid-morning today.

WINS are now offering 6.75 pence on the bid price, a hefty premium of 0.25 pence on the bid. Real price 6.75-7.20 pence. A large buy may come through again towards close. A succession of large buys have been coming through on each day this week hence may get another one today also.

nice way to end the week hey?

Would be yes patsym, though I'm very happy with the activity this week albeit no change in the price.

We have had a good week I think this week :

We have moved into an uptrend now (my Investtech post)
Lots of large buys have been coming through
The sells have been the size of peanuts, really small.
Buys are outdoing sells for the tenth trading day in a row
The price has been able to hold onto all of its gains

Pattern :

Week before last week the price was building a base at 5.00 pence
Last week the price was building a base at 6.00 pence
This week the price was building a base at 7.00 pence
Next week we could be looking at the price building a base at 8.00 pence and attacking the resistance at 8.10 pence.

Well the large buy didn't come today though level 2 closed at 2 v 2 with EVO and WINS on the bid and the real price was 6.75-7.20 pence at close. WINS paying a premium of 0.25 pence on the bid ???

At close :

Buys outweighed Sells for the tenth trading session in a row

Buys = 180,502
Sells = 67,726

Yes not much buying today but again like all the past trading sessions the buys that come in are large and the sells that come in are small.

Buys vs Sells for the last ten trading sessions :

Below in reverse order where the first batch is today's data (the buy/sell column trades are incorrect for some days), I have had to go back on previous posts and take the figures that I have posted at the close of each trading day, I have not included any rollover trades in the data as they don't affect the price :

Buys Sells

180502 , 67726
632199 , 419644
769389 , 574927
1750000 , 670688
1600000 , 1000000
9000000 , 3000000
263181 , 259503
348285 , 344279
1450000 , 597047
3600000 , 2200000

Total Buys for the last ten trading sessions = 19,593,556
Total Sells for the last ten trading session = 9,133,814

I make that about 10 million in more buys.

sh

as i have said im a holder, but your figures say to me there is one LARGE dump coming. ( albeit it would appear to be covered judging by the static price )

Hi Superrod, the calculations suggest that somebody is accumalating stock at fixed prices in ETQ at prices of around 7.00 pence, some clever accumalation buy orders getting filled by the market makers without raising the price, Level 2 gave a good hint about this on each trading day in the last week (look at the large buys at 7.00 and 7.25 pence this past trading week). The real action happens on level 2 which gives the first indication of good things about to happen and it looks like some more good news is on its way. Level 2 was looking the way it is before last friday's news release came (see my posts during last week) about the September 1 presentations to the NHS chiefs.
Having thought through the RNS regarding the NHS chiefs/presentation etc soon this is also a great achievement and shows that the NHS want to listen to ENERGY TECHNIQUE as the NHS are under pressure with the problems that exist in the UK. I think that the Energy Technique sale in the USA and data that ENERGY TECHNIQUE have from trials will have pursuaded the NHS CHIEFS to want to attend the presentations and hopefully they will WAKE up and get convinced that they need to tackle AIRBOURNE problems asap.



Investtech Analysis updates after friday's close :

Positive Candidate (Short term) - Aug 13, 2004
ENERGY TECH. ORD 1P is in a rising trend and a continued rise within this trend may be expected. In addition, the price has now fallen back towards the floor of the trend channel, which should give a reaction up. The stock has support at p 5.10 and resistance at p 8.00. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which strengthens the trend. The stock is overall assessed as technically positive for the short term.

Neutral (Medium term) - Aug 13, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. Has, however, received a positive signal from the moving average indicator, thus signaling a continued rise. The stock has resistance at p 8.70. Positive volume balance strengthens the stock in the short term. The stock is overall assessed as technically neutral for the medium long term.

Weak Positive Candidate (Long term) - Aug 13, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.40. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

WINS still after stock, offering 6.77 pence on the bid now. A 0.27 pence premium to the indicative bid of 6.50 pence.
6.77-7.17 pence.

WINS & EVO (house broker) on the bid, Level 2 still at 2 v 2.

MM tricks,

Level 2 for ETQ at 4 v 4 now, WINS and EVO moved to 6.25 on the bid just after one other.
They happily want sells to come, they making sure a buying frenzy doesn't start. Either an Holdings in Company announcement should be coming this week with regards to the accumalation of stock by someone or some more good news is forthcoming in due course. The size of the sells again which have been few at 50K or less. Watch out for any large buy(s) as always, and keep an eye on the offer price as that always gives a better indication with ETQ.
Naughty MM's :

Online buy price is still 7.17 pence.
Online sell price is 6.50 pence.

Still paying a premium of 0.25 pence on the bid.

100,000 Buy has just come through at 7.00 pence...

hi. Please read today's SUN on MRSA. Also notice all MM are levelled on thh b/o. Any comments Sue? Ta

Hi Xmortal, see my earlier posts today about the MM's. Level 2 is still at 4 v 4 with WINS continuing to offer a premium of 0.25 pence on the bid for stock as of last Thursday.

Thanks for the mention about The Sun articles Xmortal.

Here they are (MRSA still on the increase) :

NHS disgrace


A SUN investigation reveals that levels of the deadly MRSA superbug are actually INCREASING in many NHS hospitals.
Shockingly, the situation is worse in seven of ten hospitals we first tested eight months ago.

Our investigations prove that despite promise after promise, and the expenditure of billions, many NHS trusts are NOT beating MRSA.

Patients are terrified of going into hospital with good reason.

Nearly ten per cent of all patients catch infections in hospital. At least 5,000 of them are killed.

Many hospitals checked by The Sun still give an impression of being sloppy, chaotic and filthy.

Dont just take our word for it.

Last month Sir John Bourn, chief of the National Audit Office, said that despite being warned to improve FOUR YEARS ago, the NHS still does not have a proper grasp of the extent and cost of hospital-acquired infections.

Yet, as we report today, it IS possible to defeat MRSA.

Great Ormond Street childrens hospital has a strict system of cleaning and infection control and so far this year no child has been infected there with MRSA.

If Great Ormond Street can manage it, why cant the others?

NHS still dirty and deadly

Infection ... hospital superbug

By EMMA MORTON

LEVELS of killer superbug MRSA are rocketing in hospitals, a shock probe by The Sun reveals today.

Seven of ten we tested have worse figures than eight months ago, despite a vowed blitz.

Our team found dangerously high counts in places such as entrances to intensive care and even bone marrow treatment units.

Doors, lifts, pay phones and stair rails were also covered with the bug in still grimy and badly cleaned areas. The chilling findings were made as we went back to major hospitals tested in December.

Newcastle General, the worst infected last year, STILL had the highest level even though it had gone down.

And Chelsea and Westminster where Cherie Blair had son Leo recorded a seven-times increase.

Swab tests were taken at nine points in each hospital and samples analysed in a lab after two days incubation to get an average figure.

Microbiologist Chris Malyszewicz, who tested results from both probes, said he was horrified at the rises.

He measured the number of Colony Forming Units per square cm with 0.1 being low and 0.5 high.

But Chris, whose detailed findings are revealed on this page, added: You can become ill from any amount. The figures will embarrass Health Secretary John Reid who vowed a crackdown on ward bugs that kill 5,000 a year.

They follow a Sun probe last week when a reporter doing a cleaning job was told to re-use cloths that had wiped loos.

Recorded MRSA deaths are now 800 a year but the real figure is thought to be much higher. Survivors can end up having limbs amputated.

Patients groups reacted with anger at our findings. Peter Walsh, of charity Action Against Medical Accidents, said: They are shocking. Tony Field, of MRSA Support, said: We are not surprised.

The trades reported at 6.25 pence for 135,471 pence looks like a rollover. No change on Level 2 still at 4 v 4.

Those trades were a rollover for sure. They were simultaneously put through together on 2 August 2004. Exactly ten trading days ago when a lot of heavy buying occurred on that day due to mention in the daily mail on that weekend with regards to the Buy note from Evolution Beeson Gregory. Not surprising then other T10s expire today and MMs have hence widened the spread and lowered the bid to 6.25 pence even though they are still offering 6.50 pence.

The next batch of T10s expire on this coming thursday from Friday 6 August 2004 when the NHS presentation RNS was announced. As always keep an eye on the offer price, that says it all if you don't have access to level 2.

WINS could not get much stock back even with T10s exiting and hence moved to 7 pence on the offer. Remember it has been WINS chasing stock and filling the large buy orders over the last week.

Level 2 now is very positive at 3 v 1 with just WINS on the offer.

The tricks by WINS is so evident on Level 2, continued to pay a premium on the bid for the last three days and they still could not pick up any stock and hence now moved down on the offer and see if that panics some into selling.

for goodness sake!! Can`t you see the dying momentum and the similarities to january 2004

No Snip, I can't. You are not looking at the newsflow and whats happening on Level 2. This is a better stock that the one you tried to ramp up on Friday which was NMT. You're producing a different chart all the time.

It still did not happen for them, just a handful of sells. Most of the T10 holders may have decided to keep hold of their holdings with the pipeline of good news to come.
Not even one sell since WINS moved onto the offer of 7.00 pence at 4.17pm. That must be embarassing for them.

With level 2 closing at 3 v 1 at 6.25-7.00 pence which is the best it can get we should get a blue day tomorrow now. US markets look good today as well.

heh?? I know nothing about nmt and have never discussed nmt.

As you know I do NOT ramp. I say it as it is

Aplogies it was Snip24, got no idea who that is.

You're still concentrating too much on the charts, its your choice.

With the NHS presentations on 1 Sept 2004 I'm not bailing out, and with the amount of large buys I've seen compared to the minisucle sells and the action on Level 2 I think much more gains will be forthcoming in the next 4-6 weeks.

Hi Sue i have not bought her yet but i read your posts, could you explain a little more about watching the offer if you dont have level 2?

Hi John, the offer price gives you a better indication (see my earlier post). For example, today the T10 holders had their settlement due which the market makers are aware. Hence the market makers knew they would have to sell out and hence lowered the bid price and made the spread at 1 pence which is the maximum. Now they did not bring the offer price down right until ten minutes before close when they tried to panic some into selling and even they were still offering a premium of 0.25 pence on the bid all day for the third trading in a row even though they could have done without that. WINTERFLOODS who is one of the market makers is definetely upto something here, they have been paying a premium on the bid, the premium was 0.27 pence first thing this morning, and they have been filling the large buy orders that came through last week (look at the trades over the last ten trading days). It failed, and L2 closed at its strongest at 3 v 1 so expect a blue day tomorrow. They still not get any sells and I think most of them decided to keep hold of their stock by making the purchase.

Look at the trades on 2 August 2004 and 6 August 2004 for clues to my other posts. It would be a good idea for you to read through my post from when I first bought in at 4.95 pence and how things have developed since then. It will give you a further insight into the ETQ as well.

The chart may not be very pretty yet but then again it was worse when I first got in at 4.95 pence. Snip posted an investtech post about a falling trend at the time but now I can post an Investtech post about a rising trend.

The market makers always play about with the bid price, they are reluctant to bring the offer price down as this stock is on many radars an on each time the buys come in again when they do decide to that.

If you want to buy these with no risk at all then wait for the next news release.

Thanks Sue very well explained, i now see what you mean.

Checked out the ETQ website and found the following two links regarding NQ distribution of ETQ UVGI products. Well worth a look! Clearly the range of UV air filtration products available is far more extensive having just seen the one picture of the Nightingale Unit from the ETQ website.

The links are:

http://www.energytechniqueplc.co.uk/pdfs/UVGI/NQ500.pdf


and

http://www.energytechniqueplc.co.uk/pdfs/UVGI/NQclarifier.pdf


( These links to NQ distributed products are from the ETQ UVGI website page at
http://www.energytechniqueplc.co.uk/Pages/UVGIPages/UVGI_home.html )


It seems highly likely to me that NQ will have successfully sold some of these products by now. I guess we will find out before too long now.

Drug-resistant superbug threatens to break out of hospitals
15 August 2004
By EMILY WATT

Virulent new strains of the MRSA superbug have scientists worried it may soon burst through hospital doors and spread into the community.


A new strain that spreads by skin contact is infecting thousands of people across the globe. The bug has been in New Zealand communities for several years, but scientists say overseas trends suggest it may be becoming more dangerous.

MRSA is a form of staphylococcus, a bacteria found in the noses of one in three healthy New Zealanders, which can cause infections when it breaks through the skin. These can be hard to treat due to MRSA's resistance to antibiotics.

Until now, its danger has been confined to hospitals, where the bug can cause life-threatening infections among the sick and elderly.

Reported MRSA infections have rocketed by 2000 per cent in New Zealand in the past 10 years. Last year, the bug was found in 6168 New Zealanders, 2016 of whom had a strain resistant to more than two antibiotics.

Some hospitals have recently reduced their rates of MRSA through more stringent isolation measures, but scientists are worried that if the hardier bugs spread outside the hospital, there may be no way of controlling them.

NZ Diagnostics microbiologist Richard Doehring said the new strain was more virulent, could spread more easily, and may develop resistance to other drugs. "It is a more highly evolved pathogen," he said.

The infection is spreading rapidly in America and Doehring said the same could happen here.

But other scientists point out the bug has been in New Zealand for years and caused few problems. Chairman of the Health Ministry's antibiotic advisory group, David Holland, said healthy people remained unlikely to fall ill from MRSA and those affected usually had an illness or wound that made them susceptible to infection.

So far the community-based MRSA remained treatable with common antibiotics, but Holland said it was possible the bugs could pick up more resistance genes.

The bacteria can exchange genetic material and transfer resistance on to other bugs without the antibiotic being present.

Holland said the number of drugs available to treat the bugs was running out. "My colleagues are now facing an onslaught. In the long term we're going to have to deal with more of these organisms. Our job is to try to delay it as long as possible."

Holland said more had to be done to restrict the use of antibiotic use in humans and animals.

Southern Community Laboratory scientist John Aitken said the new bacteria were worrying. Once they spread through the community, there was no telling what cross-resistance they could pick up. "The bugs are getting cleverer," he said.

Aitken, Holland and Doehring called for better monitoring of antibiotic resistant bacteria to better understand and prevent the spread of infection. Aitken said not enough was known about the rates of antibiotic resistance in New Zealand. While MRSA rates were recorded, other bugs were emerging that were probably more prevalent but virtually unknown as there was no surveillance. "We're seeing these new things coming out and have no idea where they're coming from.

"We declared war on bacteria when we chucked antibiotics at them but we've only succeeded in annoying them. And when something's annoyed, it comes back at you. We've started the ball rolling and it's up to the bugs now."

Good buy has just come through for 112,143 shares at 6.74 pence. We have gone blue now as well.
My earlier post, see the game WINS were playing. It took one 100K buy to move them off the offer and back onto the bid.

Level 2 at 4 v 4 now.

Another good buy for 100,000 shares has just been reported at 7.00 pence. Re : one of my earlier posts, that the sells that come are miniscule and the buys that come are large.

Level 2 still at 4 v 4, all MM's on the same prices.

Another large buy filled today : 250,000 buy reported just now as delayed at 6.75 pence.

MLSB or WINS filled that buy order today. WINS logged ten minutes after EVO and SCAP today who logged off straight after the market close. Twenty minutes now since the market closed and MLSB are still open.
At close the online buy price was 7.15 pence, and in the morning it was 6.74 pence, in between the 250,000 buy order was put through.
As I always say the sells that come are always miniscule and the buys that come are large.

Sue, do you get all that information from level 2.

Yes John and because I have been looking at every single thing for the last three weeks. Hence I kept stating in my previous post sometimes that something good is brewing here and there is not much point just looking at the charts.

It was MLSB or WINS who filled the 250K buy. Look at the trades for the last week or so, they have been more larger buys that have come through like this one whereas even the sells which were few were miniscule.

One of the market makers MLSB are still open, twenty-five minutes after market close.

Forty minutes after market close and MLSB are still open.

MLSB have just logged off now, 45 minutes after market close.
Any more larger buys will not come through today but tomorrow now as trades over 150,000 shares are delayed in reporting by 1 hour.

Are you saying they stayed open to try and obtain more stock??

It's begining to look like a coiled spring, I may dip in for a few more pre the w/e.

SW

Lots of activity pre-market on Level 2 this morning with the price opening at 6.50-7.00 pence, normal spread restored (the price closed at 6.25-7.25 pence yesterday). WINS are on the new bid of 6.50 pence.
Level 2 at 1 v 1, 6.50-7.00 pence.

Regional news

Superbug timebomb Aug 17 2004

By Helen Clarke, Liverpool Echo

THE deadly superbug MRSA is a ticking timebomb on hospital wards and legal experts warn an explosion of compensation claims could leave the NHS facing massive legal bills.

Liverpool lawyer Ian Cohen, from Goodman's Solicitors which specialises in clinical negligence cases, says hospitals must find a way of controlling the superbug or they will have to foot huge bills from patients who take legal action.

Full article here: http://icliverpool.icnetwork.co.uk/0100news/0100regionalnews/tm_objectid=14541624%26method=full%26siteid=50061%26page=1%26headline=superbug%2dtimebomb-name_page.html

WINS moved down to 6.25 pence on the bid, joining MLSB and SCAP. Level 2 is very positive now at 3 v 1.

Still think more larger buys will be coming again hence the price is not moving at the moment. No sellers at 6.50 pence for WINS so trying out a lower bid. WINS and MLSB upto something. Keep an eye out again for any larger buys again at 6.75 or 7.00 pence later today.

Small buys trickling in, as usual no sellers about at these prices. Level 2 still very positive at 3 v 1.

Last batch of T10 traders from 6 August when the NHS RNS was announced have to settle tomorrow, hence 3 MMs sat on the 6.25 pence bid, why pay them more when the T10s have to close their positions.

Level 2 closed very positive at 3 v 1.


Their presentation to the NHS is to try and get the message across to the NHS of the effectiveness of the Nightingale system which the NHS need to include along with other measures which they need to use to prevent the MRSA problems.As the MRSA problems can be overcome through tackling cleaniness in many ways the NHS need to include as many methods as possible as only one method will not prevent the problem totally.

"The Nightingale technology has been used by hospitals internationally and two units have recently been acquired by North Hampshire Hospital in Basingstoke. Ian De Bruin, Project Director of the Estates Department for the hospital explains how they are currently being used: "North Hampshire currently has two Nightingale systems, one of which is used in the haematology unit, in the area where chemotherapy is performed and where immuno-compromised chemotherapy patients are present. The second is currently kept mobile and may be used in any part of the hospital. We plan to later move the units and use them permanently in the new isolation rooms of the haematology and oncology units at NHH, which are currently under construction.
The systems were picked up as a preventative measure for immunocompromised
patients, to keep their areas as clean as they can possibly be."

for more info see http://www.energytechniqueplc.co.uk/pdfs/UVGI/case%20study2.pdf
It's very encouraging to see that this (NHS) hospital is already planning to retain these units and "use them permanently in the new isolation rooms of the haematology and oncology units at NHH".
Other NHS hospitals are very likely to follow suit in due course in my opinion, it's just a matter of time.

More US sales may follow suit as well :

NQ has been granted a period of exclusivity to 30 September 2004, to enable it
to explore opportunities for marketing the Nightingale unit in the US and
Canadian markets. The Nightingale was exhibited by NQ at a commercial trade
show in the USA in June where interest was very encouraging. The initial sale
in the USA of product using Nightingale technology was achieved in July 2004 to
the Northwest Hospital Center in Randallstown, Maryland.

Hampshire Business South :

Technology - We have the weapon to fight superbug

A HAMPSHIRE company claims to have developed a lifesaving weapon in the fight against the lethal MRSA superbug.

But bosses of Energy Technique Plc say no one in the NHS is interested, despite its potential to prevent heartache for families across the south.

They claim the innovative 6,000 ultraviolet light device will destroy the killer bug but NHS money-men have pleaded poverty, although their American counterparts snapped it up.

The superbug hit the headlines earlier this week when new government figures showed 300,000 cases last year, more than three times as many as initially feared.

As reported in the Daily Echo this week, the number of hospital-acquired MRSA infections at Southampton University Hospitals NHS Trust rose from 53 cases in 2002-03 to 62 in 2003-04 up 17 per cent.

Experts calculate hospital infections kill up to 5,000 people each year in the UK with Methicillin Resistant Staphylococcus Aureus (MRSA) a prime cause.

Called the NightingaleR Unit, the UV device passed tests at Basingstokes North Hampshire Hospital.

The hospitals Ian De Bruin said: The UVGI systems appear capable of dealing with many airborne pathogens on a regular or emergency basis, which is certainly important when dealing with patients with weakened or non-existent immune systems.

The system is an easily serviceable piece of kit, and you dont need to do major intervention in the room with it being moveable.

Leigh Stimpson, group managing director of the former Southampton company which employs 120 people, is disappointed by the NHS response. He said: It is very sad that this sophisticated equipment, which is on sale to the NHS, has gone first to North America.

It is costing the NHS 1 billion a year to control MRSA, and instead of spending money on trying to prevent it in the first place, it is being used to try and deal with it after it has got into hospitals.

A Department of Health spokesman said it was up to trusts to decided if a product like this was suitable.

http://www.nqsouthern.com/digitalpublication/digitalpublications/index.cfm?dpid=144&section_id=1122&article_id=2550

Im afraid sue this is typical of the NHS and the Goverments way of conducting Business.It simply proves where their priorty lies. They waste millions on war / illegal immigrants etc.If the local Hospital cannot afford a Nightingale then they dont get and patients continue to suffer.The goverment will only begin to take action when it becomes political. Public start to sue the NHS. I heard on the radio yesterday that a fairly famous sportsman had become infected with mrsa after a routine operation.

The NHS tried to impliment a new pay structue, employed a lot of new staff to get it working tried it in two hospitals found it would not work so they scraped it at cost milions to the health service.

Why are some people positve on one batch of boards but on an another company's they a re negative.?

firm offer now at 6.55p expect the bid to be lowered to 6p .

MM s just play with the punters

Level 2 closed at 2 v 2. I think WINS orchestrated the drop as T10 traders which I have highlighted about previously had to close their positions today. It was all buying until the afternoon and a large buy for around 147,000 shares also came through at 6.74 pence. WINS offered 6.00 pence to a seller of 100K shares and the offer moved to 6.75 pence. I think WINS did this to get the sellers out as sellers which they may have expected today weren't coming. Immediately, WINS moved back onto the 6.25 pence bid to collect all the stock that came from the sellers, not that there was much. In line with my previous posts at these prices again there were few miniscule sells even with these actions. Level 2 actually went positive at that point to 2 v 1 but the sells were still not coming and hence I think EVO moved onto the offer of 6.75 pence and after that Level 2 was 2 v 2. Though not even one sell came through thereafter after the last small sell at 4.10pm. Trades at 6.45 for 35K, 30 K at 6.49 pence were buys. In addition, WINS & MLSB have been filling the large buys over the last week and not suprisingly both them are on the bid taking in stock.

Mystified....one just has to look at how all the large buys have come through over the last week and the size of the sells.

We last saw similar actions in the last hour prior to the buy note that came out from Evolution Beeson Gregory and day before when the NHS RNS was released.

I am holding onto all of mine, the NHS presentation is less than 2 weeks away now.

Investtech Analysis after today's close :

Positive Candidate (Short term) - Aug 19, 2004
Has broken through the floor of a rising trend channel. This indicates a slower rising rate at first, or the start of a more horizontal development. The stock has support at p 5.10 and resistance at p 7.00. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This weakens the trend break. The stock is overall assessed as technically positive for the short term.

Neutral (Medium term) - Aug 19, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. The stock has resistance at p 8.70. The RSI curve shows a rising trend, which is an early signal for a possible trend break up. The stock is overall assessed as technically neutral for the medium long term.

------------The RSI curve shows a rising trend, which is an early signal for a possible trend break up. This bit is new and has appeared after today's close

Weak Positive Candidate (Long term) - Aug 19, 2004
ENERGY TECH. ORD 1P does not show any clear trend. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock is testing the resistance at p 6.80. This should give a negative reaction, but an upward breakthough of p 6.80 means a positive signal. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which strengthens the stock. Trading volume has increased substantially lately. This shows there is an increased interest for the stock, possibly because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

----------- but an upward breakthough of p 6.80 means a positive signal. This bit is new as well after today's close.

Sue , whats 4.95p x 40% ????

Liar.

Dil, why are you always attacking Sue Helen, is it an obsession?.

cheers GF.

Cos she lies and avoids answering any direct questions in my experience gf so fair game as far as I'm concerned gf.

My turn now , why are you always defending her when you know the above statement to be true ?

Have a good day , catch you in morning.

Just cant see what you find so wrong with her stock picking. Ive always found it to be first class.

Sure your not jealous?.

cheers GF.

Which bit of my previous post did you not understand gf ?

Hey Dildo head,

why dont u look at Sue stock picking choices.... she always stated when she is in and when she is out of the stock. i dont know where u get she lies. Advise: leave this thread

As one of her side kicks you wouldn't really would you.

What a load of tripe Dil, pretty sad.

More large buys : Large buy for 154,000 shares has just come through from an hour ago at 6.45 pence. WINS moved back onto the bid after that. Level 2 at 2 v 2.

Which bit Sue ?

And as I have nothing against this company , on the face of it they don't look bad , I will stick to the QTR thread as you asked so nicely xmortal.

good riddance

sh why is the price down to 6.5 buy price,has mms got to much stock they cant rid of? cheers woodie

Dil come on please be more positive. All you seem to do these days is be a board critic.

I remember a few years back on the competitors premium board where you gave some cracking tips. As the skill deserted you? I dont think so.

cheers GF.

Dil - Squelch.

Hi Woodie, Level 2 is positive again at 2 v 1, though the spread is tight at 6.25-6.35 pence. Trades at 6.35 pence are buys. I think this activity relates to my post the other day when I mentioned that MLSB has stayed open until 5.15pm and the following morning all the MMs had changed their quotes with WINS and MLSB who have been filling the larger buys on the bid. Level 2 is positive at 2 v 1 with EVO on the offer, who could be supplying stock to WINS & MLSB to fill the larger buys. With level 2 at 2 v 1, the next tick will be up but I don't know when rather than a tick down.

Level 2 is positive at 2 v 1

Online (Comdirect):

Can sell 100,000 shares at 6.28 pence

Can buy 160,000 shares at 6.35 pence.

sh thanks for early post why the tight spread,is it because of low vol in stock?cheers woodie

Hi Woodie, i've not really got an idea but the larger buys keep coming in.

Another large buy reported for 150,000 shares at 6.35 pence. Third 150K buy in the last 24 hours.

Followed by a 100,000 buy at 6.35 pence. The 50K trade eaaier at 6.35 pence is also a buy.

And there we go, gone blue with 7.00 pence on the offer.

Its happening, 6.5 pence on the bid now on no buys at 7 pence. Level 2 at 1 v 2 with WINS on the 6.50 pence bid. WINS are the ones who have been filling the larger buys over the last 2 weeks.

Excellent close at 6.50-7.00 pence, up 3.85%. No sells again today of any note worthy but 3 large buys came through.

Actions by the MMs over the last 2 weeks have been orchestrated.

In addition, the price had to rise past 6.68 pence mid re : my Investtech post last night which gives a positive signal which we have done with the mid-price closing at 6.75 pence.

Contrary to what is says on the trades page the actual trades data for today was :

Buys = 568,623
Sells = 141,168
????? = 7,000.

thanks suehelen, thought something wasnt quite right!

Investtech Analysis after today's close :

Weak Positive Candidate (Short term) - Aug 20, 2004
Has broken through the floor of a rising trend channel. This indicates a slower rising rate at first, or the start of a more horizontal development. The stock is approaching the resistance at p 7.00, which may give a negative reaction. Volume tops and volume bottoms correspond well with tops and bottoms in the price. This weakens the trend break. The stock is overall assessed as technically slightly positive for the short term.

Neutral (Medium term) - Aug 20, 2004
Is within a falling trend, which indicates a continued decline. The stock has resistance at p 8.70. The RSI curve shows a rising trend, which is an early signal for a possible trend break up. The stock is overall assessed as technically neutral for the medium long term.

Neutral (Long term) - Aug 20, 2004
Is within a falling trend, which indicates a continued decline. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock is testing the resistance at p 6.80, which may give a negative reaction. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically neutral for the long term.

--------Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. This bit is new after today's close.

Dil
the only thing that bugs me about SH is his/her tendency to post every trade along with remarks suggesting 100k s are big buys.but i can live with that because L2 info along with charts and other info is invaluable..

other than that this thread would be dead without the input. i have no interest in this share other than as a trading opportunity. the technology in my view should be redundant.

keep posting SH ( dont take my minor criticisms to heart )

You should read all of my posts since 26 July 2004 and see why I post trades data but not every trade as you seem to think Superrod. And why I labelled the 100K buys large...
Without myself posting the online limits, there is no where most would have known that the 150K and 100K trades at 6.35 pence were buys on Friday afternoon, more hints with reasons earlier in the thread.

A reply from Leigh Stimpson regarding the article in Hants Business magazine posted here during the week.

Dear...

Thank you for your communication and concern. Please let me confirm that the article in question is not remotely accurate.

We are moving ahead with the NHS albiet not as fast as we would like, but never the less we are making positive progress.

It is sad that our first Nightingale sales have come from the United States but again this is positive progress.


Kind regards
Leigh Stimpson
Group CEO
Energy Technique

Noticed the word SALES from the US in the reply. If taken as is stated in the plural that means more than one. They could well have had more sales in the US since the first product sale. I suppose they can't announce a RNS on every sale. The first one was a landmark so it had to be announced via a RNS.

Gone quiet on here today!!! let the chart speak (as usual)

Hi Snip, what is it with you, as I say always keep an eye on the offer price. Double tick down on the bid so what the offer price hasn't come down. The price is just consolidating at this range whilst we await further news. The price has been able to hold between 6.0-7.0 pence for the last 2 weeks in the absence of news which is quite good with the price building a base at this level.

You're trying to tell me with your fancy chart that you have posted that with the NHS presentations next week, and just because a tick down is showing on the chart that all is doom and gloom. Why did you not post a chart here on Friday when it was showing a tick up for that day.

This is strange, but your stock that you recommended HSD has fallen 20% on Friday and a further 37% today and you still have not updated the vulnerable investors as to why. You have not posted any news which came out last week and today, just postings of your fancy charts as usual. I've told you before as well, you look at news first then charts. Massive falls, and you expect HSD to be 200pence in a matter of weeks from today's close of 44.00 pence.

NHS Presentations on Wednesday 1 September 2004 (Next Week).

Quote of the Day :
Close at 6.00-7.00 pence, Offer price still not coming down from 7.00 pence

"Always look at the buy price as an indication as to what folks would have to pay to get a slice of the action".

Another change on Investtech Analysis after today's close :

Short term has been upgraded to POSITIVE CANDIDATE from Weak Positive Candidate (see my previous Investtech post).

Positive Candidate (Short term) - Aug 23, 2004
Has broken through the floor of a rising trend channel. This indicates a slower rising rate at first, or the start of a more horizontal development. The stock has support at p 5.10 and resistance at p 7.00. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. This weakens the trend break. The stock is overall assessed as technically positive for the short term.

Neutral (Medium term) - Aug 23, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. The stock has resistance at p 8.70. The RSI curve shows a rising trend, which is an early signal for a possible trend break up. The stock is overall assessed as technically neutral for the medium long term.

Neutral (Long term) - Aug 23, 2004
Is within a falling trend. Continued negative development within the trend channel is indicated. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock is testing the resistance at p 6.80, which may give a negative reaction. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically neutral for the long term.

Hi Sue Helen glad to see you rid of Dilbert. He can really be a pain at times.(nice lad really)

Please keep in touch and let me know how you are going on. You look to be in prime form a bit like our 'Kellie Edwards' well done lass, your a tribute to the nation and you also saved me 500 quid when I said this teatime no British athlete would win a gold medal, PHEW. Thank god they didnt have the balls at the bar.

cheers GF.

Tick up on the bid today back to 6.25 pence on no buys.

EXCUSE ME SH. I did tell readers that HSD is a risky stock (I do assume that you can read even though your writings are very selective ie RAMP style)I sold HSD at profit again and am preparing to re-enter however that has nothing to do with this thread

RAMPING does not pull in discerning buyers by the way

Now a chart cannot lie and this is a super example of a downtrend still in formation

But you were saying that when I got in at 4.95 pence as well, if I followed your advice and not looked at the 2 news releases then 40% gain would have been lossed by myself.

Rewind back, another new chart today, why not post the same one as yesterday. Is it because for today there is a tick up at the end.

Your regular posting of the charts is becoming amusing now.

Look at newsflow first Snip.

ok a shorter time-scale chart curtesy of moneyam facilities for the discerning and knowledgable investor (ie not for sheep who are easily led by rampers)

note the ROC (rate of change) it is showing negativity

The below chart is the one you posted yesterday, why not post the same one :



Look at the nice uptrend since I first got in on 27 July 2004. The price is on the verge of a breakout above 6.50 pence. What you do Snip, draw a line from the top and one from the bottom and you'll see a big wedge forming.

.

Snip, your recommended stock HSD is down 70% in the last 3 trading days, if I had followed the same procedure as you and just look at the nice uptrend you were boasting about a day before the slide I would have been looking at a hefty loss. Now your recommendation HSD has to be the biggest ramp of the decade, no updates on newsflow or anything, just fancy charts. Now you say you sold out at a profit, why not post that on the HSD thread. I always when I buy and sell giving reasons. I suppose the 200 pence in a matter of weeks is for the bin men to collect now.

oh dear we are clutching at straws here

unfortunately that last tick did not take the graph over the 10MA and a downtrend line is still very much in place. Then again only 115k shares were bought today at an approx cost of 8050. I recollect you saying that you have a lot more shares than that. So keep clutching

No Snip, it's you who's been clutching straws here since 27 July 2004. One month on and I'm still waiting for the price to fall. Please remind yourself of that.

and in the meantime is your money making money?

well mine is

but then again you have to know how to trade

I would be grateful if the two bickering children on this board would stop

Stop competing for best/ worst ramper/investor/slanger


Keep posting your opinions and let the other readers make their opinions on the basis of your history and the level of your information in our own opinion

I make no judgement in my post and show no bias but this board has not been and nor would I want it to become a cheap slanging match like too many others

It has been civilised and informative for a long time and I would hope it can stay that way.

May I be so bold as to offer a cease fire so we can concentrate on the company's prospects rather than our personnal investment abilities.

I do not put words into others mouths(fingers?) but i feel there may be support for my views in this matter

thankyou

GN

ok ceasefire in action from me. Thank you GN you are right. Apologies for letting certain things get to me

no more postings

(and no more charts and analysis)

New Market Maker joins today :

Jefferies Intl Ld (JEFF)

New market maker JEFF on board today. 5 Market Makers in ETQ now.
A new MM on board is good news, maybe because of more investor interest will be coming in the distant future, I think the price has consolidated well here, we have to wait for news to move pass the golden 6.5 pence mark now. Yes the price has not been doing much for the last 2 1/2 weeks but its the first time looking at the chart of ETQ that the price has not really been falling as well in the absence of news and has hold onto its gains from its lows of 5 pence (buying price of 5.00 pence). As always keep an eye on the offer price.

well im out for now. my modest 10k sell knocked 0.25p off the bid and so far it hasnt recovered.
i will no doubt be back and being the nice guy i am, i wish all holders good luck.

As often happens a share price is moved by hype & not by profits.

The floor standing units only protect 1 room & are too expensive see link

http://www.moneyam.com/InvestorsRoom/ShowPostList?fID=1&tID=1108&from=38&to=38

ETQ is an ordinary, unexciting air conditioning company & UVGI is an infinitesimally small part of their business because it has hardly started yet.

The floor standing units are not where the profits are going to come from because they are not cost effective.

IF ETQ wins contracts to fit UVGI aircon systems to whole buildings then they will make BIG MONEY but I see no evidence that they are making progress on this.

The lack of decent profits & the issuing of new shares are the reasons it has fallen from the previous spikes of 28p & 15p.

Comments have been made on this thread about UVGI being a solution to MRSA but it isn't.

MRSA is mostly spread by physical contact so handwashing is the most effective way to prevent the spread because obviously no air treatment system is going to clean people's hands for them.

Many people carry MRSA in their throats & so they get it on their hands when they touch their lips.
They touch doorhandles & pass it on to other people who touch the handles so hospital cleaning is the next most effective way (after handwashing) to prevent the spread.

Very few people cough over an open wound & UVGI is not going to stop them.

UVGI can help with airborne viruses & bacteria sooooooooooooo IF ETQ wins contracts to fit UVGI aircon systems to whole buildings then the share price will rocket & over react & some of that rise will be sustainable.

BUT will it ever happen?

So far all we have got is hype on message boards with no evidence that big profits will emerge this year or next year & the current aircon business which at the moment is the business looks a little shaky judging by their track record.

I suppose that we will get more spikes each time there is some news & you might make a profit out of a spike if your timing is just right but as usual someone else will lose by buying at a high part of that spike.

I suggest that the real purpose of the floor standing units is to demonstrate the technology so that ETQ can win big contracts to fit UVGI aircon systems to whole buildings this is the key thing to look out for. If I see evidence of this then I will buy but so far I haven't.

Even if it does happen, don't expect the profits to be delivered this year or next.

its all gone quiet at the back

Has it, I wouldn't think so especially with the new MM on board today. NHS Presentations are only a week away now (next Wednesday).

nice to see you back apple

Thanks Global Nomad,

I've been away, it rained
but that's ok because it was warm & I had an umbrella.

theres a familiar feeling beginning in my head.....

and its not one I am particularly fond of....

unfortunately it seems to be the one I am more frequented by.


we seem to be in a historic pattern, waiting to break out, strong rise gentle drift down.

GN

Am out of these at present, If 6p fails look for a move back to 5p. MM s trying to move these back to pre announcement of talks.

market taking view that talks next week will be prolonged with red tape within nhs.

AQL tomorrow

two 300k buys just gone through!

dont think so...........rollover

considering talks are 1 full trading day away not much buying?

thats an understatement

whats on level 2 sue?

the only problem with etq is that they are trying to charge people/patients for what they have never been charged for b4 / ie TO BREATH FRESHER AIR/OR CLEANER AIR, personaly i think this product will boom in the states and the east but us old fashion uk folks will find it a bitter charge to face, but once we see how fashionable this product is worldwide then as usual the uk will follow ,this is just an opinion

dunker50
agree,the way this government works. when they do latch on and take the plunge to buy the nightingale systems, they'll probably put them in offices to protect the administrators that cost us billions!

funny how people stop posting as soon as the sp turns sour.


Today is the NHS presentation which may or may not start some news flow.......

When is the NHS presentation today.

it has nothing to do with price sh is main poster on this thread must be on hols

what makes you assume sue is on holidays ?.......

maybe you are unaware of this posters history.....very good information and i'm happy to be party to it, but a habit of posting very frequently and then disappearing for long periods when things don't pan out. Normally SH does tell fellow board members her position as she has here, I assume she is still holding and is waiting for something to say.

GN

SH does post interesting stuff about charts but she can't be right all the time.

This share spikes on news but then the down trend continues for financial reasons. See chart & news dates & previous posts.

However, keep your eye on ETQ. Things will change if it gets contracts for whole building aircon systems WITH UVGI.

I have just purchased 60,000 etq at 11.15 but they are shown as a sell, can someone tell me why they do this?

Shares are not reported as a trade or a sell. The MoneyAM algorithm calculates from the Bid and Offer if the transaction should go in the Sell or Buy pot, quite often the calculation is incorrect.

Rgerads

PTH

quiet thread lately




if 5 holds and it bounces up then there `may` (not a word I usually use) be a double bottom. Otherwise look to 4 to hold

Back to 4 & maybe below until the next piece of hype.

maybe is not a word I would use and I certainly wouldn`t hype. Just charting facts for me. ie a bounce off 5 is good depending on volume of course. There is a bullish tail on today`s candle so far (realtime charting system)

I have just been looking at candle volume. Candles which also show the volume in the candle and the candle today is very very thin ie it has moved on very small volume so the move today is pretty meaningless. I would not throw the baby out with the bathwater today

oops, I forgot, I did say that I wouldn`t post any more

bye all

please keep posting....

just in a measured way - thats all that was asked.

GN.

it was off 13% earlier down to 4, but seems to have recovered, temporary or not lets see.

Still not looking too good but you never know, there might be another temporary spike again soon.

yes but down heading for 4p

not necessarily momentum. We could be seeing consolidation ie a base forming.Daily Candle volume says that this downwards movement is happening on thin volume and weekly CV is simply range trading. Directional movement ADXR is in an obvious coil ie sideways. OK so 4 is too big a loss if you have 200k shares at 6 ish pence but the signs were there in the charts

if you believe in the company then this could be a speculative (if boring) buy

Some positive news on ADVFN...

BMW , is this wait you were referring to?

also With thanks to limescale on ample

who gave credit to

MBDRIVER over on ADVFN

http://www.thisishampshire.net/hampshire/archive/2004/09/17/BASINGSTOKE_NEWS_BUSINESS23ZM.html

full article below - not in particular the references to sales


First published on Friday 17 September 2004:


Nightingale joins fight to eradicate superbug


by Liz Woodford


A BASINGSTOKE company has developed an air filtration machine to kill the MRSA hospital superbug that claims thousands of lives each year.

But despite the breakthrough in technology, Energy Technique is finding sales in the UK tough going when faced with a National Health Service that is strapped for cash.

Only this month Leigh Stimpson, managing director of Energy Technique, who lives in Basingstoke, addressed a health commission in Ireland, which is looking into the superbug crisis.

The Irish meeting brought Mr Stimpson into contact with NHS chiefs and members of the public to get across the message that the Nightingale filtration unit has been shown to be 99.8 per cent effective by the Health Protection Agency at Porton Down in Wiltshire.

Mr Stimpson said: "This marked a welcome advance in our efforts to make contact with influential opinion-formers and decision-makers within the NHS."

He heads up a PLC group that has a 14million turnover a year and over the past four years has spent nearly 1million developing the Nightingale. Another 3million was raised in the city a few months ago for Energy Technique to forge ahead with its commercial development.

Nightingale uses ultraviolet radiation combined with sophisticated air-flow systems to attack the DNA of killer germs such as MRSA, anthrax and TB.

The units cost between 6,000 and 10,000 each and sales are starting to go well in America.

Now the American Defence Department is also showing interest which could result in an order of up to 500 units.

Mr Stimpson described the cost of a Nightingale unit as almost negligible compared with the cost of a life.

One unit cleanses the air in a ward of six beds, but he said it can only work effectively alongside properly-scrubbed wards and routine hand-washing by hospital staff and visitors.

Basingstoke hospital is to have some of the first Nightingale units in the country.

Mr Stimpson has donated three units and air conditioning worth 40,000 to the new oncology ward being partly-funded by the Elizabeth Hall Trust.

Mr Stimpson was full of praise for Basingstoke hospital chiefs.

He said: "They are taking the controlling of infection seriously."

Nightingale is manufactured at Energy Technique's factory in Surrey and distributed through a warehouse off Lister Road in Basingstoke.

The company has had a distribution centre in Basingstoke - where it employs 20 people - for three years. It expects the headcount to rise to 40 throughout the next year as it is doubling the size of its distribution operation on the same site.

As he fights to take Nightingale into more UK hospitals, Mr Stimpson said: "The growing threat of MRSA in our hospitals is an issue that affects everybody."

could anyone tell me if there are symptoms for MRSA?
if there are what are they.
thanks.

alderleyedge

It depends where in your body you get infected with it.

If you get it in a cut, it can kill you.

You could just get a sore throat.


Handwashing is the best defence against MRSA

The ETQ system is not really relavent to MRSA

Click here for BBC Programme info

Every time I have predicted that the downtrend on this share will continue it has. The downtrend is occasionally interupted by spikes because people don't understand MRSA or that this product is a way of levering their full scale aircon systems with UVGI into the market.

Mr Stimpson of ETQ is talking nonsense hype his product.
I think he is managing director but he sounds like a typical salesman to me.

cheers apple

Glad that you found it useful.

Apple

I am given to understand that a high percentage of dust is produced by discarded skin particles, so therefore if those particles are infected with MRSA then at some point those skin particles will be airborne. IMHO.

BMW You are clutching at straws.

If dead skin flakes are not dry then they stick to the body.
Discarded skin flakes are too dry to support MRSA so it won't survive long enough to have any significant probability of infecting a wound.

An unwashed hand can immediately transfer millions of bacteria to a wound.
A slightly sweaty hand can contaminate a doorhandle that may not dry out for an hour or so. Many people can then pick up millions of bacteria by touching that handle & then touch a patient.

Many people carry MRSA in their nose & throat without symptoms & don't sneeze until they get a cold as well.

When carriers touch their nose or mouth then they get MRSA on their hands & spread it.

UVGI will not help with handwashing.
UVGI will not stop people coughing or sneezing over a patient.


UVGI would be useful to stop airborne diseases spreading from 1 room to another, that is why the Nightingale product is mainly a technology demonstrator that may leverage ETQ into contracts for whole building aircon systems with UVGI technology.

The Nightingale product could be used to isolate people in a plastic tent where nurses work on them from the outside but I don't think that happens very often.

To prevent MRSA, wash your hands & clean the urine etc from the floor, beds etc.
Clean all surfaces because people keep touching them.

Apple you appear to be suffering from tunnel vision as there is more than one way to skin cat...do some homework.

BMW

Just what point were you trying to make with those cliches?

If everyone stops talking only about MRSA as if its the only airborne pathogen out there then we may get some measured responses. The nightingale unit effectively deals with airborne pathogens including MRSA -when airborne - and is effective at cleansing the air in a whole room/ ward hence reducing the risk of transmission betweeen patients/patients and staff/patients.

that is the point.

the hospitals need a multi layered approach to dealing with hygiene, cleanliness/ washing etc are the fundamental part that seems to have fallen away in recent years. The next level is with proper disinfection and ultimately with air cleaners - either local or whole building, preferably both operating at differing intensities to provide solutions at all levels. There is not a single answer to any major problem and unfortunately most arguements tend to be fought in a black and white way ( either or) rather than in a pragmatic rational way.

The huge cost and disruption in altering an exisitng air con system in a major building will prevent anything but small upgrades for most projects, in these mobile units make sense, in new buildings of which the NHS are embarked on many there is more scope for installing whole systems from the start, though this is unlikely to be altered by the time we see buildings under construction. There may be several years of planning design and tendering prior to that stage. Whole air systems will probably only appear in the next 2 or 3 years in projects which still are flexible enough.

Once again the nightingale unit comes into its own as an intermediate step.

in addition every large doctors surgery / clinic should have one ( where there is no overall ac system)

etc etc

GN

BMW and Globalnomad. Absolutely correct. MRSA is but one pathogen. TB is spread by airbourne droplet for example. Dust is indeed, mostly, skin cells. I totally agree with apple re handwashing but bodywashing is also important. Dust can settle in the nose and then a sneeze will propel mucus plus skin cells ie they become airbourne and so air does need to be filtered and particularly in places where people are vulnerable and not just in hospitals. Old people`s homes, London tubes etc

Once the pathogen becomes lodged in the body then it can make its way to sites where it can become problematic

No one interested in the politics of this situation? If this government can be seen to be taking positive steps against what is becoming a major issue in the Public's eye, then they will buy anything, working or not.
regards

I don't think anyone is in any doubt that the product works. The suitability and application are also being proven but may be something that requires more consideration.

The real problem will be the authorities/institutions not buying this product exactly because they buy something (cheaper) that is not effective and hence the whole market gets negative when there is no improvement. I think, tigger, you should be hoping that the powers that be are directed in the right direction and take proper time and measures to acquire the right equipment - both for our personal investment reasons and the wider health of the population.

GN

Apple

Read carefully...

http://www.crp-bangladesh.org/specials/mrsa.htm

AGM STATEMENT AT NOON TOMORROW.ANY VIEWS?

at market waiting for update re nhs talks if this is not mention more selling.cheers woodie

just as i wrote this morning no news on nhs, selling kicked in.up then down bearish tone still dominent.cheers woodie

some seriously pissed off comments over at ample.

patience is being tested.

not even sufficient positive spin to keep up any hopes. Poor PR

promises promises. No further sales or agreements could be accepted if there was more info on how they are pursuing these, the steps they are having to go through or some timescale to their expectations.

GN

There was hype about MRSA but UVGI is not a solution for MRSA.

NHS has other priorities.

UVGI would be useful on aircraft to SLOW the spread of Bird Flu which could kill more than the 1918 Flu epidemic that killed 40Million

BUT there is no sign that it will be taken up.

Well, here we are near 4p again.

Will ETQ come up with a strategy to make money out of UVGI technology?

or will it fall through 4p?

Any views on the 1,000,000 share trade this afternoon. Sell or Buy? At 3.75 it looks more like a sell, with the bid at 4.25 and offer at 4. However no affect on share price at all. I know it 'only' represents 37.5k but it does stand out like a sore thumb. Its also surrounded by sells today although small bits and pieces.

GN

There was also a "buy" of 1,000,000 @ 4.20 at 16.39, was this a coincidence or am I missing something obvious?

Signed a distributor.

I see that they are still trying to kid people that it is the solution to MRSA even though it is not much use for that bug.

http://www.moneyam.com/action/news/showArticle?id=498681

apple - you are partially correct. The Nightingale system is designed to kill 99.8% of all airborne viruses and bacteria, but the greatest means by which MRSA spreads is through direct contact with infected surfaces due to poor hygiene within hospitals. That said, MRSA can still spread as an airborne bug. But lets not worry about the hype. If the share price rises on misdirected information then I'm happy with that.

as a very modest shareholdr, i agree with apple. im only in the share because of potential commercial activity. NOT because i beleve in the products. i have been saying for months ( elsewhere )that simple hygiene is all that is required. the trouble these days is that when a problem appears ANYWHERE, a huge entourage appears with all kinds of technical solutions. when confronted by such dilemmas i remember a "space age" problem.

astonauts needed to write in space, in zero gravity, upside down, etc. america spent hundreds of millions of dollars deleloping a suitable pen.

the russians used PENCILS.

i partly agree about containing the bugs through hygene,but if they are becoming resistent then the ultra violet will at least do the airbourne job,where as the cleanseness would not always work,

Airborn spread of MRSA is sooooooo unlikely that there is no point in buying UVGI systems for it.

The only danger of airborne spread is coughing or sneezing over an open wound & no gadget will catch those bacteria in mid air.

Just ask your local hospital, don't take my opinion or that of anyone anyone else on a message board.

UVGI is a useful technology but not for MRSA.

The current portable product would be very usful for a mobile operating theatre as long as it was piped into it to cause outward airflow.

No sign yet of such an application.

The movement of airborne infections is far more complex than you think. Colds and flu are predominately spread through the air and are very common among society, simply because it is a very easy and efficient way for a virus to spread.

Bacteria and viruses spores dont just fall to the ground when you breathe. Although invisible to the naked eye, just walking through a room swirls the surrounding air and heat thermals from electrical appliances and heaters constantly keep air movement circulating.

The use of an extraction or circulation system utilising UVGI would have a positive impact on the spread airborne infection.

True bradleym

but not MRSA

As for Colds and Flu, spending money in other ways eg Flu jabs can have a much bigger impact.

This is some good news as IMO a company with an annual turnover Euro 500 million the FlaktWoods Group has the clout to give Nightingale market penetration over a large global presence!

Energy Technique PLC
04 November 2004

Energy Technique PLC ('The Company') is pleased to announce the signing of a
major distribution agreement between its subsidiary company, UVGI Ltd., which
manufactures the award winning Nightingale air filtration product, and
FlaktWoods AB of Jonkoping, Sweden, part of the FlaktWoods Group of Zurich,
Switzerland.

The deal gives FlaktWoods AB the rights to distribute the Nightingale and
related products in Scandinavia.

Energy Technique Chairman Gerard Thompson said 'This distribution agreement for
the Nightingale is a real breakthrough for the Company, and marks a further
important step in our drive to market the unit to counter the threat of the
hospital superbug, MRSA, and other dangerous germs. FlaktWoods is highly
regarded in the industry as innovative and creative. We are confident that,
over time, this relationship will develop into an important driving force in
specialised air handling in the UK and Europe.'

The Nightingale uses a combination of high intensity Ultra Violet Germicidal
Irradiation (UVGI) and airflow to destroy the DNA structure of harmful airborne
germs such as MRSA, anthrax, tuberculosis, and flu. It is already in use in a US
hospital, and has been installed for trials with a UK NHS trust. Tests at the
Porton Down facility of the Health Protection Agency have shown it to be more
than 99.9% effective.

FlaktWoods Group is a world leader in ventilation and air handling. It has a
complete 'product portfolio' covering virtually every function within an air
handling system with specialized products for different application areas.

With an annual turnover of Euro 500 million, the FlaktWoods Group has
manufacturing and engineering operations in Sweden, Finland, UK, France, Italy,
Belgium, Poland, Russia, Dubai, India, Korea, Japan, Australia and in the
Americas.

It employs 3,200 worldwide and has operations and representation in some 95
countries. Over 200,000 buildings use its air handling units, including some
300 hospitals.


This information is provided by RNS
The company news service from the London Stock Exchange

Airborne transmission is known to be the route of infection for diseases such as tuberculosis and aspergillosis. It has also been implicated in nosocomial outbreaks of MRSA, Acinetobacter spp. and Pseudomonas spp. Despite this there is much scepticism about the role that airborne transmission plays in nosocomial outbreaks. This paper investigates the airborne spread of infection in hospital buildings, and evaluates the extent to which it is a problem. It is concluded that although contact-spread is the principle route of transmission for most infections, the contribution of airborne micro-organisms to the spread of infection is likely to be greater than is currently recognised. This is partly because many airborne micro-organisms remain viable while being non-culturable, with the result that they are not detected, and also because some infections arising from contact transmission involve the airborne transportation of micro-organisms onto inanimate surfaces.

Although most nosocomial infections are associated with person-to-person contact, it has been estimated that the airborne route of transmission accounts for between 10% and 20% of endemic nosocomial infections (4). However, with the exception of tuberculosis, where the airborne route of infection has long been recognised, the contribution made by airborne pathogens towards nosocomial infection has often been underestimated. Despite this, it is now recognised that a number of nosocomial pathogens, including Aspergillus spp., Acinetobacter spp and MRSA can be transmitted by the airborne route.

Infectious microorganisms can enter the air by a variety of routes. They can be violently dispersed into the atmosphere as respiratory droplets/droplet nuclei through sneezing or coughing, or released into the air on skin squamae which are continually shed by room occupants.

Other activities, such as bed making, release large quantities of microorganisms into the atmosphere. In one study, it was found that the airborne bioburden in a patient room exceeded 6000 colony forming units per cubic meter of air (cfu/m3) during vigorous bed making (5).

thanks Chunki,

apart from the need for a glossary I think thats clarified things very well.

Wahtever people think of individual pathogens and how they are spread the fact remains that a huge number of infections / illnesses/ deaths are caused by airborne pathogens of a huge variety of forms and these need to be dealt with/protected against.

Now, I wonder when someone will invent a suitable gismo........


GN

suehelen eat your hat!!

I hope you feel guilty ramping these shares